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Abstract
Computed Tomography (CT) is an x-ray imaging technique introduced into
clinical practice in the early 70's and is now considered an essential element in
radiological imaging.
Notwithstanding the undoubted benefits of CT in health care, growth of the
techniques has taken place without full appreciation of the relatively high patient
doses involved. A national survey carried out in the UK in 1989 indicated that while
CT represented about 2% of the total of all x-ray examinations, it accounted
disproportionately for 20% of the resultant collective dose (Shrimpton et al. 1991).
Recent studies (Shrimpton et al. 1993) suggest that CT may now represent about a
third of the collective dose from diagnostic x-rays in the UK. There has been a similar
proliferation of scanners throughout the world, such that the average frequency of CT
examination in developed countries has been reported to be about 10 per 1000
population (Shrimpton and Wall 1992). Therefore CT practice is causing significant
concern and based on the ALARA principle and other advisory bodies'
recommendation (NRPB 1990), the doses to patient from this x-ray modality should
periodically be monitored and kept within guideline doses.
The most common CT dosimetry approaches are standard method, Monte
Carlo (MC) method and direct method. In the standard method CTDI is assessed
inside a head and a body perspex phantom giving an index of the CT dose efficiency.
This is used mainly for QA purposes. In the MC method the patient doses are
estimated by applying this mathematical technique to simulate the interaction of CT
generated radiation with matter inside a mathematical model of phantom. In the direct
method, measurement of organ doses is carried out directly inside an
anthropomorphic physical phantom.
We have developed the direct method by assessing CT axial and longitudinal
dose distribution in an anthropomorphic phantom. Measurement of these dose
distribution for any scanner allows us to quickly measure organ doses and effective
dose, and hence patient doses for any examination protocol with a limited number of
IV
TLDs. This work describes the underlying principles and assumption of the direct CT
dosimetry method we have developed and implemented. In addition the review of CT
dosimetry provides a comprehensive and critical analysis of the methods developed to
date. All dosimetry related concepts for the developed direct technique are
considered. Comprehensive dose measurements were carried out to estimate the level
of error involved in the developed approach. The MC approach was also used to
compare the results of our proposed direct method with this commonly used method
in CT dosimetry for routine examinations of some scanners.
The proposed direct CT dosimetry method has now been used for several
scanner models. The developed dosimetry method has been successfully implemented
to assess the radiation doses resulted from various examination protocols using the
recent modern CT modalities, that could not easily be investigated by other dosimetry
approaches. We believe that the developed direct CT dosimetry approach overcomes
many limitations imposed by other common approaches. It also provides a reliable and
practical method for the assessment of patient doses from CT practices for a wide
range of scan protocols. Another major advantage of the developed direct dosimetry
method is that, it could easily and independently be adapted and implemented for any
upcoming new model of CT scanner to be introduced into clinical practice.
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Computerised Axial Tomography or more briefly Computed Tomography
(CT) is an X-ray imaging technique providing excellent radiographic contrast between
soft tissues and high quality clinical information for localised planes within the body.
This revolutionary imaging technique was developed by Sir Godfrey Hounsfield and
was introduced into clinical practice in the early 70' s. The first commercially available
CT machine, the EMI brain scanner, was installed in London in 1972. Over nearly a
decade a large number of CT systems were introduced into the market being more
than twenty models from over ten manufacturers (Speller et al. 1981a). The number
and diversity of types of scanners continued to increase and about ten years later the
National Radiological Protection Board (NRPB) of the UK reported that around 220
scanners, comprising 39 different models from 10 manufacturers, were operating in
the National Health Services of this country (Shrimpton et al. 1991a). There has also
been a similar proliferation of scanners throughout the world, such that the average
frequency of CT examination in developed countries has been reported to be about 10
per 1000 population (Shrimpton and Wall 1992).The modality's explosive growth is
also illustrated by the fact that approximately 2.2 million CT studies were performed
in hospitals in 1980, only seven to eight years after the first commercial CT units
became available (Bunge and Herman 1987). CT is now considered an essential
element in radiological imaging. CT has replaced some other diagnostic techniques,
often of a more invasive nature, some associated with a high morbidity or even
mortality. Many of these also involved considerable patient exposures. Although this
technique is proposed more in the diagnosis, it is also used in radiotherapy planning
for the treatment of cancer and other pathological conditions and has allowed
significant advances in good patient care. For example, about one third of scanners
operating in the UK in 1989 were utilised in the planning of treatment for patients
having radiotherapy (NRPB 1992).
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There has therefore been a world-wide proliferation of scanners over the last
25 years, with the number in clinical operation in the UK rising steadily -and with no
apparent sign of saturation- to around 200 in 1989 (NRPB 1992).
Notwithstanding the undoubted benefits of CT in health care, growth of the
techniques has taken place without full appreciation of the relatively high patient
doses involved.
1.2 The Significance of the Radiation Dose Associated with the CT
An assessment of diagnostic radiology in the UK for 1983 indicated a total of
about 35 million medical and dental X-ray examinations with a collective dose
equivalent from conventional procedures of 15500 man Sv (Shrimpton and Wall
1986). Although there have been changes in practice since 1986, it is still judged that
the collective dose from conventional techniques remains unchanged at 16000 man Sv
approximately (Hughes and O'Riordan 1993).
The estimate of collective dose given above does not include a contribution
from CT. A survey recently carried out by the NRPB in collaboration with the
Institute of Physical Sciences in Medicine (IPSM)1 shows that in the UK 2.4% of all
medical and dental X-ray examinations involve CT (Shrimpton et al. 1991b). The
collective effective dose equivalent from the 200 CT scanners operating in the UK
during 1989 is estimated at about 4500 man Sv.
The overall collective dose from diagnostic radiology is the sum of those from
conventional and CT examinations. There is some uncertainty in combining data from
different periods of time because techniques of radiology continue to evolve and
usage changes. Nevertheless, a rounded value of 20000 man Sv would seem to be
appropriate as a revised total annual collective effective dose equivalent from all
radiological practices including conventional and CT practices. The relative
contribution from various types of examination are given in Table 1.1. Therefore the
available data suggest that while CT represented about 2% of the total of all X-ray
1 The BPSM name has now (1997) been changed to the Institute of Physics and Engineering in
Medicine abbreviated by IPEM.
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examinations, yet accounted disproportionately for 20% of the resultant collective
dose. Therefore it has a great impact on the total collective dose and it now represents
the major source of exposure from diagnostic X-rays (Shrimpton et al. 1991b, NRPB
1992, Hughes and O'Riordan 1993, Wall and Hart 1997). Moreover, recent
information (Shrimpton and Wall 1993) confirms the trend of ever increasing numbers
of scanners and suggests that CT may now represent about a third of the collective
dose from diagnostic X-rays in the UK.
Table 1.1: Contributions to the annual collective dose from all medical and dental X-
Examination % frequency % collective dose
Computed Tomography 2.4 22
Lumbar spine 3.3 15
Barium enema 0.9 14
Barium meal 1.6 12




Limbs and joins 25 1.5
Skull 5.6 1.5




Annual collective dose 20000 man Sv
from all procedures
Figure 1.1: Contribution of different types of manmade radiation to the collective





The dose received by patients from diagnostic medical X-rays comprise about
87% of the total collective dose to the population of the UK from all man made
sources of radiation (Figure 1.1) (Hughes and O'Riordan 1993).
Ionising radiations are associated with certain risks, the main at these levels
being the induction of cancer. The risk factor for fatal cancers for a population of all
ages and both sexes is believed to be a 45 in one million chance of death following
irradiation of 1 mSv (for low LET radiation) (ICRP 1991). Approximate estimates for
the risk of fatal cancers arising within the lifetime of patients is dependent on the age
of the patient as well as the type of examination. However, the risk factors averaged
over all ages and both sexes varies from 0.7 per million for a chest X-ray to 100 per
million for a barium enema (Table 1.2) (NRPB 1990).
Table 1,2: Typical lifetime risks of fatal cancer from X-ray examinations
Examination Lifetime risk of fatal cancer*
Lower bound Upper bound
Skull 2 7
Chest 0.7 2
Thoracic spine 15 40
Lumbar spine 30 100
Abdomen 20 60
Pelvis 15 55
Intravenous Urography 60 200
Barium meal 50 170
Barium enema 100 350
*average for all ages and both sexes (Per million)
1.3 Computed Tomography Dosimetry - General Aspects and Background
One of the principles of radiation protection is that doses should be kept as
low as reasonably achievable which is abbreviated as ALARA principle. There is a
wide range of methods for reducing doses to patients without loss of diagnostic value
and the more important ones are listed in Appendix B of the NRPB documents
(NRPB 1990). One of the radiological procedures for reducing doses to patients from
X-ray examination is periodically measuring patient doses and taking action if they
exceed "guideline doses" which has a potential of 20% dose reduction per
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examination (NRPB 1990). Furthermore it is obvious that reduction of patient dose to
a minimum is one of the objectives of good radiology practice. The simplest method
of monitoring whether this objective is achieved is to measure dose for a sample of
patients or under standard conditions. This has been recommended by a joint working
party of the NRPB and the Royal College of Radiologists (RCR) (NRPB 1990).
In recent years different dosimetry methods have been used for characterising
radiation doses associated with a CT scanner. Objectives of these measurements
include ensuring that a CT scanner meets the manufacturer's specifications and
comparing dose associated with different types of scanner, and also comparing CT
doses with radiation doses resulting from other radiological examinations.
Another important reason for investigating radiation doses associated with CT
scanners is to estimate radiation risks to patients undergoing CT examinations
(Mossman 1982, Huda and Sandison 1985, Faulkner and Moores 1987). The most
appropriate method of estimating the radiation risk associated with a CT examination
is to obtain the mean absorbed dose in every irradiated organ and tissue, permitting
each organ risk to be obtained (UNSCEAR 1988, NCR 1990, NCRP 1990, ICRP
1991). Knowledge of individual organ/tissue doses permits the computation of a
single dose descriptor such as the effective dose equivalent (HE) (ICRP 1977) or
effective dose (E) (ICRP 1991). HE and E data may be used for intercomparison of
CT techniques and also to compare the radiation risks associated with CT
examinations to other diagnostic examinations that use ionising radiation.
Since the introduction of CT in the early 1970s, dosimetric investigations have
generally followed two different tracks. One track has been the specification of
radiation dose to specific locations in patient and phantoms. The other track has been
the evaluation of effective dose equivalent or effective dose as an indicator of total
radiation risk to the patient from CT examinations.
Standard CT dosimetry techniques, generally involving the use of QA
phantom, are normally based on the first track. These techniques often give rise to
dose descriptors that are poorly correlated with patient risk such as maximum or
average surface dose and integrated dose profiles recorded either on the surface or at
the centre of the QA phantom. The second track, i.e. the assessment of the effective
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dose resulting from CT examinations, requires a knowledge of the dose to all
radiosensitive organs of the patient arising from the complex pattern of irradiation
employed in clinical practice. The assessment of the effective dose has generally been
done in one of two ways: organ-by-organ dose determination or by estimation of total
energy imparted to the patient (Atherton 1993). Based on these two tracks several
dosimetry approaches have been followed using various combinations of different sets
of equipment and methods.
Sets of equipment used for CT dosimetry could be divided into two categories
of dosimeters and phantoms. All conventional dosimeters, normally used for X-ray
dosimetry, such as: thermoluminescent dosimeter (TLD) crystals (Jucius and Kambic
1977, Dixon and Ekstrand 1978, Shope et al. 1982, Cack and Hendee 1979), special
ionisation chambers (Moore et al. 1979, Poletti 1984), and films have also been used
for CT dosimetry. A range of solid and water filled phantoms, simulating part or
whole of the human body have been used and developed over the past 25 years for
CT dosimetry purposes. These phantoms could be categorised in: regular geometry
phantoms (Speller et al. 1981a), physical anthropomorphic phantoms including epoxy-
resin based (Speller et al. 1981a) and Rando (Nishizawa et al. 1991) phantoms, and
finally mathematical anthropomorphic phantoms (Kramer et al. 1982, Drexler et al.
1984, Jones and Shrimpton 1991, Shrimpton et al. 1991b) similar to Medical Internal
Radiation Dose (MIRD) phantoms. Apart from these two broad classes of physical
and mathematical phantoms, another type of phantoms, called Quality Assurance
(QA) phantoms, designed primarily for CT performance measurements, has also been
used by some researchers to assess doses and risks to the patients resulting from CT
examinations.
Regarding methods two major methods, namely "direct" and "Monte Carlo"
methods, have been used either for the first or the second track of CT dosimetry. The
"direct" method is also referred to as "measurement" or "experimental" dosimetry
method by some researchers.
Over the last twenty five years since the introduction of CT into clinical
practice (Hounsfield 1973), researchers have used various combinations of the above
sets of equipment and methods for CT dosimetry.
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Initial investigation of radiation dose in CT followed the first track, reporting
dose to specific points in phantoms. When Sir Godfery Hounsfield introduced this
revolutionary diagnostic technique (Hounsfield 1973), he reported the exposure at the
patient's skin for an examination which provided six tomographic slices over the
whole of head. He found the CT skin dose approximately equivalent to a conventional
X-ray examination. Perry and Bridges (1973) used a conventional ionisation chamber
(IC) mounted in a short perspex cylinder filled with water as a head phantom and
reported isodose curves and gonad dose for a single scan. They concluded that the
integral dose from a single complete CT scan was likely to be less than that from a
single skull X-ray. Horsely and Peter (1976) used capsules of LiF powder inserted
around the circumference of a Rando phantom skull in the plane of the CT scan. They
produced isodose curves similar to that of Perry and Bridge (1973) for a single scan
and multiple scans for an EMI scanner. They also reported on the dose to skin from
multiple scans from this scanner as measured in a Rando phantom. They concluded
that the dose to the cranium of patients undergoing routine skull scans on the EMI
scanner was higher than previously reported by Perry and Bridge (1973). McCullough
and Payne (1976) used TLDs and an Alderson phantom and measured doses at the
centre and four peripheral locations of the phantom and reported the maximum
surface dose for three different scanner models. Weistein et al. (1976) reported the
results of surface dose measurements for some scanners using single and multiple
scans. Shrivastava et al. (1977) reported measurements of gonads and other organs
exposures due to scattered radiation from CT scans. Boyd et al. (1977) used a slightly
flattened plexiglass cylinder to simulate the contour of a torso, with a circumference
of 91 cm, filled with water. They measured and compared doses for two different
types of scanners with the TLDs inserted at the centre and four peripheral locations
inside and on the surface of the phantom. Bassano et al. (1977) measured doses for a
series of scans using TLD-100 placed in head and abdomen sections of the Alderson
phantom. They constructed isodose curves from several measurements at various
positions in the head and abdomen of the phantom and reported the range of doses.
They also used an IC for the testis and TLDs for the ovary and reported range of
doses to gonads for different scan protocols for a particular scanner. Krauss and
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Shumacher (1977) reported patient doses using similar isodose profiles for whole
body CT examinations. Jucius and Kambic (1977) reviewed methods of CT dosimetry
and discussed the use of TLDs, films, and IC to obtain exposure profiles. They used
both the TLDs and a pencil IC and measured the exposure distributions of peak
exposure for a single scan and average exposure for a series of scans. They also used
film as a qualitative exposure device to study the surface dose for a single scan and a
series of scans. Dixon and Eckstrand (1978) used a film dosimetry system to measure
surface dose for single and multiple scans in circular and elliptical acrylic phantoms.
They also measured the film response to both the entrance and exit doses relative to
that of a Farmer IC using a 20 cm thick water phantom. Villafana et al. (1978)
measured doses received by the surface of head and interior brain points, lens of the
eye and gonads. They used a Rando phantom and TLD-100 powder capsules in a grid
matrix at appropriate levels of the head placed around the exterior surface of the
phantom head. Brasch et al. (1978) used two child sized (with 36 and 66 cm
circumference) phantoms (composed of polystyrene at the centre and acrylic at the
end) on seven models of CT and TLD capsules. They reported average surface dose
and internal doses for a complete abdominal CT examination comprised of eight
scans. Flobday and Parker (1978) reported the maximum exposure to the skin from an
EMI scanner using Temex skull and body phantoms and LiF TLDs. They also
estimated doses to the lens of the eye from skin doses near to the orbit. Agarwal et al.
(1979) used a water filled (17.5 cm diameter) Lucite cylinder and ten pairs of LiF
TLD-100 to measure dose distribution from a particular scanner. They concluded that
the isodose curves for different combinations of slice thickness and scan speed were
similar, although the absolute values of the doses were different. They also concluded
that the increase in dose with slice width is linear. They also reported surface dose
measured with the TLD chips taped to the outer surface of the phantom. Wall et al.
(1979) used a Rando phantom and LiB04 TLDs to measure doses for some
neurological thoracic and abdominal examinations for three scanners. They reported
maximum skin doses and some isodose curves for these scanners based on
measurements made at the centre of and four locations on the surface of the phantom
sections. Souton (1980) measured peak doses and surface line integral doses by a row
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of TLD-100 chips on the surface of a phantom at the point of expected maximum on
either side of the centre for several scanners. White et al. (1980) proposed that dose
to the patient could be assessed for either single or multiple scans at the surface and
centre of the special skull and thorax phantom sections using film or TLDs. Moor et
al. (1981) proposed a multisegmented 1C for CT dosimetry to avoid what they
described as the drawbacks of TLDs including the inherent imprecision of
thermoluminescent dosimetry and the time required for calibration and the inventory
of individual TLD chips They concluded that there was a good agreement at
narrower beam widths (3&6 mm) between their IC profiles and TLD measurements,
although a series of ten exposures was needed to obtain the IC segment responses.
Speller et al. (1981b) carried out a survey during 1978-9 on the performance
characteristics of 29 EMI brain and body CT scanners in Britain. They presented dose
profiles for a single slice using TLD and film and a physical anthropomorphic
phantom. They reported mean doses in the form of maximum surface dose for single
slice scans and compared their results with others (Hobday and Parker 1978 and Wall
et al. 1979). They also reported typical dose profiles for these scanners at the centre
of the phantom. Shope et al. (1982) used TLD to measure point doses for single and
multiple scans in both cylindrical and anthropomorphic phantoms in scanners from ten
manufacturers. They presented surface and centre doses for the cylindrical phantoms
and the maximum dose measured in the anthropomorphic phantom. Fearon and
Vucich (1985) measured surface doses in paediatric patients for several standard
examinations and compared the results to in-phantom measured values. Storrs and
Byrd (1988) and Maclennan and Hadley (1995) measured the dose to the lens of the
eye for paediatric patients. There have also been studies of foetal or intrauterine dose
from CT (Wagner et al. 1986, Fearon and Vucich 1987, Guidozzi et al. 1987, Femlet
et al. 1990, Adams et al. 1997).
1.4 Common CT Dosimetry Approaches
Apart from the initial investigations of assessing the radiation dose associated
with the CT, the most common approaches in CT dosimetry could be grouped in
three distinctive categories and could be called as: Standard; Monte Carlo; and
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Direct approaches.
1.4.1 Standard CT Dosimetry Approach (using Quality Assurance Phantom)
This technique involves using the QA phantoms (Perspex/Plexiglass
phantoms), originally designed for evaluating CT performances, and measuring skin
dose and CTDI (Computed Tomography Dose Index) values. These terms will be
explained in more detail in the following chapter.
1.4.2 Monte Carlo CT dosimetry Approaches
Monte Carlo (MC) technique is a powerful tool in the study of radiation
transport, where known probability distribution simulate physical process and the
random paths of particles in materials and geometry of interest (Cashwell and Everett
1959). This calculation technique (MC) has been used in two ways in CT dosimetry.
In one approach it has been used to estimate the organ doses and other radiation dose
descriptors through the total energy deposited or imparted to the patients. In the other
approach this computational technique has been used to yield organ doses normalised
to the free-in-air dose on the axis of rotation of the scanner, known as CTDI, to
calculate other radiation risk indicators (HE and E).
1.4.2.1 Monte Carlo Approach using Total Energy Imparted Quantity
In this approach the assessment of the radiation doses to the patient is through
estimation of the total energy deposited or imparted to the patient. The studies cited
below claim, the energy imparted to the patient (formerly "integral dose") has been
shown to be a useful estimator of stochastic risks in diagnostic radiology. The energy
imparted is a physical quantity and is independent of organ weighting factors contrary
to other usual approaches which will be explained in the following chapters. The use
of energy imparted to a patient as a risk estimator assumes a homogeneous mix of
radiosensitive and radioresistant tissues within the body (Wall et al. 1988). This
approach, which was determined as "a less versatile way" a few years ago (Shrimpton
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et al. 1991b), has recently been developed and used for CT dosimetry and claimed to
be simpler but cruder than organ dose estimation approaches (Atherton 1993,
Atherton and Huda 1995, Atherton and Huda 1996).
Bengtsson et al. (1978) used energy imparted as a basis for risk estimates for
conventional radiographic examinations. They based their estimates on the risk
coefficient 1.65 10"2 Sv"1 for radiation workers (ICRP 1977) and identified a risk of
2.0 10"4 J"1, which corresponds to a ratio of 12.1 mSv/J. Southon (1981) reported
values for energy imparted in comparison of six different CT scanners but did not
present any explicit risk estimates corresponding to energy imparted values.
Shrimpton (1985) studied the relationship between the energy imparted and the
effective dose equivalent in common radiographic examinations and found a linear
relationship (within a factor of two) between the two of 13.8 mSv/J. Le Heron (1992)
claimed "good agreement" between the energy imparted and the effective dose in
conventional radiography, although he did not present any values. He based his work
on the NRPB organ dose data (Jones and Wall 1985).
Atherton and Huda (1995, 1996) indicated that these studies show that the
energy imparted can either be used outright as an indicator of patient risk estimate or
to estimate other risk estimators. Using this quantity (energy imparted) they have
developed a computational MC method to estimate the CT doses.
1.4.2.2 Monte Carlo Approach using Mathematical Phantoms
An alternative approach of patient dosimetry employs MC computer
techniques to simulate the absorption and scattering of X-ray photons within a
mathematical anthropomorphic phantom, yielding organ doses normalised to the
CTDI measured for a single scan, free-in-air on the axis of rotation of the scanner.
This is the method used by the NRPB in the national survey of CT practice in the UK
(Shrimpton et al. 1991a, Shrimpton et al. 1991b, and Jones and Shrimpton 1991).
This approach is based upon measurement of the CTDI with either a CT
ionisation chamber or a stack of TLDs inside a hollow, cylindrical plastic tube -and
long enough to cover the X-ray beam width -which could be positioned along the axis
of rotation of the scanner. This approach known as Monte Carlo or sometimes CTDI
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method has also been used by several groups of workers (Shrimpton et al. 1991a,
Shrimpton et al. 1991b, Jones and Shrimpton 1991, Zankl et al. 1991, Zankl et al.
1992, Poletti 1992, Atherton 1993, Gleijns et al. 1994, Atherton and Huda 1995,
Zankl et al. 1995, Poletti 1996, Caon et al. 1997).
1.4.3 Direct CT Dosimetry Approach using Physical Phantoms
In this approach a physical anthropomorphic phantom is used and direct
measurements of the absorbed dose in relevant organs are performed with TLDs. This
approach, sometimes called direct or experimental method, has also been employed by
several researchers (Faulkner and Moores 1987, Huda et al. 1989, Nishizawa et al.
1991, Gleijns et al. 1994).
1.5 Current Problems in CT Dosimetry
As noted above, since the introduction of CT into clinical practice in the early
1970s different quantities have been used to quantify patient doses resulting from CT
practice. Quantities involved include a wide range of simple quantities such as tube-
current exposure-time product (mAs), surface dose, single organ or tissue dose. As
mentioned earlier, early attempts in CT dosimetry generally involved reporting various
dose descriptors derived from the above simple quantities. These quantities often give
rise to dose descriptors that are either crude or poorly correlated with the patient risk.
Nowadays the CTDI quantity (Shope et al. 1981), and the more complex quantity of
effective dose (ICRP 1991) are being used more often. But the problem is that the
complex quantity of effective dose (formerly effective dose equivalent (ICRP 1977))
requires a knowledge of the dose to all radiosensitive organs of the patient arising
from the complex pattern of radiation employed in CT practices.
The mAs of a scanner gives information on the radiation exposure
proportional to dosimetric quantities such as surface dose, CTDI, and effective dose.
However, this quantity can only be used as a relative measure of radiation exposure
resulting from different CT scanning techniques for a specific type of scanner and
anatomical region of the body (Naidich et al. 1990, Babbel et al. 1991, Marmolya et
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al. 1991, Zwirewich et al. 1991), and can not be used for comparing different types of
CT scanners.
Surface doses in terms of maximum skin or surface dose and maximum doses
at selected locations within various types of phantom were presented in the first
reports of measurements of exposure or absorbed dose from either a single scan or
multiple scans for different CT systems. From the early time of the invention of the
CT up until recent years many researchers have reported surface doses resulting from
CT examinations for various types of scanners (Hounsfield 1973, Perry and Bridges
1973, McCullough et al. 1974, McCullough et al. 1976, Horsely and Peter 1976,
Weinstein et al. 1976, Thomas et al. 1978, Brasch et al. 1978, Villafana et al. 1978,
Dixon and Ekstrand 1978, Agarwal et al. 1979, Boyed et al. 1979, Wall et al. 1979,
Southon 1980, White et al. 1981, Speller et al. 1981a, Shope et al. 1982, Lund and
Halaburt 1982, Jones and Garett 1985, Murphy and Heaton 1985, Fearon and Vucich
1985, Evans et al. 1989, Mayo et al. 1993). There is no doubt that surface dose on a
phantom or the skin of a patient may give enough information to assess patient doses
for conventional X-ray examinations. This simple quantity can easily be measured and
used with available data sets or software (Rosenstein 1976, Rosenstein 1989, Hart et
al. 1994, Hart et al. 1996a) to assess organ doses and subsequently effective dose
values for conventional X-ray examinations. But because of the variation in X-ray
intensity as a function of position of the CT scan and the complexity and variety of
CT scanner characteristics, the surface dose quantity is rather inhomogeneous for CT
examinations. Therefore contrary to the conventional x-ray examinations this quantity
can not be obtained from a single measurement on scanners and used to derive organ
doses and effective dose values for CT examinations.
Doses to a single organ or tissue, such as the lenses of the eye (Villafana et al.
1978, Storrs and Byrd 1988), thyroid gland (Brasch et al. 1978), gonads (Perry and
Bridges 1973, Bassano et al. 1977, Shrivastava et al. 1977, Villafana et al. 1978), and
foetus (Wagner et al. 1986, Fearon and Vucich 1987, Guidozzi et al. 1987, Felmlee et
al. 1990) measured inside various phantoms using TLDs at the location of the single
organs of interest provide a better knowledge of the risk to these organs.
Nevertheless, these quantities will not lead to the assessment of the patient risk
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involved with the CT practice that requires doses to more than twenty other
radiosensitive organs. Furthermore, there are remarkable significant differences in
absorbed dose distributions resulting from CT practices and differences in dose
distributions from different types of CT systems. These differences are due to the
variety of scanning techniques, x-ray beam collimation geometries, and operating
conditions. Therefore single number dose descriptors such as the maximum or
average dose from a single scan are often inadequate.
Because of the inadequacy of single number dose descriptors and rapid
variation in x-ray intensity as a function of position normal to the plane of the scan, as
noted above profiles of the exposure or dose as a function of position along a line
parallel to the axis of rotation of the CT system were used to describe the dose from
CT systems. Such dose profiles were reported for a single scan (Cohen 1979) and
used to estimate the doses for multiple scans as a function of the number of scans and
the increments between scans (Krauss and Shumacher 1977, Hobday and Parker
1978, Brasch et al. 1978, Dixon and Ekstrand 1978, McCullough and Payne 1978,
Jucius and Kambic 1977, Cack and Hendee 1979, Olson and High 1979). Such
profiles, however, give no information about the dose distribution in "z" direction and
few CT scanning techniques consist of only one scan. Following these efforts, the
computed tomography dose index (CTDI) proposed by Shope et al. (1981) was a big
step to overcome the weakness of the above reports on the CT single dose profile.
CTDI is measured at a specific depth inside a phantom such as cylindrical PMMA
standard head or body phantom (Mayo et al. 1987, McCrohan et al. 1987, Conway et
al. 1992) or free in air at the centre of rotation of the CT scanner (Panzer et al. 1989,
Shrimpton et al. 1991b, Christensen et al. 1992). Although this dose profile, CTDI,
provides a better index for studying the performance of different CT systems (Shope
et al. 1981, Speller et al. 1981b, Shope et al. 1982, Shrimpton et al. 1991b), it does
not provide enough information, on its own, to assess the patient doses in terms of
effective dose. This can be achieved by combining CTDI with a computational
phantom and Monte Carlo techniques (Jones and Shrimpton 1991 and 1993, Zankl et
al. 1991).
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The ICRP in its 1990 recommendations (1991) has proposed that the quantity
of effective dose be used as an index for the assessment of patient doses from all
varieties of medical x-rays. In this regard, as noted above, two dosimetry approaches,
namely the MC and the direct approaches, have commonly been employed for the
assessment of patient doses from CT practices. Nonetheless, either of these common
CT dosimetry approaches have their own constraints.
If the direct approach is selected, organ and tissue doses should be measured
inside a physical phantom employing TLDs at the location of the selected
radiosensitive organs from which the effective dose value could be calculated
(Murphy and Heaton 1985, Evans et al. 1989, Brasch and Cann 1982, Wagner et al.
1986, Fearon and Vuich 1987, Sager et al. 1989, Vano et al. 1989, Nishizawa et al.
1991, Collie et al. 1994a and 1994b). This approach requires numerous TLD
measurements (>200) for just an individual CT examination making it a laborious and
impractical task for routine patient dose assessment from CT practices. If the MC
dosimetry approach is employed organ doses and subsequently effective dose values
can be calculated rapidly and easily by measuring the CTDI free in air and using
available conversion factors for a limited number of CT models (Shrimpton et al.
1991b, Jones and Shrimpton 1991, Jones and Shrimpton 1993, Panzer et al. 1989,
Panzer and Zankl 1989, Zankl et al. 1991). The problem with this method is that it is
applicable to a limited number of old CT scanners for which conversion factors are
available. On the other hand application of this method for the new CT scanner
models requires details of the scanner configuration and also implementing the Monte
Carlo computational technique. This involves acquiring the scanner configuration data
from the manufacturers and special computing facilities and expertise for the MC
technique. Although some efforts has been made to determine a correlation between
new CT models and older models for which the conversion factors are available
(Edyvean et al. 1997), the above prerequisites make this approach, too, impractical
for routine patient dose assessment from CT practices.
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1.6 Proposed CT Dosimetry Approach
It is obviously the second track of CT dosimetry, i.e. the assessment of the
radiation risk (in terms of effective dose) based on the absorbed doses in all organs
and tissues of interest, that is of importance in CT practice. In addition from various
approaches of the second track of CT dosimetry described above, the last two
approaches are common and used frequently. Hence, in this study we aimed to
determine the absorbed dose in all organs and tissues of interest and other dose
indices using these two common approaches, namely the direct approach using a
physical anthropomorphic (Rando) phantom and the MC approach using the
mathematical anthropomorphic phantom. For brevity, the "direct" and "MC" terms
will be used respectively for these CT dosimetry approaches in the rest of this thesis.
However, as mentioned above, either of these common approaches are not
quite practical to be implemented for routine patient dose assessment from CT
practices. There are two prerequisites in order to utilise the MC approach in CT
dosimetry. Firstly, it is necessary to gain the necessary data on the scanner design
from the CT manufacturers for every CT scanner model. Secondly, it is required to
write an algorithm or use others' algorithms for the MC calculations. Therefore this
dosimetry approach is dependent on the co-operation of two external bodies. Even if,
it is preferred to write down the necessary codes for the MC calculations, a
considerable amount of time must be spent to test and run the program on a suitable
computer. On the other hand if the common direct CT dosimetry approach is used, it
will require a large number of point dose measurements (-200) at the location of all
organs and tissues of interest inside a physical phantom. This, in turn, makes the direct
approach a laborious and impractical procedure for the routine assessment of patient
doses from CT practices.
Therefore to avoid these constraints, the direct CT dosimetry approach was
developed in this study. This was achieved by assessing CT axial and longitudinal
dose distribution in an anthropomorphic physical phantom. Measurement of these
dose distributions enabled us to propose a method to quickly estimate patient doses,
for any CT examination protocol performed by any CT scanner, with a limited number
of TLD measurements in a Rando phantom. All dosimetry related concepts were
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considered for the proposed direct CT dosimetry method. A spreadsheet computer
program was also designed that handles all necessary data processing and reports
organ absorbed doses and other dose indices with a very user friendly interface.
Comprehensive dose measurements were also carried out to estimate the level of error
in the developed direct CT dosimetry approach.
In addition the MC approach was also used to estimate patient doses resulting
from routine CT examinations for some of the scanners in this study for which
conversion factors were available. This enabled us to compare our developed direct
dosimetry method with this common CT dosimetry approach for some scanners. In
this regard the patient doses were estimated by combining our measured CTDI values
with calculated organ dose conversion factors provided by the NRPB (Jones and
Shrimpton 1991). The CTDI values were measured with both a stack of the TLDs
and the CT ionisation chamber.
1.7 Aims of Thesis
The ultimate goal of this work is to develop a simple and practical dosimetry
method for the assessment of patient doses from CT practice with an acceptable
degree of accuracy. The aims of this study are:
1. To provide a comprehensive and critical literature review on the dosimetry
approaches used for the assessment of patient doses from CT practice.
2. To provide an overview on the CT technical developments from the early
prototype invented in the early 70s to the state-of-the art CT models.
3. To propose a simple and practical method for routine CT dosimetry.
4. To implement and validate the proposed CT dosimetry method.
5. To evaluate different CTDI measuring techniques used for the MC CT
dosimetry approach.
6. To assess patient doses using the developed method for routine CT
practices performed by all the CT scanners operating at the NHS hospitals
in the Lothian and Fife areas of Scotland.
7. To assess patient doses with the MC approach for routine CT practices
performed by some of the CT scanners operating at the NHS hospitals in
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the Lothian and Fife areas of Scotland.
8. To compare the developed and the MC dosimetry approaches for CT.
9. To find a quick method for the estimation of patient doses for similar
protocols with a good degree of approximation.
1.8 Outline of Thesis
This thesis is organised as follows to address the aims of this study. As noted,
this chapter introduces a comprehensive background on computed tomography. It
includes a general description of CT and its importance in medical diagnostics, the
significance of the dose associated with the CT practice, a critical review of the
common dosimetry approaches used and current difficulties in the assessment of
patient doses with the common approaches, and finally a general description of our
proposed CT dosimetry method. Chapter 2 compiles the principles of CT dosimetry
including basic dosimetric quantities, CT dosimetry devices, and finally CT dose
descriptors. Chapter 3 contains an overview of common CT scanner characteristics in
which the basic operational principles and technical developments of CT, its historical
and technical developments, and the basic physical characteristics of the CT scanners
used in this study are described. Chapter 4 presents the extra design carried out on the
physical phantom required for the implementation of the proposed CT dosimetry
method. Chapter 5 is the core of the thesis presenting the practical CT dosimetry
method developed. Chapter 6 provides the results of the implementation of the
developed dosimetry method for the assessment of patient doses resulting from
routine CT practices using all the CT scanner models operating at different NHS
hospitals in Lothian and Fife areas of Scotland. Chapter 7 presents the application of
the MC CT dosimetry method in this study including the principles of the method,
CTDI measurements, and patient doses for some of the CT scanners. Chapter 8
compares the developed direct dosimetry method with the MC dosimetry method.
Chapter 9 contains a discussion on the implementation of the proposed dosimetry
method and the conclusion of the thesis. In this chapter our results are also compared
with the available data provided by the NRPB from a national survey of CT practice
in the UK (Shrimpton et al. 1991b, NRPB 1992, Wall and Hart 1997).
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2. CT Dosimetry Principles
Comprehensive assessment of risk, in CT dosimetry, requires a knowledge of
the dose to all radiosensitive organs of the patient arising from the complex pattern of
irradiation employed in clinical practice.
As explained in the first chapter, three different approaches are followed for
CT dosimetry. These are: the standard method using a quality assurance phantom, the
Monte Carlo (MC) approach using either the computed tomography dose index
(CTDI) or the total energy imparted value and a mathematical anthropomorphic
phantom, and finally the direct or experimental approach through the direct
measurements of organ or tissue doses inside a physical anthropomorphic phantom.
The standard dosimetry methods for CT have been designed primarily to
monitor CT scanner performance characteristics. These methods often give rise to
dose descriptors that are poorly correlated with patient risk such as maximum or
average skin dose or surface dose and integrated dose profiles recorded either on the
surface or at the centre of a QA phantom. On the other hand although the CT
dosimetry approach that uses the Monte Carlo technique and a mathematical phantom
through the estimation of the total energy imparted to the patient has recently been
developed (Atherton 1993, Huda and Atherton 1994, Atherton and Huda 1995,
Atherton and Huda 1996), it has already been described as a less versatile technique
for CT dose assessment (Shrimpton et al. 1991b). Hence these two approaches are
not quite common and practical in CT dosimetry if the assessment of the radiation
risks to the patients is considered.
Therefore, there are just two more common approaches for CT dosimetry.
These are the Monte Carlo approach using the CTDI value and a mathematical
anthropomorphic phantom and the direct approach using a physical anthropomorphic
phantom. For brevity in the rest of this thesis we will refer to these approaches as the
Monte Carlo and the direct dosimetry methods.
The MC approach is a very popular CT dosimetry method, at the moment, and
has been adopted by several national bodies in the UK, other European countries, and
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many individual researchers world-wide. When the NRPB used this approach for the
national survey of CT practice in the UK (Shrimpton et al. 1991a, Shrimpton et al.
1991b, Jones and Shrimpton 1991), it published organ doses for several models of CT
scanners normalised to CTDI measured in air. These data can easily be used for
calculation of effective dose, but they are limited to some older types of CT scanners.
Hence, for the assessment of patient doses from some of the CT scanners in this
study, we also used this approach parallel to our developed direct CT dosimetry
approach and compared them with each other. The fundamentals and results of
applying this dosimetry method are introduced in a separate chapter.
In the other common approach a physical anthropomorphic phantom (Rando
Alderson) is used and direct measurements of the absorbed dose in relevant organs
are performed. Doses are measured in the location of organs and tissues of interest
usually by using TLDs from which effective dose (or effective dose equivalent) can be
calculated. This approach, called the direct or experimental method, is obviously a
very time consuming and laborious procedure.
Therefore, to avoid the limitations of these two approaches, a simplified direct
method of dose measurement was developed to assess the radiation doses from CT
scanners that can be implemented more rapidly than the full survey of dose in all
organs and tissues. The details of this approach, including the extra design carried out
on the physical phantom, the material used, and the developments carried out to
simplify the method are explained in the following chapters.
In this chapter basic dosimetry quantities; different CT dosimetry devices
including dosimeters and phantoms; and finally different CT dose descriptors will be
described.
2.1 Basic Dosimetric Quantities
In this section all dosimetric quantities that are used in this study and referred
to in the following chapters will be explained. For further information about these




The fundamental dosimetric quantity in radiological protection is the absorbed
dose, D. This is the energy absorbed per unit mass and its unit is the joule per
kilogram (J kg "'), which is given the special name gray (Gy) (ICRP 1991).
The International Commission on Radiological Protection (ICRP), in its 1990
recommendations, defined a new weighted-dose quantity called effective dose. This is
based on another weighted dose, namely equivalent dose, for controlling the exposure
to radiation of workers and members of the public. According to the ICRP
recommendations, both equivalent dose and effective dose are quantities intended for
use in radiological protection, including the assessment of risks in general terms. They
provide a basis for estimating the probability of stochastic effects only for absorbed
doses well below the threshold of deterministic effects (ICRP 1991). These concepts
will be explained briefly in the following sections.
2.1.2 Equivalent dose
Since the effective dose has been defined by the ICRP as the sum of the
weighted equivalent doses in all radiosensitive tissues and organs of the body, it seems
to be necessary to explain first the concept of the equivalent dose.
The probability of stochastic effects is found to depend not only on the
absorbed dose, but also on the type and energy of radiation causing the dose. This is
taken into account by weighting the absorbed dose by a factor related to the quality of
the radiation. In radiological protection, it is the absorbed dose averaged over a tissue
or organ and weighted for the radiation quality that is of interest. The weighted factor
for this purpose is now called radiation weighting factor, wR, and is selected for the
type and energy of the radiation incident on the body or, in the case of sources within
the body, emitted by the source. The value of this factor for a specified type and
energy of radiation has been selected by the ICRP to be representative of relative
biological effectiveness (RBE) of that radiation in inducing stochastic effects at low
doses. The RBE of one radiation compared with the other is the inverse ratio of the
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absorbed dose producing the same degree of a defined biological end-point. The
weighted absorbed dose is called the equivalent dose in a tissue or organ, using the
symbol HT. The equivalent dose in tissue T is given by the following expression:
HT ~^ Wr . Dt, r (Equation 2.1)
R
where Dt,r is the absorbed dose averaged over the tissue or organ T, due to radiation
R. Since Wr is dimensionless the SI unit of equivalent dose is the same as for
absorbed dose, namely the J kg and its special name is sievert (Sv) (ICRP 1991).
The ICRP has chosen a value of radiation weighting factor of unity for all
types of radiation of low LET (Linear energy transfer, a measure of the density of
ionisation along the track of an ionisation particle), including X and gamma radiation
of all energies. The choice for other radiation is based on observed values of the RBE,
regardless of whether the reference radiation is X or gamma radiation. The values of
Wr for different types and energy ranges of radiation are given in Table 2.1 (ICRP
1991).
Table 2,1: Radiation weighting factors (source: ICRP 1991),
Type and energy range Radiation weighting
factor (TPr)
Photons, all energies 1
Electrons and muons, all energies 1
Neutrons, energy <10 KeV 5
10 KeV to 100 KeV 10
> 100 KeV to 2 MeV 20
> 2 MeV to 20 MeV 10
> 20 MeV 5
Photons, other than recoil protons, energy > 2 MeV 5
Alpha particles, fission fragments, heaw nuclei 20
2.1.3 Effective Dose and Effective Dose Equivalent
Effective dose is a quantity to measure overall risk of stochastic effects from
ionising radiation. The effective dose, E, is the sum of the weighted equivalent doses
in all the tissues and organs of the body. It is given by the expression:
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E = y. Wt. Ht (Equation 2.2)
t
where Ht is the equivalent dose in tissue or organ T and Wy is the weighting factor
for tissue T. Tissue weighting factors, Wt, have been defined by the ICRP to indicate
the radiation risk to the organs and tissues in a way that is likely to correlate well with
the total of the stochastic effects. The values of Wj are chosen so that a uniform
equivalent dose over the whole body gives an effective dose numerically equal to that
uniform equivalent dose. The sum of tissue weighting factor is then unity.
This weighted equivalent dose was previously called effective dose
equivalent (ICRP 1977). But in its 1990 recommendations (ICRP 1991) ICRP took
into account new biological information and trends for all organs and tissues and
recommended different values of tissue weighting factors compared with those
recommended in 1977 for effective dose equivalent. Therefore in its 1990
recommendations ICRP decided to use a simpler name of effective dose for this
quantity.
Table 2.2: Recommended tissue weighting factors (Wt) in 1977 and 1990 (sources:
ICRP 1977, ICRP 1991).
Tissue or organ WT (1977) WT (1990)
Gonads 0.25 0.20










Bone Surfaces 0.03 0.01
Remainder 0.30 0.05
However change in name was done to indicate the new tissue weighting
factors used in the 1990 ICRP recommendations (ICRP 1991). Effective dose has
weighting factors for a large number of specified organs and tissues and is likely to be
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a better indicator of the risk to stochastic effects than effective dose equivalent. The
unit of effective dose is J kg with the special name sievert (Sv) (ICRJP 1991). This
quantity could be used to compare the patient doses resulting from CT examination
with other diagnostic procedures involving the use of ionising radiation.
The new and old recommended values for tissue weighting factors by the
ICRP (ICRP 1991, ICRP 1977) are given in Table 2.2.
2.2 CT Dosimetry Devices
Devices used for CT dosimetry could be categorised into two major groups of
dosimeters and phantoms. Various known dosimeters have been used to measure
doses resulted from CT examinations. These include film, thermoluminescent
dosimeter (TLD), and ionisation chamber, that will be discussed in the first part of this
section. On the other hand, phantoms are devices simulating the human body.
Different materials and techniques have been used for this purpose and several types
of phantoms have been proposed for CT dosimetry. However, there are only two
types of phantoms, namely physical and mathematical anthropomorphic phantoms,
that are quite common in CT dosimetry. These phantoms will be described in the
second part of this section.
2.2.1 CT Dosimeters
Soon after the introduction of CT into clinical practice in 1972, various types
of dosimeters, normally being used for measuring doses from conventional
radiography examinations, were also used for measuring CT doses. These include
film, thermoluminescent dosimeters (TLD), an array of silicon detectors and a small
(pencil shape, or CT) ionisation chamber (Suzuki and Suzuki 1978).
2.2.1.1 Film
Film has been used in early attempts as an exposure measuring device for CT
dosimetry (Jucius and Kambic 1977). Dixon and Ekstrand (1978) used a film
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dosimetry system (Kodak XV-2 film wrapped around a cylindrical water-filled
phantom) to calculate the surface dose delivered by a CT scanner. Comparing with
TLD measurements for a variety of CT scanners they indicated that an accuracy of +/-
15 % could be achieved using this system.
Although some advantages have been encountered for CT dosimetry by film
such as: low cost, indication of exposure profile, relatively fast operation, and
availability; its disadvantages in quantitative measurement, small dynamic range,
densitometry requirement, and its restricted utility for surface dose measurements
(Jucius and Kambic 1977) has not proved it as a good indicator in CT dosimetry.
Hence, nowadays it is neither used in simple single CT dose measurements (like
surface dose or dose at the central axis of the rotation) nor in comprehensive CT
dosimetry to assess doses to individual organs and risk estimates associated with CT
examinations.
2.2.1.2 Thermoluminescent Dosimeter (TLD)
The second dosimetry device used for CT dosimetry is TLD. The advantages
of TLD are high sensitivity and dynamic range, small size, and the fact that it can be
used to measure dose profile, internal doses and surface dose (Jucius and Kambic
1977). Furthermore, compared with pencil ionisation chambers the small size of TLDs
permits easy quantitative measurement at the location of several organs of interest
without any attachment elements. Although some disadvantages have been mentioned
for TLD, such as the many dosimeters per measurement, the need for an external
system to read the dosimeters, the long time preceding final result and high initial cost
(Jucius and Kambic 1977), it is still the most common dosimetry device used for CT
dosimetry. A stack of TLDs, from 16 to -40 depending on the CT slice thickness,
could be utilised to produce the CT dose profile (Figure 2.4) either in a phantom or
free in air. TLDs with this geometry arrangement, positioning chips on their sides to
provide ~1 mm spacing, could provide desirable resolution for very narrow beams
profiles. TLDs could also easily be inserted in regions of interest in a physical
humanoid phantom. This allows the measurement of the amount of radiation doses
received by various radiosensitive organs and consequently the estimation of the
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effective dose for CT examinations.
2.2.1.3 Pencil Ionisation Chamber
The third measuring device used for CT dosimetry is the ionisation chamber.
The advantages of an ionisation chamber are: high sensitivity and dynamic range,
quantitative measurement, the ability to measure internal and surface doses, and
immediacy of readings (Jucius and Kambic 1977). The disadvantages of this device
are: the lack of information required about beam profile and the requirement of a
special chamber (pencil shape) due to the special CT X-ray field configuration (Jucius
and Kambic 1977). Utilising a very small volume ionisation chamber to measure a
cross section similar to TLD measurement has two serious disadvantages of: 1) the
large number of scans required to generate a dose profile and 2) the lower sensitivity
of a small volume ionisation chamber. In addition to these disadvantages it should be
considered that this device is just applicable for acquiring single surface doses on
phantoms or doses along an axis of interest in phantoms.
The type of ionisation chamber adopted for CT dosimetry is a long pencil
chamber which measures the entire cross section of the CT X-ray beam field. This is a
specially developed pencil-shaped ionisation chamber designed by Suzuki and Suzuki
in 1978. It is an air-equivalent, coaxial ionisation chamber and its volume is ventilated
to the environment via a small canal. The chamber measures the average "air kerma"
(Kinetic Energy Released per unit MAss of irradiated material) over its length.
Nowadays TLDs have almost been replaced with the pencil ionisation chamber
for determining the CTDI value. This is largely because this chamber could easily be
used quite straightforward compared with the relatively lengthy multiple processes
required for acquiring the CTDI value from the TLD measurements. Using this type
of chamber, CTDI value could be determined either inside a perspex (QA) phantom
for the standard CT dosimetry technique or free in air on the axis of rotation of the
scanner for the Monte Carlo CT dosimetry approach.
The measured exposure at any location utilising this chamber is equal to the
total exposure, primary and scatter radiation, along the axis. The product of measured
exposure and the active length of the pencil ionisation chamber (10 cm) gives a
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number related to the area under the CT exposure profile.
2.2.2 CT Phantoms
Any material that simulates a body tissue in its interaction with ionising
radiation is termed a tissue substitute ( ICRU 1989). For example bolus is a tissue
substitute placed in proximity to the irradiated subject to provide extra scattering or
build up or attenuation in the beam. A structure that contains one or more tissue
substitutes and is used to simulate radiation interactions in the body is termed a
phantom. Phantoms are used widely in radiotherapy, radiological imaging, radiation
protection, and radiobiology but their major application is in radiation dosimetry and
radiotherapy. Phantoms may be broadly categorised according to their primary
function as either dosimetric, calibration or imaging (ICRU 1992). Dosimetric
phantoms are used for the measurement of absorbed dose in a specified geometry.
Therefore a phantom is a structure that contains or simulates one or more
tissue substitutes and is used to simulate radiation interactions in the body in radiation
dosimetry. Since the introduction of CT into clinical practice, various types of
phantoms have been used to simulate human body in CT dosimetry. There are two
categories of phantoms used in CT dosimetry. These are mathematical phantoms, and
physical phantoms. Mathematical phantoms are computational phantoms normally
used for the first track of CT dosimetry (the Monte Carlo approach). Apart from the
early types of the physical phantoms designed for specific purposes, nowadays, mostly
two types of these phantoms are used in CT dosimetry, dependent on the chosen
approach. One type is the quality assurance phantom used for the standard CT
dosimetry approach and QA measurements. The other physical type is the humanoid
(a Rando Alderson or similar type) anthropomorphic phantom used for the second
track of CT dosimetry. This type of physical phantom has been used and redesigned in
this study. In the following sections the development and general characteristics of
these phantoms are described.
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2.2.2.1 Early Phantoms
Since the introduction of tissue substitutes at the beginning of this century
(Kienbock 1906) Phantoms in one form or another have been used extensively in
experimental radiation dosimetry. During the first two decades of this century water
and different types of wax were established as muscle or soft-tissue substitutes. A
decade later it was reported that the attenuation coefficients of wax at low photon
energies differed widely from those of muscle and soft tissues (ICRU 1992).
Therefore the high atomic number fillers, such as magnesium oxide and titanium
dioxide were then added to correct for these deficiencies. Phantoms fabricated from
these improved wax based tissue substitutes, in particular Mix D (Jones and Raine
1949) and later M3 (Markus 1956), were employed widely in radiation dosimetry.
During the fifth decade of the 20th century gradually the greater awareness of the
importance of realism in body phantom design led to production of a diverse selection
of phantoms, but the limited tissue substitutes often resulted in phantoms of dubious
relevance to the human body.
2.2.2.2 Physical Humanoid Anthropomorphic Phantom
The trend towards innovative body phantom design continued with the
introduction of two elaborate adult-sized body phantoms containing real skeletons,
body cavities and artificial lungs in the early 1960's. These were the Temex system
(Stacy et al. 1961) and the Rando Alderson system (Alderson et al. 1962). In addition
with the introduction of new plastic and resin based tissue substitutes in the 70's and
80's and associated fabrication techniques, a wider range of high quality phantoms
can now be manufactured (ICRU 1992). Improved tissue substitutes and fabrication
techniques has led to more reliable, realistic phantoms which inevitably has led to
improved radiation dosimetry and measurement.
These phantoms were originally designed for use in radiotherapy dosimetry.
From 1970 to the present day, more phantoms have been produced for other
applications such as radiodiagnosis and radiation protection.
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2.2.2.3 Standard/Quality Assurance Phantom
This type of phantom is known as standard CT dosimetric phantom or QA
phantom. These phantoms are based on the standard phantoms developed by the
Centre for Devices and Radiological Health of the US Food and Drug Administration
(FDA 1980b) mainly for CT quality assurance measurements (Shope et al. 1982).
FDA has recommended one position at the centre and four equally spaced positions
on radii of 5.0, 10.0, and 15.0 cm for the body phantom with 32 cm diameter; and one
position at the centre and four equally spaced positions on radii of 5.0, 7.0 cm for the
head phantom with 16 cm diameter (FDA 1980a, ICRU 1992). But most
manufacturers provide these phantom with means for the placement of a dosimeter(s)
along its axis of rotation and along a line parallel to the axis of rotation 1.0 centimetre
from the outer surface and within the phantom (Figure 2.1). Means for the placement
of a dosimeter(s) or alignment device at other locations may be provided for
convenience. The means used for placement of a dosimeter(s) (i.e., hole size) and the
type of dosimeter(s) used is at the discretion of the manufacturer.
Body Phantom Head Phantom
Figure 2.1: FDA Standard CT Dosimetric Phantoms.
For example the phantoms designed by Siemens, for QA measurements, are
two right circular cylinders of water-filled acrylic containers or solid blocks fabricated
from a suitable water substitute (polymethylmethacrylate of density 1.19 ± 0.01
grams per cubic centimetre). These phantoms are both 14 centimetres in length. One
of them with the diameter of 32.0 centimetres is for testing their CT systems designed
to image any section of the body (whole body scanners) and the other one with 16.0
centimetres is for any system designed to image the head (head scanners) or for any
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whole body scanner operated in the head scanning mode. As could be noticed in the
Figure 2.2 seven positions have been determined in this phantom for CTDI
measurements. One of these position is at the central axis (A) and anther one on the
surface (O) of the phantom. But the rest are all located at equal radii (one centimetre
from the edge of the phantom). Four of these peripheral positions (B, C, D, and E)
are equally spaced and one of them (F) is located in the middle of two other peripheral
positions.
Figure 2.2: CT (Plexiglass) QA phantom designed by Siemens.
2.2.2.4 Mathematical Anthropomorphic Phantom
Since the measurement of absorbed dose to organs in a physical phantom
requires a considerable experimental effort, several computational models have been
defined to represent a specific body organ or a defined groups of organs or tissues,
generally with associated mathematical relationships. These can range from a simple,
idealised geometric form, such as a sphere, cylinder or slab, to a complex, realistic
representation of a detailed anatomical feature (ICRU 1992), such as the model
designed by the NRPB (Jones and Wall 1985) for organ dose measurements from
medical X-ray examinations using Monte Carlo techniques (Figure 2.3). This phantom
was also used later in the NRPB national survey of CT practice in the UK (Shrimpton
et al. 1991a, Shrimpton et al. 1991b, Jones and Shrimpton 1991). Mathematical
models use mathematical expressions to represent plane, cylindrical, elliptical or
spherical surfaces. Mathematical models of these simple geometric shapes have been
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widely used for absorbed dose measurements (ICRP 1987). With Regard to
anthropomorphic models, such surfaces, sometimes intersecting, are combined to
replicate idealised body organs. This model was introduced by Fisher and Snyder
(1967 and 1968) for the adult human following the earlier work of Hayes and Brucer
(1960) and has been extended and refined by numerous authors (ICRU 1992). As
scaling was not appropriate for some organs, more elaborate paediatric mathematical
models have been developed by Cristy (1980) and Cristy and Eckerman (1987), while
male and female mathematical phantoms have been introduced by Kramer et al.
(1982). These two models are the most popular ones used in CT dosimetry.
The NRPB phantom (Figure 2.3) used for CT dosimetry (Shrimpton et al.
1991b, Jones and Shrimpton 1991) is based on the adult phantom described by Cristy
(1980), which in turn is derived from the MIRD-5. The MIRD-5 phantom was
primarily designed for calculating organ doses from internal sources in nuclear
"a
medicine (Snyder et al., 1969). It then had several development phases (Snyder 1974,
Cristy 1980, Cristy and Eckerman 1987, Jones and Wall 1986, Zankl et al. 1991) to
improve it for diagnostic X-ray dosimetry purposes in conjunction with Monte Carlo
techniques.
Figure 2.3: NRPB Anthropomorphic Mathematical Phantom.
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2.3 CT Dose Descriptors
As mentioned earlier, apart from early attempts reporting doses received by
single or multiple organs from CT examinations, several dose descriptors have been
adopted and used to describe or characterise the radiation delivered by CT
examinations. These include simple single point surface dose or skin dose, and more
complicated ones such as CT dose profile, CTDI, and finally effective dose equivalent
and effective dose. In this section these dose descriptors will be explained more in
details.
2.3.1 Surface Dose or Skin Dose
These dose descriptors are based on the assumption that the personal dose to
which the patient is exposed be given as the absorbed dose at the skin or surface dose.
As mentioned in the first chapter most of the early works on CT dosimetry (Horsely
and Peter 1976, Dixon and Eckstrand 1978, Shope et al. 1982, Fearson and Vucich
1985) used either surface or skin dose as their dose descriptor for CT dosimetry.
The skin dose is measured with two perspex (plexiglass) phantoms for the
cranial region (16 cm diameter) and body region (32 cm diameter) on the surface
(measured point O, Figure 2.2). Its value is given in mGy/100 mAs by most
manufacturers and refers to the routine degree of the rotation of the scanner (normally
360°) single slice, with slice thickness and kVp value cited as parameters.
2.3.2 CT Dose Profile
Dose profile is determined free in air using a stack of TLDs along the central
axis of rotation of the CT scanner. CT dose profile shows the dose as a function of
position on the axis of rotation for the particular condition of exposure and could be
used to examine the nominal slice width of the CT scanner. It determines the
significance of spreading of the CT X-ray beam beyond the nominal slice width that is
particularly useful for examining narrow thickness settings.
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Figure 2.4 shows a typical dose profile of a two millimetre slice thickness,
recorded in this study for a GE 9000 HP CT scanner, with a routine exposure setting
used for head examinations. The peak of the dose profile could be used to estimate
the overall level of dose for a single slice. But for a series of contiguous slices, there
would be an overlap of tails of such profiles and contributions to the dose in adjacent
slices. Under these circumstances, the peak dose for a single slice would be an
underestimate of the overall dose over the region scanned. The quantity that takes
account of this build-up in dose for multiple slices is the computed tomography dose
index (CTDI) which is described in the next section.
GE9000 HP, RIE(19.12.94)
120KV,250rrA (8Sec),2nmSlice Thickness (HEAD)
Distance (rrm)
Figure 2.4: A typical free in air axial CT dose profile.
2.3.3 CTDI
CTDI is the integration of the CT dose profiles. This dose descriptor
proposed, at first, by Shope et al. (1981) in an attempt for a convenient estimation for
the approximate doses resulting from CT procedures consisting of a series of scans as
a function of the distance between scans and the system conditions of operation. This
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work was based on earlier works by Jucius and Kambic (1977) and later on by Suzuki
and Suzuki (1978) who devised a special long, thin ionisation chamber for measuring
the average dose resulting from a single scan. Shope et al. (1981) defined the CTDI
by:
+00
CTDI = (1/T) JD,(Z)dZ (Equation 2.3)
-00
Where Di(Z) is the dose as a function of position along the z axis co-ordinate
for a single scan dose profile at a given point (x, y) (Figure 2.5). T is the slice
thickness as stated by the manufacturer or selected by the CT system operator.
SOURCE
Figure 2.5: Illustration of CT system geometry and co-ordinate used for CTDI
definition by Shope et al. (1981).
Later in 1985, the US Food and Drug Administration (FDA) defined the
CTDI as an objective value for the measurement of dose integrated over 14 times the
slice width along the system longitudinal axis (Z) (FDA 1985):
+77
CTDI = (1/T) \zdZ (Equation 2.4)
-IT
34
For the purpose of dose comparison, the FDA recommended CTDI be
measured in both a 16 cm and a 32 cm perspex (plexiglass) phantom at the centre
(Measurement point A) and at a depth 1 cm from the outer surface (measurement
points B-E) (Figure 2.2).
For the purpose of this definition the FDA specified that the absorbed dose
should be stated in the perspex. These CTDI values are given as the absorbed doses in
mGy and generally referred to a tube output of 100 mAs. Due to scattered radiation
and the finite slope of the edges of the dose profiles, the CTDI value depends on the
slice thickness setting and kVp values.
The FDA definition of CTDI is used just for QA purposes and examining the
CT performances. There is also another different definition for CTDI, adopted by the
NRPB (Shrimpton et al. 1991b) and used for the national survey of CT practice in the
UK, that is also used and referred to by several other researchers in the UK and other
countries (Zankl at al. 1991). Details of this definition of CTDI are mentioned in
chapter 6 where the principles of CT dosimetry using the Monte Carlo technique in
this study are explained.
2.3.4 Effective dose
As mentioned above ICRP introduced this new weighted dose quantity in its
1990 recommendations for controlling the exposure to radiation of workers and
members of the public. Since 1977 when ICRP introduced the old version of this
quantity (effective dose equivalent), it has been used widely by most of the
researchers for reporting radiation doses to patients for most of the other
conventional diagnostic procedures like different conventional X-rays modalities in
radiology and radioisotopes in nuclear medicine. However effective dose has
weighting factors for a larger number of specified organs and tissues and is likely to
be a better indicator of the risk to stochastic effects than effective dose equivalent. In
recent years, while the significance of patient doses from CT examinations has been
notified, this quantity has also been used as a dose descriptor in CT dosimetry by most
of the researchers. This makes it possible not only to compare the radiation doses
received by different CT examination protocols and different CT scanners, but also to
35
compare the patient doses resulting from CT examinations with other diagnostic
procedures involving the use of ionising radiation.
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3. Common CT Scanner Characteristics
Medical Imaging has experienced significant changes in both the technical and
clinical arenas and developed dramatically in recent years (Seeram 1994). Modern
medical imaging makes use of a large number of tomographic techniques by which
physical properties of biological tissues are displayed in three-dimensional matrices of
volumes or voxels. Selected planes within the patient can be viewed by displaying the
two dimensional distribution when one of the three position coordinates is kept fixed.
Perhaps the most widely used of such techniques is X-ray CT in which the X-ray
linear attenuation coefficient property of body cross-sections is used to reconstruct
the cross sectional images of the body. Although the mathematical principles
underlying the method were known early in the twentieth century, it was only when
digital computers became available for implementing fast reconstruction algorithms
that CT imaging became possible. The impact in medicine has become colossal and
CT imaging is in widespread use (Webb 1990).
The first part of this chapter describes briefly the events leading to the
invention of CT. The second part embraces the basic operational principles and
technical developments of CT scanners. The last part embodies the basic features of
physical characteristic parameters and common radiological factors used for routine
examinations for every CT scanner in this study.
3,1 The Invention of CT
The word "tomography" is not new - it can be traced back to the early 1920s,
when a number of investigators were developing methods to image a specific layer or
section of the body that is oriented parallel to the film. At that time, terms such as
"body section radiography" and "stratigraphy" (from stratum, meaning layer) were
used to describe the technique. However, it was not until 1935, when Grossman, who
refined the technique labelled it tomography (from the Greek tomos, meaning section).
In 1937 Watson developed a tomographic technique in which the sections were
transverse sections (cross sections). This technique was referred to as transverse axial
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tomography. These images, however, lacked enough detail and clarity to be used as a
clinical tool in diagnostic radiology (Seeram 1994).
CT overcomes these limitations by using a procedure known as image
reconstruction from projections to produce sharp, clear images of cross-sectional
anatomy. Image reconstruction from projection had its theoretic roots in 1917 when
Radon an Austrian mathematician, proved that it was possible to reconstruct (build)
an image of a two-dimensional or three-dimensional object from a large number of its
projections from different directions (Webb 1990). This procedure has been used in a
number of fields, ranging from astronomy to electron microscopy to reconstruct the
images of the sun and the molecular structure of bacteria (Brooks and Di Chirol976,
Seeram 1994). But in medicine it was in the early 70s that this procedure was used for
the first time by Hounsfield and he announced the revolutionary medical imaging
system of X-ray CT (Hounsfield 1973).
X-ray CT has been hailed as possibly the greatest innovation in radiology since
the discovery of X-rays themselves for which Wilhelm Roentgen received the first
Nobel Prize for Physics in 1903. In this respect the year 1972 has been regarded as
the birth of CT since it was in this year the EMI scanner, the first medically useful X-
ray CT scanner, was announced (Ambrose and Hounsfield 1972, Hounsfield 1973,
Ambrose 1973, New Scientists 1972). The work built on earlier experiments and
theoretical work by A. M. Cormack and for their contribution to medicine they were
jointly awarded the 1979 Nobel Prize for Physiology and Medicine (Hounsfield 1980,
Cormack 1980). The following paragraphs outline the accounts of these two
pioneering scientists whose work led to the invention of the CT.
Allan MacLeod Cormack first considered CT in 1956. Part of his time was
spent on the Groot Schuar Hospital (South Africa) where he observed radiotherapy
planning techniques. He concluded that these could be improved if there were a map
of X-ray linear attenuation coefficient in the slice being planned - what today we
would call tissue inhomogeneity corrections. Since this problem had not been thought
and solved before, he formulated the mathematics of reconstruction from projections
for simple attenuation objects with certain symmetry, while he was not aware that it
had already been done by Radon in 1917. He applied this reconstruction technique in
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1957 to experimental data with some success. In 1963 he constructed an experimental
(positron tomography) scanner used to reconstruct the asymmetrical sections of
phantoms and published the results (Cormack 1963, Cormack 1964) but there was no
expressed interest in them for clinical use. He also foresaw the possibility of proton
CT using the sensitivity of the photon range to tissue inhomogeneity and noting that
the CT sections could be used for planning proton radiotherapy. It is sometimes
remarked that Cormack's main contribution lay in the mathematics of CT but his was
also an innovative experimental contribution to winning the joint Nobel Prize. (Webb
1990).
In 1967, Godfrey Newbold Hounsfield was investigating pattern recognition
and reconstruction techniques using the computer. From this work he deduced that, if
an X-ray beam were passed through an object from all directions, and if
measurements were made of all the X-ray transmission, it would be possible to obtain
information about the internal structure of the body. It was decided that this
information be presented to the radiologist in the form of pictures that would show
three-dimensional representations (Seeram 1994).
With encouragement from the British Department of Health and Social
Security (DHSS) to investigate the clinical feasibility of the technique, an
experimental apparatus was constructed (Figure 3.1) (Seeram 1994). This equipment
used a gamma-ray source collimated to face a single detector. Between the two a
phantom was rotated in 1° steps on a turntable. The scanning movement of the
scanner and detector were provided by a lathe bed and 28000 measurements were
recorded per slice on paper tape. The data took 9 days to collect per slice and 2.5
hours to reconstruct on a mainframe computer. A further 2 hours was required to
display an image from the digitised result. By replacing the gamma-ray source with an
X-ray source the data capture time was reduced to 9 hours. However only one image
per day was possible. The machine, the first prototype head scanner, which eventually
went into clinical trial at the Atkinson Morley Hospital took high-resolution images in
just 18 minutes. The first clinical scan was made on the 1st of October 1971, that was
of a 41 year old female with a suspected left frontal lobe tumour. The project was
carefully kept secret until the 1972 British Institute of Radiology Conference in April
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(Ambrose and Hounsfield 1972). When the news broke the scientific community were
amazed at what has been achieved. Hounsfield recognised early the applicability of CT
data in X-ray diagnosis (Hounsfield 1973). The designs of CT scanners were very
soon optimised in terms of their photon utility and, in his lecture, Hounsfield pointed
to the next logical development of essentially real-time CT scanning (Hounsfield
1972, Hounsfield 1980). The company in which Hounsfield was employed (EMI)
pioneered the commercial development of transmission CT imaging (Webb 1990).
Figure 3.1: The original lathe bed scanner used in early CT experiments by Hounsfield
ofEMI (Webb 1990).
Dr. Hounsfield's research resulted in the development of a clinically useful CT
scanner for imaging the brain. For this work, prior to the 1977 Nobel Prize for
Physiology and Medicine, Hounsfield received the McRobert Award (apparently
equivalent to a Nobel Prize in Engineering) in 1972 (Seeram 1994, Webb 1990).
As might be expected the development of CT has origins which stem back
many years to unconnected pieces of research narrated very well by Webb (1990). But
it was not until the late 1960s that what today we should recognise as modern CT
came to be achieved. This was characterised by departure from the use of film as
detector, by complex mechanical and electrical engineering to implement the
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projection data capture and by digital numerical computer reconstruction which led to
quantitative, spatially accurate sensitive mapping of the X-ray attenuation properties
of body cross-sections (ibid ). Although other workers investigated the idea of CT, it
was Hounsfield who developed the first practical CT scanner. He is recognised as the
individual who opened a whole new domain for scientists, just as Roentgen was when
he discovered X-rays (Seeram 1994).
3.2 Basic Operational Principles and Technical Developments of CT scanners
In a CT examination, the patient is exposed to a narrowly collimated beam of
X-rays at a number of angular increments. The transmitted X-rays are absorbed by a
series of detectors, and the data from these projections are used to create a two-
dimensional map of linear attenuation coefficients, i.e., an image. Figure 3.2 shows
several transverse axial images of the head and body produced by a CT scanner. The
formation of CT images by a CT scanner involves a three-step process: data
acquisition; image reconstruction; and image display, manipulation, storage, and
recording (Seeram 94).
3.2.1 Data Acquisition
The term "data acquisition" refers to the collection of X-ray transmission
measurements from the patient. Once X-rays have passed through the patient, they fall
onto special detectors that measure the transmission values. Enough transmission
measurements (data) must be recorded to meet the requirements of the reconstruction
process. This measurement technique or data acquisition process consists of various
schemes to collect data from the patient, referred to as data collection schemes
(Figure 3.3) (Seeram 1994).
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Figure 3.2: Examples of CT images of the head, chest, abdomen, and spine produced
by a modern CT scanner (Seeram 1994).
3.2.2 Image Reconstruction
Once enough transmission measurements have been collected by the detectors,
they are sent to the computer for processing. The computer uses special mathematical
techniques to reconstruct the CT images in a finite number of steps called
reconstruction algorithms.
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Figure 3.3: Data collection scheme used in the first CT brain scanner: 1, object; 2, X-
ray tube; 3, collimator; 4, head support containing a water bag; 5, crystal detector; 6,
photomultiplier tube (Seeram 1994).
3.2.3 Image display, manipulation, storage, and recording
Once the computer has performed the image reconstruction process, the
reconstructed image can be displayed and recorded for subsequent viewing, as well as
stored for reanalysis at some later time. The image is usually displayed on a cathode
ray tube (CRT), although other display technologies have now become available; for
example, touch screen technology is used for scan set-up and control in some
scanners. The CRT, however, currently remains the best device for the display of grey
scale imagery. Display monitors are mounted onto control consoles that allow both
the technologist (operator's console) and radiologist (physician's console) to
manipulate, store, and record images (Seeram 1994).
3.3 Historical Development of CT
The clinical usefulness of CT quickly became established, because the
technique made possible the demonstration of a wide variety of diseases of both the
head and body. Numerous developments in this technology were made 10 years after
its introduction, not only in the technical arena but also in the clinical sphere (Seeram
1994).
In the first 10 years of CT, the number of units installed world-wide increased
dramatically. Perhaps the first significant technical development came in 1974 when
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Ledly, a physicist from Georgetown University, developed the first whole-body CT
scanner (Hounsfield's scanner referred to as EMI scanner, was restricted to scanning
only the head). This was followed by the introduction of three "generations" (a term
used to refer to the method of scanning) of CT scanners. In 1974, a fourth generation
CT system was developed. These four basic types of scanning system are illustrated in
Figure 3.4 (Seeram 1994).
The first prototype CT scanner introduced by Hounsfield (1973) had a single
detector and a pencil X-ray beam, which moved in a translate-rotate manner, i.e., the
detector and X-ray tube translated along a line parallel to the image plane acquiring
data. The tube and detector were then rotated one degree, and the process repeated.
In this CT version a finely collimated source defines a pencil beam of X-rays, one
sample at a time, by stepping linearly across the patient. After each projection, the
gantry rotates to a new position for the next projection (Figure 3.4). This system was
very slow, however, with typical acquisition time of 4 min per section, even for
relatively low-resolution images (Webb 1988).
To overcome the problems of slow scan times and poor resolution, a second
generation was devised with multiple detectors (a bank of detectors) and a small fan
shaped X-ray beam (~ 10°) (Figure 3.4). This assembly, which was the first
commercial CT scanner, traversed the patient and measured N parallel projections
simultaneously (N is the number of detectors). The gantry angle incremented by an
angle equal to the fan angle between consecutive traverses (Webb 1988). The second
generation retained the original translate-rotate motion. Data gathering was speeded
up considerably (~ 20 s).
In the third generation of CT scanners, the translate motion of the tube and the
detectors was replaced with a rotate only motion. A broad fan-shaped X-ray beam is
used to cover the whole field of view (Figure 3.4) with several hundred detectors, and
the entire tube-detector system rotates around the machine's isocentre. Consequently,
the gantry needs only to rotate, in a continuous movement, and the data gathering can
be done in 4-5 s. Detector balancing is critical for this geometry if circular ring
artefacts are to be avoided. Xenon gas chamber detectors are often chosen because of





: i ■' ' 'M ?&<&*&—. """*"•
'r * -'- '/W l- 'M V«S<«>«
,"T'■'>•V'-?K» ^oy . •
jyV,>.'-.Ml te*-^'1,1*'""
\'Jh)i Ft—•—frmmn
" Y'-V* I j ' ! /"'X'"' /if f u ' <"<(<*>
i * If' IH /
, 7,7 im'Mkl.i.u.i I f i CU—W.'WA'
■ -.*•.• ..;...
fotettar Array








A'" Generation CT Scanner
(Fa* Beam, stationary C<rtv>»r Detected
X'Bay Source
3'" Senerction CT Scanner
(Fen Beam, Bototf Only!
Figure 3 .4: Four generations of CT scanners illustrating two types of beam
the parallel beam and the fan beam (Seeram 1994).
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The fourth generation CT scanner has stationary detectors (typically 1000)
and only the X-ray tube rotates around the patient (Figure 3.4). Scan speed remains
fast and the ring artefact is overcome and since every detector is, at some time during
the scan, sampling the unattenuated X-ray beam, calibration in "real time" can be
performed (Webb 1988).
A new type of CT scanner has been developed by Imatron1. This model has no
moving parts. In these scanners, the patient lies on a large evacuated chamber. An
electron beam is scanned across a series of small tungsten targets lining the interior of
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the evacuated chamber. These targets act like the anode in a standard X-ray tube and
produce X-rays which are collimated, traverse the patient, and are detected by an
array of detectors. Both the tungsten targets and the array of detectors cover an arc of
210° (Figure 3.5).
cata acquisition system
continuous acquisition of CT data
up to 40 levels in i8 seconds
ELECTRON SUN
permits 640 mA of x tay power
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TARGET-RING
comprised of muftipie targets for optimal
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Figure 3.5: Major components of the Ultrafast CT scanner (Imatron) (Webb 1988).
These machines have the advantage of fast (50-100 ms) scan time but have
slightly poorer image quality than conventional CT scanners (Atherton 1993). This
high speed scan time permits cardiac motion to be frozen. This will allow clearer
images not only of the heart but also of organs that are well perfused with blood, such
as the liver, and which pulsate in synchrony to the heart beat. Mechanical movement is
ruled out and multiple stationary sources are prohibitively cumbersome and expensive
(Webb 1988).
One problem with the third generation scanners is the ring artefact caused by
detector failures. Ring Artefacts with 4th generation machines are not seen and their
design presents "on the fly" calibration of the detectors. However improved stability
1
Imatron Inc., San Francisco CA 94080.
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of the components has largely eliminated these problems with the 3rd generation
machines and most of the modern and state-of-the-art CT scanners are this type.
Therefore classifying CT scanners based on the generation does not seem to be a valid
nomenclature. It would seem more relevant if CT scanners are classified based on
their scanning motions. Apart from the last CT type (Imatron) mentioned above,
which could be regarded as a special purpose designed type, CT scanners could be
classified in three classes of: Rotate-Translate (RT), Rotate-Rotate (RR) and Rotate-
Stationary (RS) (or Rotate-Fixed or Rotate-only (Webb 1990, Seeram 1994, Romans
1995)). Using these terms, for example, the first and second generations could be
regarded as RT, the third generation as RR, and the fourth generation as RS CT
scanners. Modern CT scanners are either RR or RS. The RT CT scanners are no
longer in clinical use.
3.4 Technical and Computing Development of CT
CT has acquired visibility well beyond its role in medicine or even in
radiology. No one can deny that non-invasive diagnostic approaches are an extremely
important development (Moss and Goldberg 1980).
As discussed above the CT process can be broken down into three segments:
data acquisition, image reconstruction, and image display. In this section
developments taken place in these segments are discussed.
3.4.1 Data Acquisition Developments of CT
The components that are involved in the data acquisition phase of image
creation are the generator, the gantry, and the patient table. The gantry houses the X-
ray system (comprising of X-ray tube, X-ray beam filter, and collimators), and
detectors.
3.4.1.1 Generator
The generator produces high voltage and transmits it to the X-ray tube. CT
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scanners use three-phase power for the efficient production of X-rays. In the past,
generators for the CT scanners were based on either the 50-Hertz (Hz) (Europe) or
the 60-Hz (North America) voltage frequency, and the high voltage generator was a
bulky piece of equipment located in a corner of the X-ray room. CT scanners now use
high frequency generators, which are small, compact, and more efficient than
conventional generators. As a result, these generators are located inside the CT gantry
and even in some modern CT scanners it is mounted on the rotating frame of the
gantry with the X-ray tube. It is necessary to mention that spiral-helical CT, a new
type of CT examination which will be explained later, is made possible through the
use of slip-ring technology, which allows for continuous gantry rotation. Today most
CT scanners incorporate slip-ring design and, as a result, have been referred to as
continuous rotation, volume CT, or slip-ring scanners. Such rotation results in very
fast data collection. Slip-rings are "electromechanical devices consisting of circular
electrical conductive rings and brushes that transmit electrical energy across a rotating
interface" (Brunnett et al. 1990).
3.4.1.2 X-ray tube
Formerly RT CT scanners (1st and 2nd generations) used fixed anode, oil-
cooled X-ray tubes, but because of the demand for increasing output resulting from
faster scan times typical of modern CT scanners, rotating anode X-ray tubes have
become standard in CT. These tubes produce a beam of radiation from a large
diameter anode disk with focal spot sizes to facilitate the spatial resolution
requirements of the scanner. The introduction of spiral CT, made possible with
continuous rotation scanners, has placed new demands on X-ray tubes. Because of the
continuous rotation of the tube for a long period of time (compared with conventional
scanners), it must be capable of sustaining higher power levels. One significant change
for slip-ring scanners is that they are designed to increase not only the heat storage
capacity but also the cooling rate (dissipation).
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3.4.1.3 Filtration
Ideally the photon beam for CT scanners should be monochromatic, but this is
not achievable in practice. It is essential, therefore, that the polychromatic beam be
shaped so that it appears to be a monochromatic beam to satisfy the requirements of
the reconstruction process.
Without filtration the X-ray polychromatic beam will result in the beam
hardening artefact. One purpose of using filters is to reduce this effect. Two types of
filters are used in CT scanners. One is a substance such as aluminium and copper
which reduces the range of X-ray energies that reach the patient. This removes soft,
or low energy, X-ray beams which do not play a role in CT image formation and
minimises patient doses. On the other hand because of the circular shape of the cross
section of the body the radiation path through the body varies. Hence certain filters
are used to reduce the beam intensity at the periphery of the beam, corresponding to
the thinner areas of patient's anatomy, and shape the profile of the radiation beam to
make it more uniform. In this respect specially shaped filters have been designed for
CT scanners. The shape of these filters should conform to the shape of the object
being scanned. Because of their shape these types of filters are often referred to as
"bow tie filters". These filters are positioned between the X-ray tube and the patient,
and shape the beam to produce a more uniform beam at the detectors.
3.4.1.4 CoIIimation
The main purpose of collimation is to produce a beam of the required width
for the slice thickness of interest being scanned. On the other hand it also protects the
patient by restricting the beam only to the anatomy of interest. In CT collimation is
important, because it not only protects the patient by restricting the beam only to the
anatomy of interest but also improves image quality by reducing the effects of
scattered radiation.
In CT two collimators are used: pre-patient or proximal collimators and post-
patient or pre-detector or distal collimators. In general a set of collimator sections is
carefully arranged to shape the beam. The collimators, both proximal and distal are
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arranged to ensure constant beam width at the detector and therefore define the
thickness of the slice to be imaged. Slice thickness is generally variable and can range
from 1.0 to 12 mm, depending on the type of the scanner. Pre-detector collimators
also help remove scattered radiation and therefore improve contrast resolution and
consequently image quality.
3.4.1.5 Detector Characteristics
To be useful in CT, a detector must exhibit several characteristics that are
essential for CT image production. These include efficiency, response time, dynamic
range, high reproducibility, and stability. It should be noted that the total detector
efficiency, referred to as the dose efficiency, is the product of capture efficiency,
absorption efficiency, and conversion efficiency that is often listed in the product
specification literature by CT manufacturers.
Two types of detectors are used in CT scanners: scintillation detectors and
ionisation detectors.
Scintillation detectors
In the past scintillation detectors consisted of a scintillation crystal coupled to
a photomultiplier (PM) tube. Early scanners used sodium iodide (Nal) crystals. Later,
because of afterglow problems and the limited dynamic range of Nal, other crystals
such as calcium fluoride (CaF2) and bismuth germinate (BuGejOn, BGO) were used.
Today, scintillation detectors with PM tubes have been superseded by scintillation
crystal detectors with solid-state photodiodes. Photodiodes are normally used with
amplifiers because the output from the diode is very low. In addition the response
time of a photodiode is extremely fast, about 0.5 to 250 nanoseconds, depending on
its design. Solid state crystal detectors are made from a variety of materials. Two
scintillation materials that are currently used with photodiodes are cadmium tungstate
(CdW04) and a ceramic material made of high-purity, rare earth oxides. These
crystals are optically bound to the photodiodes. The advantages and disadvantages of
these two scintillation materials can be discussed in terms of the detector
characteristics mentioned earlier. Specifications literature should be consulted for
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details of the performance of these detectors (Villafana 1987, CT manufacturers
product specifications catalogues).
Gas lonisation Detectors
The gas ionisation detectors were introduced with the development of third-
generation scanners. These consist of a series of individual gas chambers usually
separated by tungsten plates to prevent cross over of scattered radiation. The gas
chambers are filled with high pressure xenon and are up to 50 mm deep to increase
the detector efficiency which is within the range of 35%-50%. The signal current,
resulting from the ionisation of the gas is proportional to the number of photons
absorbed by the chamber. Xenon detectors offer good stability with fast response
times, and do not have afterglow problems. Modern CT scanners use an arrangement
referred to as detector modules, in which the entire array of detectors consists of
groupings of detectors. Each grouping is known as a detector module, and each
detector module plugs into a mother board unit of the detection system.
3.4.2 Image Reconstruction Developments of CT
Image reconstruction techniques were first developed for use in
radioastronomy by Bracewell (1956) for the purpose of identifying regions of the sun
which emitted microwave radiation (Brooks and Di Chiro 1976). The introduction of
the first X-ray CT scanner in 1972 by EMI Ltd (Hounsfield 1973) was preceded by a
number of less sophisticated experiments and demonstrations very well explained in
the Brooks and Di Chiro's review article (1976). In these experiments the back
projection mathematical approach was used for image reconstruction. This is a crude
method of reconstruction easily implemented without need of a computer or
sophisticated mathematics but produces reconstruction with substantial artefacts.
The "back projection technique", also referred to as the "summation method"
or "linear superposition" method, was first used by Oldendorf in 1961 and Kuhl and
Edwards in 1963 (Seeram 1994). Since this technique does not produce a sharp image
of the object it is not used in clinical CT (ibid.).
Another approach to image reconstruction is based on "iterative techniques".
An iterative reconstruction starts with an assumption and compares this assumption
with measured values, makes corrections to bring the two into agreement. This
process is repeated until the assumed and measured values are the same or within
acceptable limits (Curry et al. 1990). The algebraic reconstruction technique was one
of several different iterative techniques which was used by Hounsfield in the first EMI
brain scanner (Hounsfield 1972). Because of the limitations of these techniques they
are not used in commercial scanners nowadays (Seeram 1994).
The third category of reconstruction algorithms used in CT is the "analytical
reconstruction method" based on exact mathematical solutions to the image equations
and is faster. These algorithms have been developed to overcome the limitations of
the back-projection and iterative algorithms. These algorithms are used in modern CT
scanners and have sound mathematical bases (ibid.). The two analytical reconstruction
algorithms are "filtered back-projection" and the "Fourier" reconstruction algorithms.
The filtered back-projection, used in most commercial CT scanners, is also referred to
as the "convolution method". This is similar to the back-projection technique, but its
striking difference is that the projection profile (data) is filtered or convolved (using
mathematical filters) to remove the problem of image blurring characteristics of simple
back-projection (ibid.). The Fourier reconstruction technique is a practical algorithm
used by some CT scanners, based on the Fourier theorem. Essentially, Fourier
reconstruction transforms the object from the spatial domain to the frequency domain
using Fourier transform. All the projection data collected from the object are Fourier-
transformed into spatial frequencies, which are subsequently interpolated onto a
rectangular grid. Finally by using inverse Fourier transform, the interpolated image is
converted into a spatial domain image.
Another most recent reconstruction algorithm is the "3D algorithm". Three-
dimensional CT imaging uses 3D surface and volumetric reconstruction. The
algorithms for 3D imaging are based on those used in such fields as computer
graphics and visual perception science. Essentially these algorithms are based on at
least two processes, pre-processing and display, and consist of the following four
operations: interpolation, segmentation, surface formation, and projection. A
comprehensive report on 3D algorithms has been published by Udupa and Odhner
(1991).
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For more detailed description of image reconstruction techniques the reader is
referred to several reviews in this regard (Brooks and Di Chiro 1975, Brooks and Di
Chiro 1976, Edholm 1975, Peters 1975, Gordon et al. 1975, Budinger and Gullberg
1974, and Gordon and Herman 1974, Strong et al. 1990, Udupa and Odhner 1991,
Seeram 1994).
3.4.2.1 Three-dimensional imaging
Three-dimensional (3D) imaging has become a popular technique in CT
because of the availability of large amounts of digital data. 3D imaging is now
possible on CT scanners and the results have been promising. 3D-CT is already being
used in radiation treatment planning, craniofacial imaging, surgical planning, and
orthopaedics (Seeram 1994).
3D images can be obtained by using a hardware-based or software-based
approach. The hardware approach uses specialised equipment such as electronic
computer display units to execute algorithms (sets of instruction to carry out a
particular task) for 3D imaging, and the software approach uses computer
programmes (software-coded algorithms). These algorithms have been referred to as
rendering techniques. These techniques transform the transaxial CT data into
simulated 3D images (Figure 3.6). 3D CT has opened up a whole new area of interest
for scientists (ibid.).
One area of computer science that has played a role in the evolution and
refinement of 3D imaging is computer graphics. Computer graphics involves the
creation, manipulation, and display of pictures or images using the computer. It allows
the user to express ideas and information in a visual format. It includes various ways
to represent data to create and display images using graphics programming languages
and image processing techniques.
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Figure 3.6: Examples of 3D images now available through CT technology (Seeram
1994).
3.4.2.2 Spiral or Helical CT
The need for shorter scan times to sub-second levels and for improvements in
three-dimensional imaging, as well as the limitations imposed by conventional start-
stop CT systems in which the data is acquired slice-by-slice, has been met and
overcome by the development of continuous rotation scanners. These scanners are
based on the use of slip-ring technology, which makes it possible to acquire the data
in volumes- that is, complete organ volumes or sub-volumes, rather than slice by slice.
Continuous rotation CT scanners have led to the introduction of a new
scanning technique that may be considered as one of the most significant recent
developments in CT, and that has become common in CT applications. This technique
is referred to as spiral, helical or volume CT. In the rest of this section this technique
will be referred to as spiral CT.
The spiral method uses a continually rotating X-ray gantry with constant X-
ray outputs and uninterrupted table movements. Required data for each
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reconstruction slice is interpolated at each projection angle from the data measured on
either side of the slice. The pitch of a spiral scan is defined as the ratio of distance
made by the patient per revolution of the tube and the slice width. Increase of pitch
reduces dose and scan time but increases the uncertainties in the interpolated values.
Spiral scanning has the advantage in reducing scan times and eliminating slice
misregistration. This is of particular importance in examinations of the chest in which
detail can be lost in conventional scanners due to inconsistent breath holds from slice
to slice. It is also of great benefit to remove movement artefacts when undertaking 3-
D reconstruction method. The data volume may be viewed as conventional transaxial
images or with multiplanar and three-dimensional methods. Spiral scanning is already
of proved efficacy for vascular and airway imaging as well as for identifying and
characterising pulmonary nodules. It may be anticipated that the indications for the
use of spiral imaging will continue to expand. Of particular interest is the ongoing
development of reconstruction algorithms that allow high-quality images to be
obtained with rapid table incrementation while simultaneously reducing radiation
exposure (Naidich 1994).
3.4.3 Image Display Development of CT
From another angle, CT is classified as a digital imaging system because it
uses computers to process images. In CT scanning computers are used to control the
operation of the scanner, to reconstruct the transaxial or spiral image, display and
manipulate the image and also for further 3-D reconstruction.
Developments in computer hardware including processing speed, memory
size, storage capacity, display system and data transmission have had major influence
on CT capability. On the other hand software developments in the recent years and
the recent achievement of image processing techniques have brought significant
benefits to CT. These benefits are made possible through the use of special image
processing algorithms. For example, CT images can be enhanced, restored and
analysed.
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3.5 Basic Physical Characteristics of the CT scanners
This section outlines the basic physical characteristic parameters of various
models of CT scanners used in this study. These are routine radiological technique
factors including kV, mA, scan time and mAs; tube characteristics, geometry; and
filtration characteristics. It must be considered that the peak electrical potential across
the X-ray tube is abbreviated as "kV", the current through the X-ray tube is
represented by "mA", and the product of the exposure time and the tube current is
abbreviated as "mAs". The reported CTDI values by manufacturers mentioned in this
section are based on the FDA definition of CTDI and CT dosimetry phantoms (US
Office of Federal Register 1984). However for some of the CT models in this study,
manufactured before the above regulations became made effective, the CTDI values
were presented for different values of mAs. Therefore to make all the CTDI values
concordant and in accordance with the ImPACT2 reports, they are expressed in
mGy/lOOmAs for all different models of CT scanners in this section.
Information regarding the physical characteristics of the CT scanners in this
study derived from the technical and user manuals provided by the relevant
manufacturer and also from the ImPACT reports (MDD 1991, MDA 1994, MDA
1995) if they were available.
Several types of CT scanner are used at different hospitals in the Lothian and
Fife areas of Scotland. When this study started there were several models from three
different CT manufacturers, namely: Siemens 3; GE Medical System 4; and Philips 3.
Different models of CT scanners were operational at different hospitals. The
operational CT scanners at the Western General Hospital (WGH) of Edinburgh were
a model of Siemens and a model of GE Medical System. However the older type of
GE scanner at this hospital was replaced with a GE HiSpeed Advantage scanner in
1996. In the Royal Infirmary of Edinburgh (RIE) all operational scanners were made
2 ImPACT (Imaging Performance Assessment of Computerised Tomography) is the MDA's
(Medical Device Agency, formerly Medical Devices Directorate(MDD)) CT evaluation facility of
the UK Department of Health (London WC1B 5EP)
3
Siemens Aktiengescllschaft, Medical Engineering Group HenkestraBe 127, D-8520 Erlangen,
Germany.




by GE Medical System. When this study started the GE HiSpeed Advantage CT
model was not in use at the RIE. After installing this new model of CT scanner at RIE
in late 1995, the other relatively older scanners were taken out of clinical use. The
two older types of GE CT scanners at the RIE and the WGH (GE 8800 and GE 9000
HP) were included in the national dosimetry survey on CT scanners in the UK
(Shrimpton et al. 1991a and 1991b, Jones and Shrimpton 1991). Therefore performed
measurements on these scanners were quite necessary to be able to compare different
dosimetry methods used in this study with each other. The CT scanner of St. Johns
Hospital in Livingston was a Tomoscan model of Philips. Finally the CT scanner of
Queen Margaret Hospital in Dunfermline district (QMH) was a GE Sytec 3000 Plus
model. The locations, manufacturers and models of all the CT scanners used in this
study are summarised in Table 3.1. Since there were two identical models of GE
scanners (8800 & HiSpeed Advantage) operating at the RIE and the WGH, the dose
measurement was carried out only on one of these CT scanners.
Table 3,1: The locations, manufacturers, and models of the CT Scanners.
CT Scanner Locations CT Scanner Type








RIE (Edinburgh) Radiology GE HiSpeed Advantage
8800 *
9000HP *
QMH (Dunfermline) X-Ray GE Sytec 3000 Plus
St. Johns (Livingston) Radiology Philips Tomoscan CX/S
* These models are no longer in clinical use.
3.5.1 Siemens Somatom Plus
This scanner is a high-voltage slip-ring RR scanner. It features a continuously
rotating tube-detector system and functions according to the fan beam principle with
spiral capability. Spiral scanning of a volume of up to 30 cm long is achieved with
continuous table feed and continuous data acquisition.
Three peak tube potentials available are 80, 120, 137 kV. However, Siemens
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recommends that 120 kV be used for optimised standard operation, 80 kV for special
application, and 137 kV for contrast enhancement in strongly absorbing regions, e.g.
spine or shoulder. The tube current range available is from 70 to 320 mA, and the
scan times available are: 0.7 (for 240° rotation); 1; and 2 sec (for 360° rotation). The
generator has a high-frequency waveform with continuously supplied voltage.
The X-ray tube has a flying focal spot with two nominal focal spot sizes of
I.3x1.2 mm and 0.8x0.9 mm. The inherent filtration is equivalent to 2.7 mm A1
equivalent at 120 kV.
The available slice thickness settings (1, 2, 3, 5, andlO mm) are specified at
the isocentre. The source-to-isocentre distance is 70 cm, and the source-to-detector
distance is 113.5 cm. There are two scan angles (240°, and 360°) available with this
scanner. The gantry tilt range is ±25° with respect to vertical.
The CTDI values are reported by the manufacturer for this scanner for both
standard and spiral techniques and for different slice thickness settings. But we just
mention the values for 10 mm slice thickness here.
For conventional CT, using the standard head phantom and the recommended
techniques (10 mm, 360° ), reported CTDI values (in mGy/lOOmAs) are: 2.2 (80 kV),
8.5 (120 kV), and 11.0 (137 kV) in the centre; and 2.5 (80 kV), 9.2 (120 kV), and
II.7 (137 kV) in the maximum value position (1 cm from the edge of the phantom).
But for the standard body phantom the reported CTDI values are: 0.7, 3.4, and 4.5 in
the centre; and 1.7, 6.4, and 8.3 in the maximum value position for 80, 120 and 137
kVs respectively.
For spiral CT, using the same standard technique, the CTDI values (in
mGy/100mAs) are reported just for 120 kV. These values are: 8.5 and 3.4 in the
centre; and 9.2 and 6.4 in the maximum value for the standard head and body
phantoms respectively. This indicates that based on the manufacturer data the CTDI
values are the same for both of the conventional and the spiral examinations for this
CT scanner.
58
3.5.2 GE HiSpeed Advantage
This model is the GE top-of-the-range CT scanner. It is also a RR slip-ring CT
scanner with helical (spiral) capability.
Four peak tube potentials are available (80, 100, 120, 140 kV), with 140 kV
recommended by GE for standard head scans in America, whereas in Europe 120 kV
is more commonly used. The tube current range available is from 40 to 400 mA, with
10 mA increments. The scan times available are: 1, 2, 3, and 4 (for 360° acquisition,
full scan), and 0.6 sec (for 225° acquisition or partial scan). The generator is a high-
frequency on-board or gantry mounted with continuous operation, and low voltage
generator with 48 kW output power .
There are two focal spot sizes: 0.7x0.9 mm and 1.2x1.2 mm. The smaller one
being automatically employed for tube currents of 200 mA or less.
The inherent tube filtration is equivalent to 2.7 mm A1 equivalent at 140 kV
and the anode angle is 7 degrees.
All slice widths: 1,3,5,7, and 10 mm, specified at the isocentre, are collimated
on the tube side of the patient. A routine scan time of 1 sec, with 1 sec inter-scan
delay, is available as standard on this model. With the continuous scan option, scans
can be acquired continuously for up to 60 sec with no inter-scan delay, and may be
carried out either with helical with or without (cine) table incrementation. The helical
scan pitch is variable between 1:1 and 2:1. The focus to isocentre distance is 63 cm,
and the focus to detector distance is 109.9 cm. There are two scan angles (360°, and
225°) available with this model, although 360° is routinely used. The gantry tilt range
is ±30°, in 0.5° increments.
The manufacturer has reported the CTDI values, using the standard scan
techniques, regardless of the scan being conventional or helical. The reported CTDI
values (in mGy/100mAs) for the standard head phantom are: 11.8 (120 kV), in both
the centre and the maximum value position; Whereas for the standard body phantom
these values are: 3.2 (120 kV) and 5.9 (120 kV) in the centre and the maximum value
position respectively.
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3.5.3 GE SYTEC 3000 Plus
This CT scanner is also a GE RR model and employs a continuous rotation
fan-beam design, with rotation of both the X-ray tube and detectors.
The peak tube potential is 120 kV. The tube currents available with this
scanner are: 40, 60, 80, 100, 130, and 160 mA; and the scan times available are 1.8,
2.7, and 4.5 sec.
The scanner X-ray tube has just one focal spot size with the nominal size of
0.7 mm x 0.9 mm.
The four slice widths available with this scanner (1, 3, 5, 10 mm) are specified
at the isocentre. The tube-to-isocentre distance is 52.5 cm. There are two scan angles
available with this model; partial scan for the lowest scan time and full 360° rotation
scan for the other scan times. The gantry tilt range is ± 25°.
The inherent filtration is equivalent to 2.7 mm A1 equivalent at 140 kV and the
anode angle is 9 degrees.
The reported CTDI values (in mGy/100mAs), using the standard head
technique, are: 62 in the centre and 62-65 in the locations 1 cm under the edge of the
standard head phantom. For the standard body phantom, using the same standard
technique, the reported CTDI values are: 19 in the centre and 32-36 in other locations
1 cm from the edge of the phantom.
3.5.4 GE 9000HP
This CT scanner is an early GE RR model that employs a continuous rotation
fan-beam design, with rotation of both the X-ray tube and detectors.
The X-ray tube peak potential is 120 kV. The tube currents available are 50-
250 mA; and the scan times available are 3, 5 and 8 sec. The generator is a pulsed
constant potential. The pulse length time is 3.7 millisecond, and the number of pulses
are 344, 460, and 576 for scan times of 3, 5 and 8 sec respectively.
The inherent tube filtration is equivalent to 2.7 mm A1 equivalent. The unit has
two shaped filters of PMMA type; one for head examinations and the other one for
body examinations.
60
The three available slice widths (2, 5, 10 mm) are specified at the isocentre.
The focus-to-isocentre distance is 78 cm. There are two scan angles of 212°, and
360° available with this model, although 360° is routinely used.
The CTDI values, using the recommended head technique, are: 6.2 in the
centre and 5.4-6.0 in the locations 1 cm under the edge of the standard head phantom.
For the body phantom, using the same technique, the CTDI values are: 1.2 in the
centre and 1.9-2.5 in other locations 1 cm from the edge of the phantom. These values
are in mGy/lOOmAs unit; converted from the values reported by the manufacturer in
another unit.
3.5.5 GE 8800
This is another early RR model of GE CT scanners that employs a continuous
rotation fan-beam design, with rotation of both the X-ray tube and detectors.
The X-ray tube peak potential is 120 kV. The tube currents available are 20-
600 mA, and the scan times available are 6, 7, and 12 sec, although the 12 sec is
routinely used. The generator is a pulsed constant potential. The pulse length time is 4
msec and the number of pulses are 288, 342, and 576 for the respective scan times of
6, 7 and 12 sec.
The three available slice thickness settings (1.5, 5, 10 mm) are specified at the
isocentre. The source-to-isocentre distance is 78 cm. There are two scan angles of
212°, and 360° available with this model, although 360 is routinely used.
The inherent filtration is equivalent to 2.7 mm A1 equivalent at 120 kV. The
unit has two shaped filters of PMMA type; one for head examinations and the other
one for body examinations.
No CTDI values have been reported for this CT model by the manufacturer.
3.5.6 Philips Tomoscan CX/S
Like the previous models this model is also a RR CT scanner that employs a
continuous rotation fan-beam design, with rotation of both the X-ray tube and
detector.
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Only one peak tube potential is available (120 kV) with this scanner. The tube
current range available is from 120 to 370 mA (120, 170, 220, 270, 320, 370), and
the scan times available are 2.8 (for 224° rotation), 4.5, and 9 sec. The generator is a
pulsed constant potential with a 3.0 (msec)/8.3 (msec) ratio of pulse width to pulse
period.
The three slice widths available with this scanner (2, 5, and 10 mm) are
specified at the isocentre. The source-to-isocentre distance is 60 cm. Two scan angles
of 224 °, and 360 ° are available. The partial rotation is used with 2.8 sec scan time
and the full rotation with the other scan times. The gantry tilt range is ± 20 °.
The inherent filtration is 1.0 mm A1 plus 0.1 mm Cu and the anode angle is 9
degrees. Information on the collimator adapter was provided by the manufacturer for
this CT model.
Neither the manufacturer nor the MDA has reported the CTDI values for this
model of Philips CT scanner.
3.6 Routine CT Examination Protocols
Several different protocols were in use for routine examinations performed by
the CT scanners in this study. However, not all of these protocols were commonly
used. Therefore, through consulting with the CT users, radiologists and
radiographers, the most common examination protocols as used for the head, chest,
abdomen and pelvis areas of the body were chosen. The routine radiological factors
were determined for all the routine protocols. These factors include: kV; mA and scan
time (or mAs); slice width (thickness); couch increment (table feed) for conventional
or pitch value for spiral or helical examinations; number of slices (or scan volume);
and the starting position of scans. The radiological factors for all the common CT
examinations performed by all the CT scanners are mentioned in chapter five and six
where the dosimetry results are presented. It must be noted that all examinations were
assumed to be performed with the patient in supine position and from the head
towards the toe, except for the head region examinations where the scans are
normally performed from the toe towards the head.
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Based on the determined locations of organs or regions of the body in an
anthropomorphic physical phantom (Rando Alderson), the patient related data (scan
starting position and scan volume) were adopted for the phantom. This was carried
out in a way to simulate an average size patient for every specific routine CT
examination. Details of the modifications to the phantom made for this purpose are
mentioned in the next chapter. In addition, the patient related data (scan starting
position and scan volume) were also adopted for the mathematical phantom
(Shrimpton et al. 1991a, Shrimpton et al. 1991b, Jones and Shrimpton 1991) in a way
to simulate every common CT examination being performed for an average size




The dosimetric phantom used in this study was a complex-realistic body
(anthropomorphic) Rando phantom. The phantom is composed of various tissue
substitutes and real human skeleton simulating the human body with respect to size,
shape, spatial distribution, mass density and radiation interaction. Although this type
of phantom has originally been designed for use in radiotherapy dosimetry, its physical
properties, namely its tissue-equivalence (density and elemental composition), and the
suitability of its tissue substitute has also been investigated for X-rays of diagnostic
qualities by Shrimpton et al. (1981). From their reported results it has been concluded
by several authors (Huda and Sandison 1985, NRPB 1990) that the Rando phantom is
suitable for dose determinations at the relatively high photon energies that are typical
for CT examinations.
4.1 Reference (Standard) Man
In estimation of radiation doses to the human body from external sources like
CT, apart from the spatial distribution of dose over the body, it is necessary to take
into account the interaction coefficient of X-rays for different types of materials
composing each organ or tissue of interest. This requires a certain amount of data
about the mass and elemental composition of the organs and tissues concerned. Hence
to achieve this, reference was made to the ICRP report of the Task Group on
Reference Man (ICRP 1975). The elemental compositions recommended by the ICRP
for all organs and tissues of interest were used for calculating the relevant interaction
coefficients of X-rays produced by the CT scanners in this study. Details of the work
carried out in this regard are explained in the following chapter, where our developed
direct CT dosimetry method has been described.
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4.2 Description of the Physical Phantom
The dosimetric phantom used for CT dosimetry in this study was an
anthropomorphic Rando Alderson type (RT-HUMANOID PHANTOM) produced by
Humanoid Systems, Incorporated, USA (Alderson et al. 1962). This is an Average-
Man Rando phantom (Figure 4.1). Two Rando Breast phantoms were also obtained
that can be attached to the Average-Man to simulate a female phantom (Figure 4.2).
Figure 4.1: The Alderson Rando phantom.
The Average-Man Rando phantom has no limbs and consists of 36
sequentially numbered sections (0 to 35) each 2.5 cm thick with section 0 located at
the top of the head and section 35 located at the upper most region of the thighs that
is about four times thicker than other sections (Figure 4.1). The breast phantoms are
cut into 2-cm-wide sections in the frontal plane (Figure 4.3). The phantom is modelled
about a 50th percentile human skeleton, 175 cm (5' 9") tall and 77 kg (162 lbs) in
weight. The phantom is comprised of a human skeleton embedded in tissue equivalent
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material and the lungs are simulated by lung equivalent material. The lung equivalent
material is made of a plastic foam material providing normal radiographic appearance
(Figure 4.4).
•_ 'v' :;"'A
Figure 4.2: The Alderson Rando phantom with breast sections.
Figure 4.3: The breast phantoms, cut in two sections in frontal plane with the holes
for holding the dosimeters.
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Figure 4.4: A CT image (topogram) of the chest, abdomen and pelvis regions of the
Rando phantom showing the embedded human skeleton and two different materials
used to simulate soft tissues and lungs in the phantom.
4.3 Positioning of Organs and Tissues in the Phantom
For calculating effective dose equivalent (ICRP 1977) and effective dose
(ICRP 1991) resulting from CT practices it was necessary to determine the doses
received by all those organs and tissues recommended by the ICRP. These organs and
tissues are gonads, red bone marrow, colon (lower large intestine), lung, stomach,
bladder, breast, liver, oesophagus, thyroid, skin, and bone surface, which all have a
significant and quantified risk of induced cancer. A group of tissue or organs has also
been regarded as "Remainder", that is composed of the following additional tissues
and organs: adrenals, brain, upper large intestine, small intestine, kidney, muscle,
pancreas, spleen, thymus, and uterus. These are the organs that are likely to be
selectively irradiated and some of them are known to be susceptible to cancer
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induction but for which the risk has not been accurately estimated yet. Therefore it
was required to determine the location and proportion of these organs and tissues in
the phantom.
The location of organs and tissues of interest, in each section of the phantom,
were demarcated using an atlas of human cross-sectional anatomy (Ellis et al. 1991).
In this regard, based on the position of the skeleton, embedded in the phantom, the
position of every organ and tissue of interest was determined and its approximate
boundary was demarcated in each section of the phantom. Figure 4.5 shows four
typical sections from the head (Section 2), chest (Section 14), abdomen (Section 26),
and pelvis (section 31) regions of the Rando phantom illustrating demarcated
positions of the organs and tissues of interest. The estimated location of all organs and
tissues of interest in every individual section of the Rando Alderson phantom are
collected in Appendix A.
Figure 4.5: Four typical sections from head (Section 2), chest (Section 14), abdomen
(Section 26), and pelvis (section 31) regions of the Rando Alderson phantom showing
demarcated positions of organs and tissues of interest.
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The skeleton was not embedded very well in the phantom and its location
within the sections of the Rando phantom was not anatomically correct at all levels.
Comparing with the normal position of the skeleton within the body it seems that it
has been slightly moved towards the posterior within those sections comprising the
head part (Figure 4.6), but moved towards the anterior within other sections
comprising the abdomen part (Figure 4.7) of the phantom. In other words the
skeleton was displaced in the anterior/posterior direction in many sections. This
required certain compromises in determining the location of organs in the Rando
phantom. Therefore although the position of skeleton was taken as a reference point,
necessary corrections were made for the above displacements. Generally the position
of the organs were determined in respect of their position with respect to bony
structures. This position was adjusted in the anterior/posterior direction based on the
displacement of the bone structures in particular the spine.
Figure 4.6: A CT image (topogram) of the Rando Alderson phantom showing the
displacement of the skeleton in the sections (0-8) that comprise the head region of the
phantom.
For organs with complex distribution over a large region of the body, for
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example the intestines, areas encompassing the complete structure of the organ were
drawn rather than trying to reflect the structures given for an individual patient in the
atlas of Ellis et al. (1991). The reader is referred to appendix A for approximate
locations and boundaries of all organs and tissues of interest within each section of the
Rando phantom. Regarding the chest region, it must be considered that the lung tissue
has been simulated in this region of the phantom by applying a different material by
the manufacturer. Therefore there was no need for determining the location of this
organ in the phantom. The demarcation of this organ was carried out based on the
simulated area of this organ in the relevant sections of the Rando phantom.
Figure 4.7: A radiograph of section 24 of the Rando phantom showing the
displacement of the skeleton within one of the sections that comprise the abdomen
region of the phantom.
4.4 Volume Distribution of Organs in Sections of the Phantom
Software developed as a part of a radiotherapy treatment planning system
(Redpath 1991) was used to determine the area of each organ within each section of
the phantom. This was achieved by tracing the outline of the organ on the surface of
each section of the phantom using a light pen. From this the volume of the organ in
each section was determined, from which its percentage to the total volume of the
organ in the phantom was calculated. Using this method the distribution of every
organ and tissue of interest, except skin, red bone marrow (RBM), bone, and muscle
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in all sections of the phantom was determined. Then the fractional value of each organ
and tissue of interest in every section of the Rando phantom was derived and rounded
off to 3 significant figures in a way to sum to unity over the phantom.
The distribution of skin, RBM and bone were derived from a study by Huda
and Sandison (1984). They obtained the values of skin by taking the measured surface
area for every one of the 36 sections of the Rando phantom and expressing it as a
fraction of the total surface area (180000 cm2) given for the Adult Reference Man
(ICRP 1975). They also obtained the values of bone by estimating the volume of
skeleton in X-ray radiographs for every one of the 36 sections of the Rando phantom
and multiplying it by 0.667, that is the fraction of the total skeleton within the skull
and trunk for the ICRP Reference Man (ICRP 1975). They also derived the RBM
distribution from documents provided by others (Cristy 1981, Ellis 1961). On the
basis of their data, 15% of the RBM was taken to be located within sections 0-9, 43%
within sections 10-26 and the remaining 42% within sections 27-35. For each section
within these regions, it has been assumed that the RBM content is proportional to the
skeletal mass in that section. It has also been assumed that there is no RBM in the
limbs. The fractional values for these tissues in every section of the phantom have also
been rounded off to 3 significant figures in a way to sum to unity over the phantom.
Based on the ICRP report (ICRP 1975) the major proportion (75%) of the
muscle is located in limbs. In addition, normally in all routine CT examinations, the
limbs are kept outside the scan volume and are not practically exposed to the X-ray
radiation. Therefore, the distribution of this tissue in the phantom was not determined
and it was not taken into account for CT dose measurements in our study.
The experimentally determined fractional values for all the organs and tissues
of interest in the Rando phantom are presented in the following sections.
4.4.1 Brain
The brain is located within sections 1-4 of the Rando phantom inclusive, with
the proportional fractions of 0.214, 0.318, 0.294 and 0.174.
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4.4.2 Parotid, Thyroid and Thymus Glands
The parotid gland is located in sections 5-7 inclusive with relative fractional
values of 0.373, 0373, and 0.254. The thyroid is positioned in section 9 (0.739) and
section 10 (0.261) and the thymus is equally divided between section 12 and 13.
4.4.3 Lung and Oesophagus
The lungs are located within sections 10-19 inclusive and the result of their
experimentally determined values in each section of the phantom is summarised in
Table 4.1. The oesophagus is located within sections 9 to 19 of the phantom as shown
in Table 4.2.
Table 4.1: M easured fractional va ues of the lungs for Average-Man Rando phantom.
Section No. 10 11 12 13 14 15 16 17 18 I 19
Fraction 0.008 0.039 0.080 0.112 0.135 0.145 0.146 0.141 0.118 j 0.076
Table 4.2: Distribution o: "the oesophagus in t te Rando phantom.
Section No. 9 10 11 12 13 14 15 16 17 18 19
Fraction 0.069 0.120 0.101 0.101 0.101 0.101 0.101 0.101 0.101 0.101 0.101
4.4.4 Liver, Spleen, Stomach, Pancreas, and Intestines
The liver in located within sections 18 to 25 of the phantom by the fractional
values mentioned in Table 4.3 . The spleen is located within sections 19 to 22 of the
phantom by the relevant fractional values of 0.127, 0.352, 0.361, and 0.160. The
stomach extends to one more section and is located within sections 19-23, with the
relevant fractional values of 0.170, 0.331, 0.235, 0.147, and 0.117. The pancreas is
divided among section 21 (0.244), section 22 (0.396), section 23 (0.204), and section
24 (0.156) of the Rando phantom. The small intestine (SI), upper large intestine
(ULI), and lower large intestine (LLI) spread over a large proportion of the body
(over 12 sections), and their measured values all over the individual sections of the
phantom are summarised in Table 4.4.
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Table 4 3: Relative distribution of the liver in the Rando phantom
Section No. 18 19 20 21 22 23 24 25
SI 0.067 0.177 0.233 0.216 0.147 0.087 0.050 0.024
Table 4 4: Relative distribution of the intestines in the Rando phantom
Section No. 21 22 23 24 25 26 27 28 29 30 31 32 33 34
SI 0.006 0.018 0.039 0.062 0.077 0.090 0.120 0.136 0.135 0.147 0.115 0.054 - -
ULI 0.018 0.032 0.022 0.025 0.123 0.213 0.174 0.113 0.083 0.061 0.063 0.075 - -
LLI - 0.011 0.020 0.017 0.011 0.011 0.011 0.008 0.007 0.061 0.295 0.323 0.152 0.073
4.4.5 Kidneys and Adrenals
The Kidneys are located within sections 22-25 of the Rando inclusive, with the
respective values of 0.062, 0.227, 0.297, 0.245, 0.169. One third of the adrenals is
located in section 20 and their remainder is located in section 21.
4.4.6 Ovaries, Prostate, Uterus, and Bladder
Since the sizes of these organs are quite small their locations can be readily
determined by consulting the above CT atlas (Ellis et al. 1991) which indicates that
the ovaries are located in section 31, the prostate in section 33, one third of the uterus
in section 31 and the rest of it in section 32, and finally the bladder is divided among
three sections (32,33, and 34) with the respective values of 0.348, 0.492, and 0.160.
4.4.7 Skin, Bone, and Red Bone Marrow
As mentioned above the fractional values for these tissues were derived from a
study by Huda and Sandison (1984). The resultant fractional values of these tissues in
each section of the Rando phantom are summarised in Table 4.5.
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Table 4.5: Fractional values for the skin, bone, and red bone marrow (RBM) in each
section of the Rando Phantom.
Section No. Skin Bone RBM
0 0.011 0.010 0.010
1 0.008 0.030 0.030
2 0.008 0.010 0.010
3 0.008 0.010 0.010
4 0.008 0.030 0.030
5 0.008 0.030 0.030
6 0.007 0.005 0.005
7 0.006 0.010 0.010
8 0.006 0.005 0.005
9 0.007 0.010 0.010
10 0.010 0.030 0.048
11 0.014 0.040 0.062
12 0.014 0.030 0.048
13 0.015 0.020 0.032
14 0.014 0.020 0.032
15 0.014 0.010 0.016
16 0.013 0.020 0.032
17 0.013 0.010 0.016
18 0.013 0.010 0.016
19 0.012 0.010 0.016
20 0.012 0.010 0.016
21 0.012 0.010 0.016
22 0.012 0.010 0.016
23 0.011 0.010 0.016
24 0.011 0.010 0.016
25 0.011 0.010 0.016
26 0.011 0.010 0.016
27 0.012 0.010 0.034
28 0.012 0.030 0.053
29 0.012 0.030 0.053
30 0.012 0.030 0.053
31 0.013 0.020 0.034
32 0.013 0.030 0.053
33 0.013 0.030 0.053
34 . 0.014 0.020 0.034
35 0.044 0.030 0.053
4.5 Summary and Conclusion
The anthropomorphic physical phantom chosen was the Rando Alderson
phantom produced by Humanoid Systems, Incorporated, USA (Alderson et al. 1962)
being proved'to be suitable for CT dosimetry purposes (Huda and Sandison 1985,
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NR.PB 1990). This was an average-man phantom. Two breast phantoms could be
added to form a female phantom if required. The phantom had no limbs. It was cut
into 36 sections (0 to 35) each 2.5 cm thick with the last section being located at the
upper most region of the thighs with a thickness four times thicker than other
sections.
The position of the organs required for the calculation of effective dose
determined with reference to a standard atlas of human cross-sectional anatomy (Ellis
et al. 1991). The proportion of each organ and tissue of interest in every section of the
phantom was derived. The distributions of bone, red bone marrow and skin in the
body were chosen with reference to a report by Huda and Sandison (1984). The
fractional values of these tissues were also normalised to 1.000 for the whole body.
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5. CT Dosimetry using the Physical Anthropomorphic
Phantom (Materials and Methods)
5.1 Introduction
As explained in the first chapter two dosimetry approaches, namely the Monte
Carlo approach using a mathematical phantom and the CTDI and the direct approach
using a physical phantom, are used commonly for the assessment of patient doses
from CT examinations. The application of the Monte Carlo dosimetry approach in CT
dosimetry and the way it was used in our study will be discussed in detail in chapter
seven. In this chapter the only alternative common CT dosimetry method, that is the
direct approach, and the way it was developed and used in this study will be
explained.
The direct dosimetry approach has been followed by several researchers for
the assessment of patient doses from CT practices (Hashemi-Malayeri and Williams
1996a, 1996b, and 1996c; Wright et al. 1996; Collie et al. 1994a and 1994b; Kron
1995; Geleijns et al. 1994; Ekestubbe et al. 1993; Nishizawa et al. 1991; Wall et al.
1979; Horsely and Peters 1976). As mentioned earlier, this dosimetry approach is
based on the direct measurement of organ doses at their approximate locations in a
physical phantom simulating an average human body. There are 23 organs and tissues
of interest for which the average absorbed doses need to be determined. Therefore,
considering the distribution of organs inside the physical phantom used (Rando
Alderson), if this dosimetry approach is employed, at least 200 TLD measurements
will be required to estimate organ doses and other dose indices for every CT
examination. Due to this fact, this approach has been described as a laborious and
impractical procedure for routine CT dosimetry studies and has not attracted the
attention of many researchers in this field of study.
On the other hand, although the Monte Carlo dosimetry approach, as used in
this study, is quite easy and practical for routine patient dose assessments from CT
examinations, it is limited to those models of CT scanners that were included in the
national survey of CT practice in the UK (Shrimpton et al. 1991b). This survey
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included the CT scanners that were operational in the UK before 1989. As our study
indicates, most of these scanners have either been taken out of service or replaced
with the new CT models. Unfortunately, neither any data file nor the required
manufacturer data on the scanner design appears to be easily available, that are
required for implementing this dosimetry approach for new CT models.
Hence a preliminary study was first undertaken to establish an easier practical
direct approach for CT dosimetry, with an acceptable degree of accuracy and
confidence. It was aimed to develop this approach in a way that not only, it will be
independent of the type of the scanner but also, it will be quite simple and practical to
be carried out routinely for the assessment of patient doses from CT examinations.
This chapter covers the underlying principles and the steps followed to
improve and simplify the direct dosimetry approach, that eventually led to our
proposed developed direct CT dosimetry approach. This includes the description of
the method, the materials used, the dosimetry aspects considerations, and other
processes employed for the simplification of the method.
The description of the developed dosimetry method will be presented in the
following sections. This includes the assumptions made and the phases followed for
the development of the direct CT dosimetry approach.
The results of applying our developed dosimetry method for the assessment of
patient doses from several models of CT scanners will be presented in chapter six.
5.2 The Developed Direct CT Dosimetry Method
The common direct CT dosimetry approach requires a physical humanoid
phantom, to simulate a standard average human body, as recommended by the ICRP
(1975). It also requires a suitable radiation dosimeter to measure the radiation doses
received at the approximate locations of the organs of interest throughout the
phantom.
From available physical humanoid phantoms, the Rando Alderson
anthropomorphic phantom was chosen being concluded to be suitable for dose
determinations at the photon energies typical for CT examinations (Shripmton et al.
1981, Huda and Sandison 1985, NRPB 1990). As explained earlier except for some
77
organs or tissues, the position and distribution of other organs and tissues of interest
were not defined in this phantom by either the manufacturer or other researchers.
Hence, an additional design was carried out on the Rando phantom to determine the
position and distribution of all the organs and tissues of interest recommended for the
calculation of effective dose by the ICRP (1991). This stage of the work has been
described in the previous chapter and appendix A. Therefore the reader is referred to
chapter four and appendix A for the details of the work carried out on the phantom to
make it suitable for our developed direct CT dosimetry.
Having the approximate locations of all organs determined in every section of
the phantom, a suitable dosimeter must be used to measure the radiation doses
received at the locations of all organs and tissue of interest throughout the phantom.
Then the average absorbed dose delivered to every individual organ or tissue of
interest can be calculated, from which other dose indices can be estimated. The
radiation dosimeter must have such a physical shape and size, that could offer enough
spatial resolution and could be easily accommodated in various locations in the
phantom. On the other hand, the dosimeter must posses suitable dosimetry
characteristics required for the typical X-ray spectra of CT scanners. The dosimeter
must also meet minimum requirements as regards for accuracy and precision. From
the available X-ray dosimeters, the lithium fluoride (LiF) thermoluminescent
dosimeter (TLD) was chosen, providing both the physical and the dosimetric
characteristics required for this CT dosimetry approach.
The common direct dosimetry approach is the only alternative approach that
does not have the limitations of the MC approach and could provide an indication of
the patient risk involved with CT examinations. On the other hand, if this approach is
employed for the assessment of patient doses from CT practices, it will require a
knowledge of the dose to all radiosensitive organs and tissues of the body. This could
be achieved, as noted before, by numerous point dose measurements at the location of
all organs and tissue of interest throughout the phantom. Therefore it is brought to the
attention that, although this dosimetry approach does not have the limitations of the
MC approach, it imposes other restrictions. Not only, this approach is limited to a
particular CT examination for a particular scanner, but also it requires a considerable
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number of point dose measurements for every examination. These constraints have
made this dosimetry approach rather a laborious and impractical procedure for
monitoring patient doses from CT practices.
Hence the primary objective of the developed direct dosimetry method was to
overcome the limitations imposed by the common direct dosimetry method and to
establish a practical and reliable method for estimating the levels of patient doses
resulting from CT practices with an acceptable degree of accuracy.
In this regard a study was designed and implemented in the following four
phases:
(I) The basis for the assessment of patient dose from CT practice was the use of a
common physical phantom to simulate the human body. Extra design needed to
be carried out on the phantom to locate the position and determine the
distribution of all radiosensitive organs and tissues of interest.
(II) A suitable dosimetry device was chosen and a calibration procedure was
established for it, with an acceptable degree of confidence. In addition necessary
calculations was carried out for determining all factors required for the
assessment of the risk from CT procedures in terms of the absorbed dose to all
radiosensitive organs and other dose indices. This required a knowledge of the
CT X-ray spectra and the concept of the organs' mass energy absorption
coefficient for converting the measured quantity of exposure to absorbed dose in
organs and tissues.
(III) Calculations were performed to provide a basis for simplifying and reducing the
number of measurements required for the common direct CT dosimetry
approach. In this regard three assumptions were made:
1. Dose distribution, inside the scan volume, in parallel sections of three
relatively homogenous regions of the phantom; namely the head, the Chest,
and the abdomen and pelvis; can be represented by a single dose distribution to
a representative section, chosen from these regions and normalised to the
central axis dose value in the section. This assumption was based on earlier
studies reporting similar isodose dose distributions for single scans using a
particular CT scanner as mentioned in chapter one.
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2. Dose distribution in sections of the phantom outside the scan volume can be
represented by a simple function characteristic to the scanner central axis dose
and the region of the body. This assumption was based on earlier studies
reporting small amount of the scattered dose outside the CT scan volume as
mentioned in chapter one. Another base for this assumption was the new
configurations of filters available with modern CT scanners providing a very
well collimation beam as mentioned in chapter three.
3. The proportion of the muscle tissue being irradiated during CT practices is not
significant. Therefore the contribution of the absorbed dose to this tissue can
be ignored for the calculation of the dose indices. This assumption was based
on the fact that, the major portion of the muscle tissue is located in the limbs
that are normally kept outside the scan volume as a convention in CT
practices.
These assumptions were made in order to be able to determine the organs
absorbed doses and the other dose indices with a limited number of
measurements on the central axis of the phantom. This made us able to
overcome the limitation of the direct dosimetry method and simplify it in away
that it could be implemented for the routine patient dose assessment from many
diverse and fast growing CT practices.
(IV) Further to simplify the developed direct dosimetry approach, a spreadsheet was
customised using a common computer program (Microsoft Excel ®). This
spreadsheet was designed to store the calculated data regarding the phantom, the
CT scanners, and the calibration of the dosimeters. It also handles the input of the
required data, and reports the resultant patient doses in terms of the organs
absorbed doses and the other dose indices recommended by the ICRP (1977,
1991) as its output. The spreadsheet was designed in a way to perform the data
processing in a very user friendly manner.
Regarding the phase one, as was already noted, a comprehensive work was
carried out for the extra designs required on the physical Rando phantom. Chapter
four and appendix A were resulted from the implementation of this phase of the study.
The other phases were resulted in the following sections of this chapter.
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Section 5.2 describes the dosimetry device used for the dose measurement.
This includes our rationale for choosing this type of dosimeter (LiF TLDs), the
procedure established for its calibration factor calculation, and the estimated level of
uncertainty in the measurements.
The absorbed dose corrections will be explained in section 5.4. This includes
one part of our preliminary study carried out to determine and take into account the
CT X-ray spectra and the organs and tissues mass energy absorption coefficients.
Dose distribution studies are introduced and discussed in section 5.5. In this
regard dose distributions inside and outside the CT scan volume are presented,
discussed and analysed. This was done in an attempt to simplify the common CT
dosimetry approach by overcoming the cumbersome of the numerous point dose
measurements required for the implementation of this dosimetry approach.
Section 5.6 contains the results of the measurements carried out for the
validation of the assumptions made for the dose distributions. In this regard the
accuracy of the method sued for calculating dose distributions from orthogonal
measurements in the representative sections of the "head", "chest", and "abdomen &
pelvis" areas of the phantom are validated. In addition the assumption made about the
similarity of the dose distributions in parallel sections to that of the representative
sections in the overlap region between chest and abdomen has been validated.
Section 5.7 describes the computer program customised for the automation of
data processing for the developed dosimetry method. In this section the computer
spreadsheet program used and customised for further simplification of the direct
dosimetry approach is provided. This includes data storage handling, data processing,
and reporting the resultant organ and tissue doses and other dose indices of interest
for a particular CT examination.
Finally the summary of the developed direct CT dosimetry method will be
presented in the last section of this chapter.
5.3 TLD Study
To achieve the minimum exposure to patients from CT examinations
consistent with good diagnosis, the accurate measurement of radiation doses is
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important in the assessment of patient doses exposed to ionising radiation resulting
from this diagnostic procedure. The dose measurements for conventional X-ray
examinations have traditionally been carried out using devices such as air ionisation
chambers and film badges, although nowadays TLDs are increasingly being used
(McKinlay 1981). Thermoluminescent dosimeters have been available for dosimetry
of ionising radiation for nearly 100 years (Kron 1995). The variety of these materials
and their different physical forms allow the determination of different radiation
qualities over a wide range of absorbed dose. This makes TLDs useful in radiation
protection where dose levels of about 10 pGy are monitored as well as in
radiotherapy where doses up to several Gy are to be measured.
TLD has proved to be a useful dosimeter in the assessment of patient doses
from diagnostic X-rays and has been used successfully in CT dose measurements
(Hashemi-Malayeri and Williams 1996a, 1996b, 1996c; Wright et al. 1996; Collie et
al. 1994a and 1994b; Kron 1995; Geleijns et al. 1994; Ekestubbe et al. 1993;
Nishizawa et al. 1991; Wall et al. 1979; Horsely and Peters 1976). TLDs offer
obvious advantages over ionisation chambers for CT dosimetry. The major
advantages of these radiation detectors are their small physical size and that no cable
or auxiliary equipment is required during the dose assessment. Therefore
thermoluminescent (TL) detectors allow point dose measurements, in the approximate
position of organs in phantoms, as required for the direct CT dosimetry approach.
Furthermore, if in vivo measurements are required they are radio-transparent and less
obstructive to most X-rays. Figure 5.1 is a CT image showing the TLDs positioned in
some points of interest in a single section of the Rando phantom.
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Figure 5.1: The TLDs (white circles) positioned in some points of interest in a single
section of the Rando phantom.
5.3.1 Type of TLDs
Various types of TL materials are used for radiation dosimetry. The material
chosen for radiation dose monitoring is based on the popularity of use, commercial
availability and specific applications, including personal, clinical and environmental
dosimetry. The most important families of TL materials used in clinical dosimetry are
lithium fluoride (LLF), lithium borate (LhELO?), calcium sulphate (CaSCL) and
calcium fluoride (CaF2) phosphors. From these families, LiF based TLDs demonstrate
a linear dose response from between 50 and 100 mGy threshold to between 3 and 10
Gy depending on the form of the dosimeter (McKinlay 1981). In addition, LiF has a
photon effective atomic number of Zeff=8.2, that if compared with the average value
of 7.4 for body tissues, it can be considered to be approximately tissue-equivalent for
most applications (ibid.). Considering the particular peak of the LiF glow curve,
normally used in practical dosimetry, the fading of this type of TLD is negligible over
a long time (~ 80 years half-life) (ibid.). Hence, the dosimetric characteristics of LiF
based TLDs make it particularly well suited for use in X-ray dosimetric studies of
diagnostic qualities, such as CT, in view of its ease of use (loading in the Rando
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phantom), linear dose response, and its negligible fading. The reader is referred to
McKinlay's (1981) book on the thermoluminescence dosimetry for a full theoretical
background, description and application of all types of TL materials.
For all CT examinations, dose measurements were achieved using LiF doped
with magnesium and titanium (LiF: MgTi). This is one of the most commonly used
family of thermoluminescence phosphors, first investigated in 1953 and abandoned
due to its variable TL properties. But, later interest in this material was renewed in
1961 (ibid.) and this type of TLD has been the first choice for TLD users for over the
last 30 years and is still being used widely. Its chemical stability, close "tissue
equivalence" and well-defined response to ionising radiation make it ideal for
diagnostic X-ray dosimetry.
Harshaw Chemicals produces a commercial LiF phosphor known as TLD 100
and its isotopic variants TLD 600 and TLD 700. By comparing the TLD 700
(comprising of 0.01% 6Li and 99.99% 7Li phosphor type) with some other LiF based
phosphors, it has been concluded that TLD 700 is the most sensitive TLD (ibid.).
From this family of TLDs, LiF-7 round chips (Figure 5.2) manufactured by Vinten
Instrument Limited1 were used. Based on the manufacturer's data sheets, this type of
TLD has been designed for general purpose dosimetry for penetrating photons and
electrons. This TLD has a diameter of 4.5 mm and a thickness of 0.8 mm. 99.95% of
this TLD is LiF-7 and is claimed to offer high sensitivity with a performance compares
favourably with the well-known Harshaw TLD-100 chips, being approximately 25%
more sensitive and ideal for accurate, low dose (0.01 to 1000 mGy) measurements.
The measuring range is claimed to be linear from 20 p.Gy to 2 Gy with better than ±
2% reproducibility and repeatability. It is also stated that its fading is less than 2% in
30 days, dependent on read anneal cycle, and its reusability is more than 200 cycles
(Vinten Instruments Limited).
1 Vinten Instruments Limited, Jessamy Road, Weybridge, Surrey KTI3 8LE, England.
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Figure 5.2: A box ofLiF: MgTi round TLDs containing 50 chips.
5.3.2 Calibration of TLDs
A batch comprising of 250 round TLD chips was used in this study.
Dosimeters were read out on a Toledo TLD reader with an automatic sample changer
(Vinten Instruments Ltd, Weybridge, UK) (Figure 5.3). First, all 250 TLDs were read
out to eliminate any possible background history. Then all TLDs were given a known
dose (about 20 mGy at 100 kV) generated from a conventional X-ray machine and
were read out on the TLD reader. This process was repeated three times and the
average (AVG) value and the standard deviation (STD) for the batch of TLD were
calculated. Those TLDs which consistently showed a value out of the "AVG ±
(2xSTD)" range were excluded and the rest were used for our dosimetry
measurements. In this way TLD chips whose sensitivity was significantly different
from the remainder of the batch were excluded.
TLDs, irradiated during each CT examination, were processed using a single
calibration factor determined from twenty TLDs. These TLDs were comprised of ten
non-dosed controls (subjected only to the background radiation) and ten dosed
controls. The dosed controls were exposed at lOOkV constant potential to a dose of
approximately 20mGy generated from a conventional X-ray machine, along with an
ionisation chamber (Radcal2 Model 20X5-3 chamber with Model 2025 electrometer).
The ionisation chamber had a traceable calibration in terms of exposure. The ten
2
NE Technology Limited, Bath Road, Berkshire RG7 5PR England.
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dosed TLDs and the traceable ionisation chamber (IC) were positioned on the surface
of a bloc of perspex perpendicular to the central axis of the beam as shown in Figure
5.4. The bloc of perspex was used to produce a uniform and consistent backscatter
radiation. In addition, in order to avoid the heel effect, the IC was positioned along
that central axis of the radiation field that was perpendicular to the anode-cathode
direction of the X-ray tube. The dosed TLDs were put on two parallel lines at an
equal distance along both sides of the active length of the IC. Figure 5.4 shows
schematic drawing of the set up of the dosed TLDs, the ionisation chamber, and the
X-ray unit as set for the calibration measurement.
Figure 5.3: Toledo TLD reader with automatic sample changer.
The following equation was used to determine TLDs calibration factor
(CFtlo):
po j1
CFtld= 1/(R- Rsgd) - M.(y -). CFIC./ (Equation 5.1)
where CFic is the calibration factor for the ionisation chamber, R is the
average of dosed TLD readings, Rbgd is the average of control TLDs readings, M is
the IC reading (in roentgen), Po and T0 are the standard pressure (760 mmHg) and
temperature (293 °K) values, P and T are the ambient pressure and temperature
values, and/,is the exposure to absorbed dose conversion factor. The value of/ was
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assumed to be 8.73 mGy/R based on the definition (ICRU 1980) of the roentgen
(2.58x 10-4 C/Kg), and the reported value (ICRU 1979) of the average energy (33.85
J/C) required to create an ion pair in air.
As could be noted in Figure 5.4, the dosed TLDs were exposed with their
major planar surfaces perpendicular to the X-ray beam while they were not oriented in
this way during CT scan. Earlier reports (Shope et al. 1982) assumed that no
correction is required for variation in TLD response as a function of orientation.
Nevertheless measurements were carried out to compare the TLD response as a
function of orientation with respect to the direction of the incident X-ray beams
during a CT scan. Our measurements indicated that an approximate correction (1.08)
must be applied to the response of the TLDs, to account for variation in TLD
response resulting from its different orientation to the direction of the X-ray beam
during our calibration procedure and the CT scanning.
Figure 5.4: Schematic drawing of the set up of TLDs, a traceable ionisation chamber,









5.3.3 Uncertainties in the TLD Measurements
Over the whole period of the study 35 sets of calibration measurement were
carried out. This provided 35 data sets each one comprising ten dosed and ten control
TLD measurements. These data sets were used to determine the uncertainties
involved with the use of TLDs for CT dose measurement in our study.
The level of uncertainties for every data set was calculated for the 95% level
of confidence in terms of the standard error resulting from both the dosed and the
control TLD measurements. Figure 5.5 shows the variation of the calculated TLD
calibration factor (CFtld) over the whole period of the study, with the level of
uncertainties for every data set.
This variation in calculated CFtld is due to some systematic errors involved in
the process of the TLD calibration measurement. There were some factors over which
we had neither control nor information on their level of uncertainties. These could be
taken to be responsible for the observed variation in CFtld values. For example, there
were uncertainties in the consistency and accuracy of the calibration factor of the
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Figure 5.5. The variation of the calculated TLD calibration factor over the period of
the study. The error bars represent "2xstandard deviation" of each calibration data
set.
A systematic uncertainty raised from the processing procedure of the TLDs in
the TLD reader was detected and avoided in this study. For about 1-2% of all
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readings, unexpectedly low values were observed. It was concluded that this
systematic uncertainty is caused by the poor contact between either the TLDs and the
trays or the trays and the heater compartment of the TLD reader.
The bigger error bars may have been noted for three calibration data sets in
the above figure. These are due to the above systematic error. The highest observed
level of uncertainties is estimated to be about 10.8% at the 95% confidence level for
an individual TLD calibration measurement if the identified systematic error is
ignored. But, if this systematic error is excluded, the highest observed uncertainty is
estimated to be about 5.4% for an individual calibration measurement.
The overall uncertainties in the TLD measurements could be estimated by
further analysis of the calibration data sets. For every calibration data set a weighted
coefficient variation (CV) could be calculated from the CV values of the dosed and
control TLDs. Then, if the root mean square of all the weighted CVs is taken, it will
indicate that there is an overall 4.8% uncertainty in the TLD processing procedure.
The point doses could have been determined using only one TLD
measurement at every location of interest in the phantom. But, in order to exclude the
above identified systematic uncertainty, a pair of TLDs was used for every single
point dose measurement in the phantom. The average value of the pair of TLDs was
taken to represent the single point dose at every location of interest in the phantom.
However, if one TLD read more than 10% of the second, then it was concluded that
the systematic error had occurred and the higher reading was chosen to represent the
point dose value.
Based on the overall estimated uncertainty in the TLD measurements, the level
of uncertainties in the measurements of point doses in the phantom is estimated to be
about 6.8% at the 95% confidence level.
5.3.4 Other Technical Considerations with the Use of the TLDs
To measure the central axis dose values, a hole was drilled at the centre of
each section of the Rando phantom to host the pair of TLDs. It was necessary to
accommodate the TLD round chips in the middle of these holes. This was made
possible by using a pair of plastic rods with 5 mm diameter. The TLDs were kept
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between the pair of rods in every hole. The length of the pair of rods, including the
pair of TLDs, was long enough to encompass the whole thickness of an individual
section of the phantom (25mm). In addition, plastic rods with 25 mm length were
used in the phantom to fill any hole not used for dosimetry to maintain a nearly
homogenous phantom.
The type of TLDs used in this study were quite fragile. To avoid the TLDs
from being cracked during the loading and unloading process, the holes were drilled
with a few tenths of millimetres larger diameter than that of the TLDs and plastic
rods.
5.4 The Absorbed Dose Corrections
As mentioned in the second section a preliminary study was carried out to
investigate other dosimetric aspects specific to CT. Other dosimetric aspects, specific
to CT, which needed to be examined were the X-ray spectra of the CT scanners and
the ratios of mass energy absorption coefficients for different organs and tissues of the
body to that of air.
As mentioned in the previous section, the calibration factor of the TLDs was
determined in exposure (roentgen) and converted to absorbed dose in air (mGy) using
the conversion factor determined from the ICRP (1977, 1980) reports. But, it was
needed to determine absorbed doses in different organs or tissues of the body
composed of materials other than air. The quantity that could be used for this purpose
is the mass energy absorption coefficient (pen/p)- Pen/p is a measure of the average
fractional amount of incident photon energy transferred to kinetic energy of charged
particles as a result of interactions between these photons and matter that occur in a
given mass-per-unit area thickness of material concerned. The energy absorbed per
unit mass of various materials subjected to the same energy fluence is proportional to
the mass energy absorption coefficients of those materials. So having the absorbed
dose in air (Dair), the absorbed dose in other materials (Dm) could be derived from the
following equation.
90
r—* (.Lien I p\n
Dm = Dair x (Equation 5.2)
yJLlen / p)air
Therefore, to estimate absorbed doses in the organs and tissues of interest, it
was necessary to determine the ratios of mass energy absorption coefficient of organs
and tissues of interest to that of air.
For materials with atomic number close to that of air the factor
(M.en/p)m/(lWp)air varies only slowly with photon energy. But, for materials of higher
atomic number, such as bone or those with a high hydrogen content, this rule does not
apply and the ratio of the mass energy absorption coefficients should be calculated
based on the photon energy distribution of the X-ray. Therefore, it was required to
take into account the CT scanners' output photon energy distribution that, like any
other X-ray generator, is a spectrum. Hence, in order to calculate the ratios of
(|J-en/p)m/(M-en/p)air for different models of CT scanners, we had to determine the CT
scanners' X-ray spectra first.
In addition, as mentioned earlier, to determine organ or tissue doses, using the
common direct CT dosimetry approach, numerous point dose measurements are
required. To overcome this cumbersome task and make this dosimetry approach
simpler and more practical, it was necessary to decrease the number of these
measurements. Hence, we also studied dose distributions inside and outside the scan
volume for different CT scanners in this study.
In this section the above concepts will be explained in detail and our proposals
will be introduced. First the CT X-ray spectra will be discussed. Then the calculated
ratios of mass energy absorption coefficients will be introduced.
5.4,1 CT X-ray Spectra
As mentioned above to take into account the ratios of pen/p for different
organs and tissues of the body to that of air, it was required to determine the X-ray
spectra for all CT scanners in this study. CT X-ray spectrum comprises X-rays
varying in photon energy from lower energies near to zero of up to the maximum
energy attained by electrons from the applied voltage across the tube. The unwanted
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lower energy X-rays are normally removed by added filters. The shape of the CT X-
ray spectrum, or the CT photon energy distribution, is dependent on the tube target
material, the anode angle, the filtration, and finally the applied potential (kV) across
the tube.
Lately, an electronic version of the EPEM Report 78 prepared by D. Sutton
(Cranley et al. 1997), that is a spectrum processor software, became available to us.
This software could be used to generate the X-ray spectrum if the required input data
is provided. The required input data includes the applied potential (kV), the target
material, the anode angle and the tube filtration. Table 5.1 shows these data for all the
CT scanners in this study. These data were obtained by referring to the available CT
scanners' manuals provided by the manufacturers.
Table 5.1: Different radiological factors used for determining the CT X-ray spectra.
CT Scanner Model Tube voltage Target Anode angle Filtration
(kV) material (degree) (mm)
Siemens Somatom Plus 120 & 137 * Tungsten 10 2.7 Al
Philips Tomoscan CX/S 120 Tungsten 9 1.0 Al & 0.1 Cu
GE HiSpeed Advantage 120* Tungsten 7 2.7 Al
GE Svtec 3000 Plus 120 Tungsten 9 2.7 Al
GE 9000HP 120 Tungsten 9 2.7 Al
GE 8800 120 Tungsten 9 2.7 Al
*Other kVs were also available with these scanners but only the mentioned settings were routinely used.
Using data mentioned in Table 5.1, as the input data for the above software,
the X-ray photon spectra for all the CT scanners were determined at 0.5 Kev
intervals. Figure 5.6 shows a typical X-ray spectrum determined for one of the CT
scanners in this study. The CT X-ray spectral data were then used to determine the
ratios of mass energy absorption coefficients of body tissues to that of air for every
CT scanner as explained in the following section.
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Siemens Somatom Plus CT Scanner X-ray Spectrum















Figure 5.6: A typical CT X-ray spectrum.
5.4.2 Mass Energy Absorption Coefficient
In order to calculate pen/p values it was first required to determine the
compositions of all organs and tissues of interest. For this purpose reference was
made to the ICRP publication 23 (1975). It was noted that the contribution of major
elements in various organs or tissues compositions, except bone and red bone
marrow, were very close to each other. Therefore, the Pen/p values were determined
for dry air and three tissue categories of bone, red bone marrow and muscle. The
latter represented all various organs and tissues of interest of the body except bone
and red bone marrow.
The Pen/p values for these categories were taken from the ICRU (1992) tables
of photon mass energy absorption coefficients for all the photon energy ranges existed
in the CT X-ray spectra. Having determined the X-ray spectrum for every CT scanner
as explained in the previous section, the sum of the amount of photons at each energy-
interval was calculated from the X-ray spectrum of that scanner. Then for each
category the pen/p value at each energy range interval was weighted by the relevant
sum of the amount of photons at that energy interval for every CT scanner. Then for
each category the integral of the weighted pen/p values was taken over the entire
energy range of every CT X-ray spectrum, to represent the p^/p value of that
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category for that particular scanner. Figure 5.7 shows the variation of weighted pen/p
for the three tissue categories and dry air for two different CT models by photon
energy.
The following equation shows the way the p^/p values were calculated:
£ max
( —) (tissue,air) = j (—)£.— (Equation 5.3)
P eL P V
where (pc/p)# is the mass energy absorption coefficient at E energy level of the tissue
or air, ilcp is the amount of photons at E energy level, cp is the sum of photons over the
entire energy range, and e^ and are the integral lower and upper limits
determined from the relevant CT X-ray spectrum for every CT scanner.
The pen/p calculations were carried out for the above three tissue categories
representing all organs and tissues of interest of the body and dry air. This was done
for every CT scanner model, based on its calculated X-ray spectrum derived from its
relevant setting of parameters as was already mentioned in Table 5.1.
The ratios of the mass energy absorption coefficient (pen/p) to dry air for bone,
red bone marrow and muscle (representing all other body organs and tissues) were
calculated for each CT model (Table 5.2). Then these data were incorporated in a
spreadsheet designed for CT dose assessment, using the Microsoft® Excel program
as explained in section 5.7.



















Muscle 1.06 1.06 1.06 1.06 1.06
Cortical bone 5.96 5.95 5.65 6.01 5.78
Red bone marrow 0.91 0.91 0.92 0.90 0.92
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Figure 5.7: Variation of (weighted) |aen/p by photon energy for different body tissues
and air for two different CT scanners.
5.5 Dose Measurement Methods
Based on the assumptions described section 5.2, dose distributions had to be
determined and analysed in the representative sections of the head, chest and abdomen
& pelvis areas of the phantom for all the CT scanners. This was necessary to cut
down numerous point dose measurements required for the common direct CT
dosimetry approach and to simplify the developed dosimetry approach in a way that it
could be carried out easily for routine patient dose assessments. Extra dose
measurements were also required to validate the accuracy of the method adopted for
the dose distribution calculations in the representative sections. Measurements were
also required in some of the parallel sections in the overlap region between the chest
and abdomen areas of the phantom to validate the assumption made above for dose
distributions in these sections.
In this section the results of our study on dose distributions inside and outside
the scan volume for all the CT scanners are presented. In this regard the method
adopted for determining the dose distributions inside and outside the scan volume are
explained and typical dose distributions calculated for one of the CT scanners is
presented. In addition, the concept of "central axis doses" from which the organs
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doses and the other dose indices are derived by the developed direct CT (Stewmetty
approach will be introduced and explained. The concept of packing factor wiedl fer
some special CT examination techniques will also be presented, The rramfe of tte
measurements carried out to validate the accuracy of the calculated dose
and the assumptions made above with regards to the dose distribution® w passIM
sections will be presented in section 5.6.
5.5.1 Dose Distributions inside the Scan Volume
For each scanner in the study an axial dose distribution was de&mmmd rail-
representative sections of the phantom at three levels of the body:: the "headF,, the
"chest", and the "abdomen" for a full CT scan which included that section.. these
regions comprised sections 0-9. 10-19, and 20-34 of the phantom respectively. Dose
distributions in section 2, 14, and 26 were chosen to be representative of these
regions. It was assumed that the dose distribution in the other sections ©f each ofthe
regions were represented by these sections. This was done based on erne of the
assumptions made above that, "inside the scan volume, the dose dissnilkijtom
normalised to the scanners' isocentre are identical in parallel sections i® these tfiaree
relatively homogenous regions of the bodyr".
To determine the dose distributions in the three representative sections of the
phantom, TLDs were put at 2 cm intervals along two perpendicular axes, Grossing
each other at the centre of the section as shown in Figure 5.S for atypical ©me..
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Figure 5.8: A typical section of the phantom showing the way the TLDs were put in
the section for dose distribution measurements.
The measured TLD values along these orthogonal axes were normalised to the
central values of the section. Using the result of these measurements and an available
computer graphic program (UNIMAP3), the dose values were interpolated for a
2cmx2cm grid covering the extreme limits of these three regions of the body.
Figure 5.9, Figure 5.10, and Figure 5.11 show three typical dose distributions
in the three representative sections of the phantom for one of the CT scanners.
Based on these dose distributions, a parameter, named dose factor, was
determined for all organs and tissues of interest in every section of the phantom for
each scanner. The dose factor represents the average dose to the organ within the
specific section normalised to the central dose. Whenever an organ or tissue had a
considerable large size in a section, enough locations were selected, to reflect the
variation of dose distribution over the entire portion of the organ or tissue in the dose
factor.
Details of all the organ dose factors are presented in a long table in Appendix
B. The table includes all organs and tissues of interest, the location of point doses
3
UNIMAP, Interactive Mapping System, Copyright © 1985 by European Software Contractors
A/S. 7, Narregade, DK-28000 Lyngbv, Denmark.
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being considered for each organ in every section of the phantom, and their calculated
point and average dose factors for all the CT scanners.
These dose factors were then incorporated in the customised spreadsheet
designed for the CT dose assessment, using the Microsoft Excel® computer program
as explained in section 5.7.
Figure 5.9: A typical dose distribution in the head area of the Rando phantom (section
2, GE HiSpeed Advantage CT scanner).
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Figure 5.10: A typical dose distribution in the chest area of the Rando phantom
(section 14, GE HiSpeed Advantage CT scanner).
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Figure 5 .11: A typical dose distribution in the abdomen area of the Rando phantom
(section 26, GE HiSpeed Advantage CT scanner).
5.5.2 Dose Distribution and Fall Off of the Dose outside the Scan Volume
Besides the dose distribution inside the scan volume, dose distribution and fall
off of the dose outside the scan volume were studied. These studies showed a
negligible variation in dose distribution within these sections and an exponential
reduction in the dose with the distance from the edge of the scan volume. This
provided a sufficiently accurate method for dose estimation outside the scan volume
requiring just a few TLD measurements. Based on the experimental results the
following formula was used to estimate the radiation dose in those sections of the
phantom that fall outside the scan volume.
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D„ - Dr e_bt (Equation 5 .4)
where Dn is the central axis dose in section "n", Dr is the central axis dose in the
reference (r) section located at that edge of the scan volume, x is the distance (in cm)
between section "n" and section "r", and finally "k" is a constant derived from a
measurement made at 10 cm distance (four sections away) from the edge of the scan
volume as presented in the following equation:
k= In ( — )/10 (Equation 5.5)Dr + 10
Equation 5.4 was employed for various examination protocols using all the
various CT models. It provided a good approximation for estimating the fall off of the
dose outside the scan volume, requiring just one extra central axis dose measurement.
Figure 5.13, Figure 5.13, and Figure 5.14 show typical comparisons between the
measured values of the central axis doses in sections outside the scan volume and our
calculated values using the above equations for three particular "head", "chest" and
"abdomen & pelvis" examinations using the Siemens Somatom Plus CT scanner.
Measured \alues —0—Calculated \alues
Section no. (Rando phantom)
Figure 5.12: Comparison of measured and calculated phantom central dose values
outside the scan volume for seven sections (5-11) for a particular "head" examination.
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Figure 5.13: Comparison of measured and calculated phantom central dose values
outside the scan volume for five sections (6-10) for a particular "chest" examination.
Measured values —Calculated values
Section no. (Rando phantom)
Figure 5.14: Comparison of measured and calculated phantom central dose values
outside the scan volume for five sections (16-20) for a particular "abdomen & pelvis"
examination.
5.5.3 Central Axis Dose Measurements
Knowledge of the pattern of dose distributions inside and outside the scan
volume of the phantom facilitates the direct CT dosimetry approach by limiting the
required measurements to only several central axis dose measurements. The exact
number of the required measurements depends on the length of the scan volume. At
least one central axis dose measurement is required in every section of the phantom
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located inside the scan volume. In addition, two extra central axis dose measurements
are required outside the scan volume to estimate the fall off of the dose if there are
two tails for a particular CT examination. Otherwise, if there is only one tail outside
the scan volume, like most routine head and pelvis CT examinations, one extra
measurement outside the scan volume will be sufficient.
Based on the justification made in section 5.3.3, to eliminate the identified
systematic uncertainties from the point dose measurements, a pair of TLDs was used
to determine the central axis dose values for each section of the phantom inside the
scan volume. The pair of TLDs were put in the centre of each section of the Rando
phantom. The TLDs' average value was taken to represent the central axis dose value
in the section if the difference between their readouts was not greater than 10%.
Otherwise, the TLD which showed the highest value was chosen to represent the
central axis dose value in that section of the phantom.
As mentioned in section 5.5, when the dose distributions were determined
inside the scan volume, they were normalised to the central axis dose values for every
representative section. Therefore, the measured central axis dose values in every
section of the Rando phantom inside the scan volume can be used as an index to
estimate the value of doses at any desired location in these sections. We called this
index the phantom central dose for our developed direct CT dosimetry method.
Hence, if the phantom central dose is combined with the relevant normalised dose
distribution inside the scan volume, the radiation doses received at the location of all
organs and tissues of interest from CT examinations could easily be estimated. The
way this is carried out has been explained in section 5.7 where the designed computer
spreadsheet program for our developed direct dosimetry method has been described.
5.5.4 Packing Factor
The developed direct dosimetry method was designed for contiguous
conventional CT examinations, or in the case of spiral CT examinations for the pitch
value of one. However, other scan protocols are quite common in CT practice in
which the conventional scans are not performed contiguously or the pitch value of the
spiral scans is not equal to one. For these types of examinations a packing factor
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should be applied to the measured values of the phantom central doses (TLD
readings) with contiguous condition (or with the pitch value of one if a spiral scan is
performed). Then the resultant values should be regarded as the phantom central dose
values to be entered in the computer spreadsheet program.
The packing factor, p, is given by the following expression:
w
P =— (Equation 5.6)
where w is the slice width (in mm) and c is equal to the couch increment (in mm) if a
conventional scan is performed. For spiral scans p is the inverse of pitch. It is obvious
that we will have:
• p=J: for contiguous conventional examinations (when the slice width is equal to
the couch increment), or for spiral examinations with the pitch value of 1.
• p> 1. for overlapping conventional examinations (when the couch increment is less
than slice width) or for spiral examinations with the pitch value of less than 1.
• p<l: for the conditions where there is a gap between slices in a conventional scan
(i.e. couch increment is more than slice width) or for spiral examinations with the
pitch value of more than 1.
This constraint is due to the fact that the TLDs used in this study did not have
such a size to encompass the entire thickness (25 mm) of the sections of the Rando
phantom. Therefore, if scans with a couch increment bigger than the slice width or
spiral scans with a pitch value more than one were carried out, the TLDs in some
sections would fall in the gaps between consecutive scans and lead to an
underestimation of the central dose values. In addition, if scans with a couch
increment less than the slice width or spiral scans with a pitch value less than one
were considered, the TLDs in some sections may fall in the overlaps between
consecutive scans and lead to an overestimation of the central dose values. Applying
the above packing factor to the contiguous conventional scans (or spiral scans with
the pitch of one) provides a good approximation of the average central dose values
for these scanning techniques.
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5.6 Validations of Dose Distributions
The methods described in section 5.5 were used to determine patient doses
from six CT scanners and the results are presented in chapter 6. Following these
studies some further investigations were made to validate some of the assumptions in
the assessment of effective dose.
Three assumptions were made in this study with regard to dose distributions.
Firstly that the dose distribution in a section of the phantom can be adequately derived
from measurements of the dose profile on two orthogonal axes using a contour
mapping system. Secondly that the dose distributions in representative sections of the
phantom can be used with sufficient accuracy to represent the dose distribution in
parallel sections in the same anatomical region. Thirdly that the dose distributions in
sections outside the scan volume are uniform.
5.6.1 Representative Sections
To validate the method employed in this study for determining the dose
distributions in the three representative sections of the Rando phantom, these sections
were drilled on a 2 cm by 2 cm rectangular grid. Locations within 1 cm of the surface
or within bone were omitted. Points were also omitted from the regions near the edge
of the phantom, particularly in the chest sections, where no organs of interest were
located. A total of 34, 69, and 89 locations were used in the representative sections of
the "head" (no. 2), "chest" (no. 14), and "abdomen & pelvis" (no. 26) respectively.
To estimate the relative dose received at every position, a pair of TLDs was
used. It was noted previously that intermittent low readings were experienced with
the TLD reader. When the readings from one TLD in a pair was 10% less than the
other, then the higher value was used. Otherwise an average was taken.
Three complete routine "head", "chest" and "abdomen & pelvis" examinations
were carried out separately using the Siemens Somatom Plus CT scanner covering the
three representative sections in these areas of the phantom. For every examination the
average value of 10 unirradiated TLDs was taken as the background reading. The
background was subtracted from the average measured reading at each position. Then
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for each representative section all the values were normalised to the central position
of the section.
The ratios of the measured to the calculated normalised values were calculated
for all the positions in the three representative sections of the Rando phantom. The
calculated values were derived from the original three sets of orthogonal dose
measurements in the representative sections which were made with the UNIMAP
program to obtain the dose distributions from which the doses in chapter 6 were
derived. It may be noted that the dose contour maps showed values bigger than one
for the isocentre locations to which data were normalised. This may be due to the
limitation of the interpolation approach used by the UNIMAP program. When
calculations were made in these distributions, the central doses were set to the TLD
readings.
The following scan protocols were used: "head" (sections 1-4), 120 kV, 420
mAs, 10 mm slice width, 10 mm slice increment, 10 slices; "chest" (sections 10-19),
137 kV, 210 mAs, 10 mm slice width, 10 mm slice increment, 27 slices; "abdomen &
pelvis" (sections 20-34), 120 kV, 210 mAs, 10 mm slice width, 10 mm slice
increment, 38 slices.
Table 5.3 shows the average ratios of the measured to calculated normalised
doses in the three representative sections along with the standard deviation (s.d.),
minimum and maximum values resulting from the above scan protocols.
Table 5.3: The average ratio of the measured to the calculated normalised doses in the
CT examination head chest abdomen & pelvis
no. of positions 34 69 89
average 1.03 1.05 1.02
standard deviation 0.04 0.05 0.07
minimum 0.94 0.93 0.87
maximum 1.09 1.16 1.22
As mentioned earlier there is an overall 5% uncertainty (s.d.) in the TLD
measurement. Therefore the expected uncertainty in the paired TLD measurements
will be ± 7% at the 95% confidence level. When the ratios of the dose at each position
were calculated, the TLD values were normalised to the central values. Hence the
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expected uncertainty in the calculation of the ratios will be ± 10% (equivalent to 5%
s.d.).
The measured variance in the results can be mainly attributed to the
uncertainties inherent in the TLD readings. However, closer inspection of the result
for the "chest" and "abdomen & pelvis", shows that there are positions for which the
discrepancy between the measured dose distribution and the calculated distributions
differ by more than 10%.
Figure 5.15 shows the calculated dose distributions in the representative
section of the "chest" area (section 14). Table 5.4 shows the results of TLD
measurements in section 14. The ratios between the measured and calculated values
for all the selected positions are shown in Table 5.5. As can be seen in this table the
most significant discrepancies are towards the edge of the phantom.
Figure 5.15: Calculated dose distribution in the representative section (no. 14) of the


















-18 -16 -14 -10 -8 -6 -4 -2 0 2 4 6 8 10 14 16 18
10 - . 456.08 - . - . -
8 - 458.44 448.53 414.63 - - - -
6 - - - 411.32 436.29 419.28 434.59 399.62 413.10 450.97 429.95 389.33 - - -
4 - - 376.80 375.40 397.52 418.51 424.16 - 406.24 428.40 407.61 392.52 - - -
2 - 377.54 376.98 389.31 381.66 - 396.28 403.77 421.37 392.62 381.06 . . -
0 374.24 366.14 354.05 362.78 388.54 375.42 386.86 387.04 374.66 409.35 373.02 420.85 376.72 385.97 362.23 327.36 369.27
-2 - 357.94 363.31 391.78 363.62 357.28 - 380.39 387.27 395.79 364.25 . - -
-4 - 363.00 375.30 381.13 378.01 - - . 394.70 374.62 382.11 370.53 . - -
-6 359.37 379.59 395.34 - 389.35 - - - 359.54 - - - -
* Approximate TLD calibration factor was 0.0370 (mGy).
Table 5.5: Ratios of the normalised measured values to the calculated values in the




-18 -16 -14 -10 -8 -6 -4 -2 0 2 4 6 8 10 14 16 18
10 - - - - - - - - 1.02 - - - - - - - -
8 1.06 1.04 0.99 - - - -
6 - - - 1.08 Ill 1.00 1.04 0.93 - 0.98 1.07 1.05 0.95 - - -
4 - - - 1.06 1.02 1.04 1.06 - 1.04 - 0.99 1.09 1.04 1.00 - - -
2 - . - 1.06 1.06 1.06 1.00 - 1.04 - 1.03 1.10 1.03 1.04 - - -
0 1.05 1.03 0.99 1.02 1.09 1.02 1.05 1.05 1.00 1.11 1.02 1.15 1.06 1.13 1.06 0.96 1.08
-2 - - - 1.01 1.02 1.10 1.02 - 1.00 - 1.07 1.10 1.16 1.07 - - -
-4 - - - 1.02 1.05 1.07 1.11 - - - 1.16 1.10 1.12 1.09 - - -
-6 - - - 1.01 1.07 1.16 - 1.14 - - - 1.05 - - -
Figure 5.16 shows the calculated dose distributions in the representative
section of the "abdomen & pelvis" area (section 26). Table 5.6 shows the results of
TLD measurements in section 26. The ratios between the measured and calculated
values for all the selected positions in this section are shown in Table 5.7. In common
with the chest section, this table indicates that the largest discrepancies are towards
the periphery of the phantom, particularly in the posterior region in which the
calculations appear to underestimate the dose.
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Figure 5.16: Calculated dose distribution in the representative section (no. 26) of the
"abdomen & pelvis" area for the Siemens Somatom Plus CT scanner.





-12 -10 -8 -6 -4 -2 0 2 4 6 8 10 12
10 - - - - - - 512.25 - - - - - -
8 - - - - 496.79 505.66 517.57 541.23 521.27 504.05 - - -
6 - - 518.80 524.53 496.79 488.22 490.55 484.43 506.74 521.61 549.89 - -
4 - 533.66 508.91 499.88 466.53 423.94 440.91 442.32 458.64 475.69 475.47 518.62 -
2 - 517.33 473.45 457.82 430.84 413.62 415.65 406.73 428.03 451.22 485.65 499.88 -
0 - 528.01 467.76 431.29 415.49 380.55 333.26 362.38 400.74 448.55 445.82 491.76 -
-2 558.04 496.71 477.88 405.33 411.47 - - - 386.04 428.18 450.53 493.66 497.41
-4 - 489.11 434.34 428.29 403.04 - 300.34 - 407.81 439.04 460.42 468.87 -
-6 - 510.64 447.58 451.35 451.64 400.27 - 414.98 434.74 446.94 453.95 472.50 -
-8 - 445.47 428.21 449.44 488.67 435.82 475.13 441.00 475.43 464.76 453.33 436.27 -
-10 - - - - 447.21 - 398.43 - 414.42 - - - -
* Approximate TLD calibration factor was 0.0370 (mGy).
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Table 5.7: ratios of the normalised measured values to the calculated values in the




-12 -10 -8 -6 -4 -2 0 2 4 6 8 10 12
10 - - - - - - 1.00 - - - - - -
8 - - - - 0.97 0.99 1.01 1.05 1.02 0.98 - - -
6 - - 1.01 1.02 0.97 0.95 0.96 0.94 0.99 1.06 1.11 - -
4 - 1.04 1.03 1.01 0.98 0.89 0.93 0.90 0.96 1.00 1.00 1.09 -
2 - 1.05 0.96 0.96 0.98 0.99 0.99 0.89 0.94 0.99 1.02 1.05 -
0 - 1.11 0.98 0.94 1.03 0.99 1.00 0.90 0.95 1.02 0.94 1.03 -
-2 1.17 1.09 1.05 0.97 1.07 - - - 0.96 0.97 0.95 1.04 1.04
-4 - 1.11 1.03 1.06 1.10 - 0.87 - 1.01 1.00 0.97 0.98 -
-6 - 1.22 1.07 1.12 1.18 1.09 - 1.08 1.04 1.02 0.99 1.03 -
-8 - 1.06 1.02 1.11 1.21 1.04 1.13 1.05 1.08 1.06 0.99 0.96 -
-10 - - - - 1.07 - 0.91 - 0.94 - - - -
5.6.2 Parallel Sections
We assumed that the dose distributions are similar in parallel sections to the
three representative sections chosen for the "head", "chest" and "abdomen and pelvis"
areas of the phantom. To test this assumption in the overlap region between the chest
and the abdomen areas, measurements were performed on sections 18, 20, 22, and
24. In this regard around 30 positions were selected in each of these sections arranged
in a 4 cm by 4 cm grid. The measuring technique described above was also employed
to calculate the normalised dose values at each position for these sections.
"Chest" area
To estimate the level of error caused by the assumption made for dose
distributions in parallel sections for "chest" examinations, the ratios between the
normalised measured values in section 18 and the calculated values in the
representative section of the "chest" were calculated and analysed.
It was assumed that the dose distribution in section 18 was identical to that for
section 14. Table 5.8 shows measured TLD results in section 18. The ratios of the
normalised measured dose values in section 18 to the calculated dose values in the
representative section of the chest (no. 14) are shown in Table 5.9. Overall, the
average ratio of the measured values in section 18 to the calculated values in section
14 for the 30 positions was 1.25 with an s.d. of 13% s.d. and a range of 1.00-1.68.
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-12 -8 -4 0 4 8 12
12 - - - 450.17 - - -
8 - 439.41 444.71 425.84 423.47 595.38 -
4 361.97 424.44 371.71 359.92 370.69 400.31 408.65
0 381.55 379.86 350.92 317.46 361.32 394.00 393.28
-4 366.17 373.26 354.53 - 347.30 371.01 365.70
-8 402.21 - 386.30 386.52 394.77 - 401.02
* Approximate TLD calibration factor was 0.0370 (mGy).
Table 5.9: Ratios of the normalised measured values in section 18 to the calculated





-12 -8 -4 0 4 8 12
12 - - - 1.19 - - -
8 - 1.32 1.25 1.13 1.16 1.67 -
4 1.20 1.36 1.12 1.04 1.07 1.20 1.31
0 1.27 1.26 1.13 1.00 1.16 1.31 1.36
-4 1.21 1.24 1.23 - 1.20 1.28 1.27
-8 1.33 - 1.34 1.38 1.37 - 1.39
The likely reason for the increased heterogeneity in dose for this section is that
in the lower region of the chest, the cross sectional area of the lungs is reduced. This
is liable to result in a greater dose heterogeneity in this section than is represented by
the dose distribution in section 14 (Figure 5.15).
The main organs of interests which contribute significantly to effective dose
and are located in the scan volume for a routine chest examination are lungs,
oesophagus, breasts, bone, and red bone marrow (RBM). Lungs are located totally in
the scan volume. The underestimation of the dose to this organ will be most
significant in those section for which the lung area is small. This implies that the error
in calculation of the integrated dose to the lung is much less than 25%, probably no
greater than 10%. There will be an underestimate of the dose to the liver and
stomach. However, only 25% and 17% of these organs respectively are included
within the scanned region, so that the calculated error is correspondingly small. For
oesophagus there is no error since it is located at the centre of each section of the
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phantom, where there is a direct measurement of the dose. Breasts are located close
to the representative section of the chest. Therefore the degree of underestimation in
their dose is likely to be comparable to the differences represented for section 14
(Table 5.5). For bone and RBM the average values for the whole sections were used
based on the method described by Huda and Sandison (1984). Hence the doses to
these tissues will be affected in the same way as dose to the lungs.
Section 20 is outside the scan volume for the chest examination. The
dosimetry method assumes that the dose distributed outside the scanned region is
uniform. Table 5.10 shows the results of TLD measurements in section 20. These
values were normalised to the central dose to demonstrate the distribution of the dose
in this section (Table 5.11).




-12 -8 -4 0 4 8 12
8 - 107.42 120.66 129.68 129.11 112.04 -
4 94.96 128.37 133.32 140.81 139.55 130.81 105.43
0 102.82 126.20 133.03 128.44 135.21 135.34 106.86
-4 90.64 120.81 123.05 - 119.49 129.43 104.35
-8 - 101.12 108.87 110.42 116.18 - -
* Approximate TLD calibration factor was 0.0370 (mGy).





-12 -8 -4 0 4 8 12
8 - 0.84 0.94 1.01 1.01 0.87 -
4 0.74 1.00 1.04 1.10 1.09 1.02 0.82
0 0.80 0.98 1.04 1.00 1.05 1.05 0.83
-4 0.71 0.94 0.96 - 0.93 1.01 0.81
-8 - 0.79 0.85 0.86 0.90 - -
Overall the average ratio of the measured values normalised to the central
values in section 20 for 29 positions was 0.93 with an s.d. of 11% and a range of
0.73-1.10.
There are clearly errors in the assumption of uniform dose in this section with
the dose towards the periphery of the section being significantly reduced. However
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the overall effect is relatively small since the central doses of the sections outside the
scan volume exponentially decreases when we move away from the scanned region on
either side of the region. Integrating the scattered central doses outside the scan
volume for the two ends of the phantom shows that it represents approximately 19%
of the total integrated dose over the scan volume (sections 10-19). The overall
overestimate of the estimated dose in these sections due to the assumption of uniform
dose is therefore negligible, since it is only at the lower end of the scan volume that
the dose contributes significantly to effective dose.
"Abdomen & Pelvis" area
To estimate the level of error caused by the assumption made for dose
distributions in parallel sections for "abdomen & pelvis" examinations, the ratios
between the normalised measured values in sections 20, 22, and 24 and the calculated
values in the representative section of the "abdomen & pelvis" were calculated and
analysed.
It was assumed that the dose distribution in all the parallel sections in
"abdomen & pelvis" area are identical to that for section 26 (Figure 5.16). The ratios
of the normalised measured dose values in sections 20, 22, and 24 to the calculated
values in section 26 are summarised in Table 5.12.
Table 5.12: The average ratio of the normalised measured values in section 20, 22,
and 24 to the calculated values in the representative section of the "abdomen &
Section no. 20 22 24
no. of positions 30 30 26
average 0.98 0.92 0.85
standard deviation 0.13 0.09 0.08
minimum 0.72 0.71 0.67
maximum 1.27 1.11 1.00
Table 5.13, Table 5.14, and Table 5.15 show the results of TLD
measurements in section 20, 22, and 24 from the "abdomen & pelvis" examination.
The ratios of the normalised measured values in section 20, 22, and 24 to the
calculated values in the representative section of the abdomen & pelvis are shown in
Table 5.16, Table 5.17, and Table 5.18 respectively. As can be noted in the tables, the
ratios are significantly higher in the posterior regions of the sections indicating that
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the degree of anterior posterior asymmetry in the dose distribution in figure 2 does
not properly represents the dose distribution in these parallel sections.





-12 -8 -4 0 4 8 12
8 - 421.07 375.83 359.95 370.52 354.60 -
4 269.23 308.85 307.66 288.16 302.11 328.79 259.11
0 353.06 307.33 273.19 243.04 281.38 291.80 322.47
-4 350.40 306.58 278.82 - 270.09 310.03 382.84
-8 - 383.32 373.54 355.16 364.67 380.82 -
* Approximate TLD calibration factor was 0.0370 (mGy).





-12 -8 -4 0 4 8 12
8 - 463.32 468.61 470.68 491.84 453.11 -
4 386.76 452.29 409.88 389.08 421.91 385.51 357.84
0 342.52 385.34 359.33 324.16 353.57 376.21 448.24
-4 394.76 381.16 366.16 - 361.58 404.98 458.42
-8 - 445.67 436.03 394.21 424.33 435.74 -
* Approximate TLD calibration factor was 0.0370 (mGy).





-12 -8 -4 0 4 8 12
8 - - 512.13 521.24 516.60 - -
4 - 460.38 435.35 422.30 451.15 455.37 -
0 415.49 425.73 402.85 385.19 386.59 448.92 477.01
-4 466.81 433.25 401.99 - 391.96 424.00 370.05
-8 - 485.01 461.69 465.35 395.06 467.99 -
* Approximate TLD calibration factor was 0.0370 (mGy).
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Table 5.16: The ratios of the normalised measured values in section 20 to the





-12 -8 -4 0 4 8 12
8 - 1.13 1.00 0.96 0.99 0.95 -
4 0.72 0.86 0.89 0.83 0.87 0.95 0.75
0 0.98 0.88 0.93 1.00 0.92 0.84 0.93
-4 1.09 1.00 1.04 - 0.92 0.89 1.10
-8 - 1.25 1.27 1.16 1.14 1.14 -
Table 5.17: The ratios of the normalised measured values in section 22 to the





-12 -8 -4 0 4 8 12
8 - 0.93 0.94 0.94 0.99 0.91 -
4 0.77 0.94 0.88 0.84 0.91 0.83 0.77
0 0.71 0.83 0.92 1.00 0.87 0.81 0.97
-4 0.92 0.93 1.03 - 0.92 0.87 0.99
-8 - 1.09 1.11 0.97 0.99 0.98 -
Table 5.18: The ratios of the normalised measured values in section 24 to the





-12 -8 -4 0 4 8 12
8 - - 0.86 0.88 0.87 - -
4 - 0.81 0.79 0.77 0.82 0.83 -
0 0.73 0.77 0.86 1.00 0.80 0.82 0.87
-4 0.92 0.89 0.95 - 0.84 0.77 0.67
-8 - 1.00 0.99 0.96 0.78 0.89 -
The results of the measurements on section 24 indicates an over estimation of
15% in the calculated doses due to the assumption of the similarity of the dose
distribution in parallel sections to the representative section of the "abdomen &
pelvis" area for the examinations performed over this area of the body. From the other
sections (20 and 22) the discrepancy is smaller. However, it should be noted that the
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significant organs and tissues used for the calculation of effective dose are in the
anterior part of the phantom. Inspection of the data in Table 5.16, Table 5.16, and
Table 5.18 indicates that the calculation method may give rise to an overestimate in
dose of between 10 and 20%.
Section 18 is outside the scanned volume for the "abdomen & pelvis"
examination. The dosimetry method assumes that the dose distributed outside the
scanned region is uniform. Table 5.19 shows the results of TLD measurements in
section 18. These values were then normalised to the central dose to demonstrate the
distribution of the dose in this section (Table 5.20). Overall the average ratio of the
normalised measured values to the central value in section 18 for 30 positions was
0.87 with an s.d. of 12% and a range of 0.63-1.08.





-12 -8 -4 0 4 8 12
12 - - - 43.86 - - -
8 - 65.31 72.84 83.18 74.99 64.04 -
4 76.92 81.96 90.32 95.70 100.24 82.84 69.68
0 78.02 90.69 89.99 94.76 94.69 90.55 76.81
-4 73.81 88.27 89.90 - 88.88 102.26 76.32
-8 60.88 - 81.21 76.38 87.75 - 59.87
* Approximate TLD calibration factor was 0.0370 (mGy).
Table 5.20: The normalised measured values to the central value in section 18 for the




-12 -8 -4 0 4 8 12
12 - - - 0.46 - - -
8 - 0.69 0.77 0.88 0.79 0.68 -
4 0.81 0.86 0.95 1.01 1.06 0.87 0.74
0 0.82 0.96 0.95 1.00 1.00 0.96 0.81
-4 0.78 0.93 0.95 - 0.94 1.08 0.81
-8 0.64 - 0.86 0.81 0.93 - 0.63
As for "the" chest examination, the dose distribution on this section indicates
that there are errors in the assumption of uniform dose in the sections outside the scan
volume, with the dose towards the periphery of the section being significantly
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reduced. These measurements were carried out by positioning only one TLD in every
location due to limited number of available TLDs. Therefore some of the extremely
low values in the table could have been due to the intermittent low readings
experienced with the TLD reader as explained earlier. However, these results show
that the errors in the assumption of uniform dose outside the scan volume for the
"abdomen & pelvis" examination, are very similar to what noted earlier for the "chest"
examination. If similar analysis is carried out in the same way accomplished for the
"chest", it can be shown that the overall overestimate of the dose due to the
assumption of uniform dose is small, considering that there is only one tail outside the
scan volume (top end) over which this error occurs for the "abdomen and pelvis"
examination.
5.6.3 Evaluation of Errors in Measurements of Effective Dose
To provide an overall assessment of the accuracy of the dosimetry method, the
errors causing by various parts of the calculations of effective dose were assessed.
Three sources of error were considered: (1) the use of discrete points to represent the
average dose to each organ, as listed in appendix B, rather than a full integration of
the dose distribution over the organ; (2) the use of a single representative section of
the phantom to describe the dose distributions rather than additional distributions for
each section, measurement to validate this aspect of the technique were presented in
section 5.6.2; (3) the random errors associated with TLD measurements as explained
in section 5.3.3.
Errors in organ doses due to the use of discrete points were assessed for the
lungs in section 14 and the colon in section 26. These are the organs in these sections
which give the highest contribution to effective dose due to the high weighting factor,
Wt=0. 12, in each case. The distribution of doses in these sections overlaid in Figure
5.15R and 5.16R for a "chest" and an "abdomen & pelvis" scan respectively.
Integration of the dose distribution over the organ was derived by estimating the area
between contours and weighting the dose in respect of the area, summing and dividing
by the total area. The ratios of doses obtained from the discrete points given in
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appendix B to the dose obtained by full integration of the distribution were 1.01 and
1.02 respectively for the lungs and colon.
It has been shown in Table 5.3, Table 5.5, and Table 5.7 that there were
differences between the distribution calculated from the orthogonal data set and from
a full series of measurements in the representative section for the "chest" (14) and
"abdomen & pelvis" (26) and further errors are introduced when considering the
intermediate sections (18 (Table 5.9 and Table 5.20); 20 (Table 5.11, Table 5.16); 22
(Table 5.17); and 24 (Table 5.18)). This assessment of errors in organ doses was
made for the organs principally contributing to effective dose in these sections: lungs;
liver; stomach; and colon.
The errors in organ doses were assessed by taking the ratios of the organ
doses at the representative location normalised to the central value derived from the
calculated dose distributions (Figure 5.15R and 5.16R) to the actual dose ratio
derived from the measurements in the validation study. Whenever a required single
point value was not available in the measured data set, the average of surrounding
points was taken to represent it. The ratios between the calculated and the measured
average normalised values are summarised in Table 5.21 for the "chest" and
"abdomen & pelvis" examinations.




calculated measured ratio *
chest lungs 14 1.00 1.09 0.92
18 0.96 1.22 0.79
liver 18 1.05 1.16 0.91
abdomen & pelvis liver 20 1.41 1.31 1.08
22 1.49 1.34 1.11
24 1.51 1.19 1.27
stomach 20 1.46 1.39 1.05
22 1.54 1.37 1.12
colon 22 1.32 1.13 1.17
24 1.43 1.17 1.22
26 1.43 1.40 1.01
* calculated to measured values.
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The results of estimated patient doses using the developed direct dosimetry
method for all the scanners are presented in the following chapter. The tables of
results presented for a typical "chest" examination by the Siemens scanner (Table
6.15) shows that lungs and liver contribute 60% and 10% respectively to the effective
dose when their absorbed dose values and their relevant weighting factors are used for
effective dose calculation. Similarly, for a typical "abdomen & pelvis" examination by
the Siemens scanner (Table 6.16) liver, stomach, and colon contribute to the resultant
effective dose by 6%, 16%, and 16% respectively. The average of errors noted above
for these organs can be weighted by these values and by the proportion of the organs
in the parallel slices to assess the level of error introduced in the effective dose caused
by assuming the same dose distributions in parallel sections in this dosimetry method.
In addition, as noted before there was 4.8% statistical uncertainties in TLD
measurement. This in turn causes a 3.4% error in the central axis dose measurements
in the Rando phantom sections being measured with a pair of the TLDs in the
developed dosimetry method. Ten and fifteen central axis dose measurements are
carried out for a typical "chest" and "abdomen & pelvis" examination respectively.
Therefore for a typical "chest" and "abdomen & pelvis" examination an error of 2.2%
and 1.8% is introduced in the value of effective dose by this statistical uncertainty
respectively.
If the uncertainty introduced in the dosimetry method by the discrete point
doses (to the average of contour values) and the average of errors introduced by
assuming the same dose distribution in parallel sections are combined with the
statistical uncertainties resulting from the central dose measurements with the TLDs,
an estimate of the error in effective dose can be estimated for a typical "chest" and
"abdomen & pelvis" examination with the developed CT dosimetry method. This is
shown in Table 5.22.
Since the errors in methodology are not random, the dose ratios have been
multiplied and the resultant error added to that for the TLD measurements.
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Table 5.22:The overall uncertainties in estimated patient doses for two typical CT
examination organ error/uncertaintv (%)
dose distributions discrete central doses overal
contribution points (TLD) (total)
chest lungs 9% 1 % 2% 12%
liver 1 %
abdomen & pelvis liver 9% 2% 2 % 16%
stomac 1 %
colon 2%
5.7 Customised Computer Spreadsheet Program
As mentioned in section two, to further facilitate our proposed direct CT
dosimetry method, a computer spreadsheet program was designed. A very basic
spreadsheet program was primarily used and designed to handle the data management
required for the developed CT dosimetry method. But, during the course of this study
a new and more powerful version of the Microsoft Excel™ computer program
became available. Therefore, further developments were carried out using this
program in an attempt to simplify the data input and data output and to automate the
data processing required for the developed dosimetry method.
Figure 5.17 shows the data components of the spreadsheet. The spreadsheet
has been designed in a way that could be used routinely for regular assessment of
patient doses resulting from all routine CT examinations with all the CT scanners used
in our study. It could also easily be adapted for any upcoming CT scanner model if the
necessary modifications are made in its stored input data.
The input data components of the spreadsheet are either stored or entered by
the user. Two macros are provided to make the input data process quite simple and
user friendly. The output data is also generated automatically by other macros
provided with the spreadsheet. The input and output macros could be run either by
using simple shortcut keys or by pushing the macro buttons provided for this purpose.
In this section all the components of the spreadsheet computer program will
be described and its data flow chart will be explained. The reader is referred to
appendix C, where details of all the macros used in the spreadsheet could be found.
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5.7.1 Input Data
The spreadsheet input data could be divided into two categories of stored
input data and the input data required to be entered by the user.
Input Data
I. Phantom
A. Organs and tissues distribution (Mass Factor)
II. CT Scanner
A. Axial dose distribution (Dose Conversion Factor)
B. Ratios of p.en/p of organs and tissues to that of air
III. Calibration
A. Dosed and control TLDs readouts
B. Traceable ionisation chamber CF and readout
C. Ambient pressure and temperature values
IV. CT Protocol
A. Examination parameters





Organ and tissue absorbed doses
Effective dose equivalent
Effective dose
Figure 5.17: The Data components in the spreadsheet Computer Program.
The stored input data includes the input data for the phantom and the input
data for the CT scanners. As basic stored input data for the phantom, the spreadsheet
stores the location and proportion by weight of all organs or tissues for each section.
This category of data has been called the "mass factor" in the spreadsheet. As stored
input data for the CT scanner, the spreadsheet stores another category of data called
the "tissue dose factor", for all organs and tissues of interest in every section and for
all the CT scanners. These are based on the dose distributions for the three
representative sections of the Rando phantom for each scanner and the location of
121
organs. The other CT scanner related data, stored in the spreadsheet, are the ratios of
mass energy absorption coefficients to that of the air. These ratios have been
calculated for the three categories of tissues, mentioned above, representing all organs
and tissue of interest for all the CT scanners (Table 5.2).
The input data required to be entered by the user in the spreadsheet are the
calibration data, the CT examination parameters, and the phantom central dose values
(TLDs readings). The required calibration data includes: the readouts of ten dosed
and ten control TLDs, the calibration factor and readout of the traceable ionisation
chamber, and the values of the ambient pressure and temperature. The CT
examination parameters required to be entered by the user are: the scan volume area
(head or chest or body) and the sections of the phantom located inside the scan
volume, the scanner model, the settings of the kV, mAs, slice width (thickness),
table/couch increment/feed (conventional CT) or scan pitch (spiral/helical CT), and
the number of slices scanned for the particular CT examination. The phantom central
dose values required to be provided include: the readings of the pair of TLDs put in
every section located inside the scan volume and one or two extra sections located
outside the scan volume. As mentioned in section 5.5.2, the number of the required
extra phantom central dose measurements depends on the scan volume. If the scan
volume extends to either the top end (head) or the bottom end (pelvis) of the
phantom, only one extra central dose measurement is required outside the scan
volume. Otherwise two extra central dose measurements must be carried out outside
the scan volume along the two tails on either side of the scan volume. Two macros
have been provided to simplify the data input and make the spreadsheet interface
more user friendly. The first macro asks the user to enter the required calibration data
consequently. The second macro asks the user to enter the CT examination
parameters and the phantom central doses (the pair of TLDs readings) depending on
the examination parameters. Details of these macros could be found in appendix C.
Therefore, to assess patient doses for each CT examination protocol, TLD
measurements need to be made at no more than 15 locations, on the central axis of
the phantom, using no more than 30 TLD chips. These are besides the TLD chips
used for calibration measurements. The exact number of TLD measurements depends
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on the scan volume. For example in a complete "head" examination, the scan volume
normally begins at the base of the skull and concludes at the top end of the head. This
CT examination will only cover the five top end sections of the Rando phantom.
Therefore, input of only twelve TLD measurements are required at five locations
inside and one location outside the scan volume to estimate the patient doses resulting
from this CT examination. On the other hand, if an "abdomen & pelvis" examination
is considered, it normally covers a larger volume of the body of the phantom
beginning from section 20 and finishing at the bottom end of the phantom (section
34). To estimate the patient doses resulting from this CT examination, input of 30
TLD measurements at fourteen locations inside and one location outside the scan
volume will be required.
5.7.2 Output Data
From the above mentioned stored input data and other input data entered by
the user, the spreadsheet automatically calculates and reports organs and tissues
absorbed doses. Two macros have also been provided allowing the user to estimate
both the effective dose and effective dose equivalent values based on the ICRP
recommendations (1977, 1991). Clearly effective dose equivalent (ICRP 1977) has
been replaced with effective dose in 1990 ICRP recommendations (ICRP 1991). This
option was included in the spreadsheet computer program to make it possible to
compare the results with others reporting patient doses from CT or other related
practices in terms of effective dose equivalent.
Two types of user interface have been provided to run these macros. The
macros could be run by either the short cut keys or two macro buttons, provided for
this purpose with the spreadsheet computer program. Details of these macros could
also be found in appendix C.
5.7.3 Data Flow Chart
Figure 5.18 shows the data flow chart of the spreadsheet computer program.
When the master copy of the spreadsheet is opened, a macro button named "Data
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Input 1" will become available to the user. When the user pushes this button, he will
be asked to enter consequently, the data required for the TLD calibration factor
calculation, as mentioned earlier in section 5.7.1. This input data includes the values
for: the ten dosed TLDs, the ten control TLDs, the ionisation chamber calibration
factor and its readout, and finally the ambient pressure and temperature. This enables
the spreadsheet to calculate the TLD calibration factor. Then another macro button,
named "Data Input 2" becomes available to the user. When this button is pushed, the
user will be asked to enter consequently: all the required CT examination parameters,
as mentioned earlier (section 5.7.1) and the readings of the pair of TLDs located at
the central axis of the sections inside and one or two sections outside the scan volume
of the phantom. At this stage, spreadsheet calculates the organ and tissue absorbed
doses. Then two more macro buttons, one named "Effective Dose" and the other one
named "Effective Dose Equivalent" become available to the user. Whichever of these
buttons is pushed, enables the spreadsheet to calculate and report the relevant dose
index for the CT examination.
Data Input 1
(TLD Calibration Data) Data Input 2
(CT Examination Data)
TLD CF Calculations






Figure 5.18: The data flow chart of the spreadsheet computer program.
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5.8 Summary of the Developed Direct Dosimetry Method
The direct dosimetry approach was developed in this study to make it a more
simple and practical approach for the assessment of patient doses resulting from the
diverse and fast growing CT practices. The approach was chosen to avoid the
complexity and extensive work involved in the common MC and direct CT dosimetry
approaches respectively. The reduction of the extensive measurements was achieved
by three assumptions made for the dose distributions resulting from the CT scanners.
The measurements carried out for the validation of the accuracy of these assumption
confirmed that overall these assumptions do not cause an error more than the degree
of uncertainties (-20%) reported by the NRPB for the Monte Carlo dosimetry
approach (Shrimpton et al. 1991b). However it is possible to decrease more the
degree of this error caused mainly by the assumption made regarding the dose
distribution in parallel sections of the phantom. More improvements could be
achieved for the developed CT dosimetry method by choosing extra representative
sections in the phantom to decrease the degree of error caused by the significant
inhomogeneity existed specially in the overlap region between the "chest" and
"abdomen" areas of the phantom.
The dosimeter chosen for the dose measurement (LiF TLDs) showed a good
degree of consistency and low degree of uncertainty (4.8%). However a systematic
uncertainty (low readings) was detected with dosimetry system used in this study.
This error is caused by the poor contact between the TLD trays and the heater
compartment of the TLD reader. This systematic error was avoided by using a pair of
TLDs for the point dose measurements. Necessary corrections were also made to take
into account differences in the mass energy absorption coefficients of body tissues for
different CT X-ray spectra used by various CT scanners, although the differences
observed among the different CT models were not significant (Table 5.2).
The customised computer spreadsheet developed in this study using the
Microsoft Excel ® program provides a very simple and user friendly tool for further
simplification of the developed CT dosimetry method. This spreadsheet does all the
calculations required to estimate the organs absorbed doses and effective dose as
recommended by the ICRP (1991) from a very limited number of TLD readouts for
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all the different CT scanner models in this study. In addition this program could be
used for upcoming new models of the CT scanners in the market if the initial
measurements are carried out to determine the stored data required.
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6. CT Dosimetry using Physical Anthropomorphic Phantom
(Results)
The developed direct CT dosimetry approach was implemented and enabled us
to assess the patient doses resulting from all the CT scanners used at different
hospitals in the Lothian and Fife areas of Scotland. The CT scanners' characteristics
were described earlier in chapter three.
Details of the routine CT examination protocols were determined through
consulting with the radiologists and radiographers who used the scanners. The
parameters considered for CT scan protocols were: applied potential (kV), exposure
setting (mAs), number of slices (or scans), nominal slice width (or slice thickness)
(mm), couch increment or table feed (mm) (for conventional CT scans), pitch value
(for spiral CT scans), physical filter setting (if variable), and the first and last section
of the phantom located in the scan volume. These were the same parameters applied
for the dose assessment using the Monte Carlo dosimetry approach that will be
described in the next chapter.
In this chapter the results of the patient dose assessment using our proposed
direct CT dosimetry method will be presented for all routine CT examination
protocols, performed by every CT scanner in this study. The results will be presented
in terms of organ or tissue absorbed dose, effective dose (E), and effective dose
equivalent (HE) values. As mentioned earlier two models of the scanners (GE 8800
and GE 9000HP) were taken out of service or replaced with a newer model of GE
HiSpeed Advantage in 1996. However, the measured values resulting from the
developed direct CT dosimetry method on these model are presented here to make it
possible to compare our proposed dosimetry approach with the Monte Carlo
dosimetry approach. The calculated values resulting from the MC approach are
presented in the following chapter. The differences between the results from the dose
the developed direct dosimetry approach with that from the MC dosimetry methods
are presented and discussed in chapter eight.
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6.1 GE 8800 CT Scanner
As was already noted in chapter three, this scanner was rather an old GE
model. Two scanners of this type were in use at two hospitals in the area. One of
these scanners was not frequently in use and was mostly used as a backup for another
GE 9000HP model. The measurements were carried out on the other one that was
actively used. This scanner could have been used for whole body CT examinations
including head, chest and abdomen and pelvis regions of the body. But, since it was
installed in a clinical neuroscience department, it was mostly used for head and neck
area CT examinations. The relevant parameters are listed in Table 6.1, for all the
routine CT examinations used to be carried out with this scanner.
Table 6.1: Typical clinical scanning parameters for the routine examinations with the
GE 8800 CT Scanner.
Examination Physical kV mA mAs Slice Couch No. Scan
filter width increment of volume *
(mm) (mm) slices
Head Head 120 320 737 10 10 4 4- 1
250 576 10 10 4
160 369 10 10 2
Orbit Head 120 320 737 5 3 9 4-3
250 576 10 10 1
Posterior Head 120 400 922 5 5 7 4- 1
fossa 320 737 10 10 3
250 576 10 10 3
200 461 10 10 1
* First and last sections of the Rando phantom included in the scan volume.
Organ and Tissue Doses and other Dose Indices:
Table 6.2 shows the calculated organ doses, effective dose equivalent, and
effective dose values for the above three routine CT examinations performed by this
scanner.
128
Table 6.2: Calculated organ doses and dose indices for the routine examinations with
the GE 8800 CT scanner.
Organ/tissue Calculated dose (mGy)
Head Orbit Posterior fossa
Gonads 0.00 0.00 0.00
Red hone marrow 1.50 1.21 1.98
Colon 0.00 0.00 0.00
Lungs 0.01 0.01 0.02
Stomach 0.00 0.00 0.00
Bladder 0.00 0,00 0.00
Breasts 0.00 0.00 0.00
Liver 0.00 0.00 0.00
Oesophagus 0.06 0.04 0.10
Thyroid 0.30 0.22 0.52
Skin 0.75 0.55 0.97
Bone surface 9.85 7.96 12.95
Remainder (mSv, ICRP 26) 1.38 1.01 1.73
He (mSv) 1.86 1.40 2.38
Remainder (mSv, ICRP 60) 0.47 0.31 0.57
E (mSv) 0.77 0.56 0.98
6.2 GE 9000HP CT Scanner
This was another old GE CT scanner. This scanner was used for whole body
CT examinations including head, chest, abdomen and pelvis areas of the body in an X-
ray department. The relevant parameters are listed in Table 6.3 for all the routine CT
examinations used to be carried out with this scanner.
Table 6.3: Typical clinical scanning parameters for the routine examinations with the
GE 9000HP CT Scanner.
Examination Physical kV mA mAs Slice Couch No. Scan
fdter width increment of volume*
(mm) (mm) slice
Head Head 120 250 888 10 10 5 4-3
200 710 10 10 6 3 -0
Chest Body 120 250 533 10 15 18 10 - 19
Abdomen & pelvis Body 120 250 533 10 15 28 20 - 34
* First and last sections of the Rando phantom included in the scan volume.
Organ and Tissue Doses and other Dose Indices:
Table 6.4 shows the calculated organ doses, effective dose equivalent, and
effective dose values for the above three routine CT examinations performed by this
scanner.
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Table 6.4: Calculated organ doses and dose indices for the routine examinations with
the GE 9000 HP CT scanner.
Organ/tissue Calculated dose (mGy)
Head Chest Abdomen & pelvis
Gonads 0.00 0.04 11.57
Red bone marrow 3.28 4.56 5.89
Colon 0.00 0.19 13.19
Lungs 0.02 17.08 2.03
Stomach 0.00 7.55 17.54
Bladder 0.00 0.04 13.09
Breasts 0.00 20.03 3.11
Liver 0.00 7.73 10.139
Oesophagus 0.13 14.83 1.19
Thvroid 0.67 5.14 0.08
Skin 1.66 2.46 4.32
Bone surface 21.51 19.00 22.73
Remainder (mSv, ICRP 26) 2.97 3.52 5.68
He (mSv) 4.03 9.90 10.68
Remainder (mSv, ICRP 60) 1.01 0.58 0.65
E (mSv) 1.68 6.73 9.54
6.3 Philips Tomoscan CX/S CT Scanner
This was a modern model of Philips CT scanners, but had a rather poor and
slow scan and reconstruction time compared with the other modern CT models in this
study. The scanner was used for whole body CT examinations including head, chest,
and abdomen and pelvis areas of the body in an X-ray department. The relevant
parameters are listed in
Table 6.5, for all the routine CT examinations being carried out with this
scanner.
Table 6.5: Typical clinical scanning parameters for the routine examinations with the
Examination kV mA mAs Slice Couch No. Scan
width increment of volume*
(mm) (mm) slices
Head 120 220 356 10 10 11 4-1
Neck 120 220 356 10 10 10 6 - 10
Posterior fossa 120 270 437 5 5 6 4-0
220 356 10 10 9
Chest 120 220 356 10 15 18 10 - 19
Abdomen & pelvis 120 270 437 10 15 28 20-34
Lumbar spine 120 270 437 5 5 10 26-29
* First and last sections of the Rando phantom included in the scan volume
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Organ and Tissue Doses and other Dose Indices:
Table 6.6 shows the calculated organ doses, effective dose equivalent, and
effective dose values for all the routine examinations performed by this CT scanner.
Table 6.6: Calculated organ doses and dose indices for the routine examinations with
the Philips Tomoscan CX/S CT scanner.







Gonads 0.00 0.00 0.00 0.06 20.51 3.69
Red bone marrow 3.33 3.88 3.33 6.85 12.12 5.01
Colon 0.00 0.00 0.00 0.26 25.45 5.84
Lungs 0.03 1.98 0.04 25.71 2.87 0.10
Stomach 0.00 0.03 0.00 10.89 27.93 1.29
Bladder 0.00 0.00 0.00 0.04 24.22 2.73
Breasts 0.00 0.37 0.00 27.82 4.49 0.16
Liver 0.00 0.04 0.00 11.51 26.17 1.66
Oesophagus 0.14 9.23 0.19 20.35 1.57 0.06
Thyroid 0.72 50.95 0.91 8.70 0.05 0.00
Skin 1.66 1.89 1.73 3.61 6.66 1.84
Bone surface 20.30 18.25 20.26 26.55 43.41 17.70
Remainder (mSv, ICRP 26) 2.97 2.17 2.85 4.89 10.02 3.32
He (mSv) 4.00 5.01 3.89 14.05 18.93 5.41
Remainder (mSv, ICRP 60) 1.01 0.04 1.02 0.77 1.17 0.65
E (mSv) 1.68 3.98 1.70 9.75 16.80 3.28
6.4 GE Sytec 3000 Plus CT Scanner
This was a lower range RR model GE CT scanner. The scanner was used for
whole body CT examinations including head, chest, and abdomen and pelvis areas of
the body in an X-ray department. The relevant parameters are listed in Table 6.7 for
all the routine CT examinations being performed by this scanner.
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Table 6.7: Typical clinical scanning parameters for the routine examinations with the











Posterior fossa 120 100 450 5 5 8 4 - 1
80 360 10 10 5
60 270 10 10 2
Chest 120 130 234 10 10 25 10 - 19
Abdomen & pelvis 120 130 351 10 10 38 | 20 - 34
* First and last sections of the Rando phantom included in the scan volume
Organ and Tissue Doses and other Dose Indices:
Table 6.8 shows the calculated organ doses, effective dose equivalent, and
effective dose values for the above three routine CT examinations performed by this
scanner.
Table 6.8: Calculated organ doses and dose indices for the routine examinations with
the GE Sytec 3000 Plus CT scanner.
Organ/tissue Calculated dose (mGv)
Posterior fossa Chest Abdomen & pelvis
Gonads 0.00 0.02 42.08
Red bone marrow 5.27 10.58 26.32
Colon 0.00 0.17 50.69
Lungs 0.05 35.58 4.67
Stomach 0.00 12.27 53.06
Bladder 0.00 0.01 40.48
Breasts 0.01 40.08 7.27
Liver 0.00 13.25 47.47
Oesophagus 0.26 35.80 2.60
Thvroid 1.30 22.62 0.10
Skin 2.75 5.43 12.27
Bone surface 34.53 44.43 101.16
Remainder (mSv. ICRP 26) 4.66 6.87 18.95
He (mSv) 6.37 20.43 37.31
Remainder (mSv, ICRP 60) 1.53 0.38 2.20
E (mSv) 2.62 13.50 32.81
6.5 GE HiSpeed Advantage CT Scanner
This was a modern and top of the range GE CT scanner substituted for the GE
9000HP model in 1996. The scanner was used for whole body CT examinations
including head, chest, and abdomen and pelvis areas of the body in an X-ray
department. This scanner had capabilities to perform a variety of different
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conventional and spiral (called helical by the GE manufacturer) CT examination
protocols. The results of our dose measurement carried out for some of the routine
and spiral CT examinations performed with this scanner will be mentioned separately.
6.5.1 Conventional CT Examinations
The relevant CT parameters are listed in Table 6.9, for all the routine
conventional CT examinations being made with this model of GE scanner.
Table 6.9: Typical clinical scanning parameters for the conventional routine.
examinations with the GE HiSpeed Advantage CT Scanner.
Examination kV mA mAs Slice Couch No. Scan
width increment of volume*
(mm) (mm) slices
Head (1) 120 280 280 10 10 10 4-1
Head (2) 120 340 340 10 10 6 o1Tt*
280 280 10 10 6
Head (3) 120 340 340 10 10 12 4-0
Posterior fossa 120 340 340 5 5 5 o1
340 340 10 10 5
280 280 10 10 5
Chest 120 120 120 10 10 27 10 - 19
Abdomen & pelvis (1) 120 280 280 10 10 38 20-34
Abdomen & pelvis (2) 120 150 150 10 10 38 20-34
* First and last sections of the Rando phantom included in the scan volume
Organ and Tissue Doses and other Dose Indices:
Table 6.10 shows the calculated organ doses, effective dose equivalent, and
effective dose values for all the routine conventional CT examinations being
performed with this scanner.
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Table 6.10: Calculated organ doses and dose indices for the routine conventional
examinations with the GE HiSpeed Advantage CT Scanner.















Gonads 0.00 0.00 0.00 0.00 0.01 18.10 8.43
Red bone marrow 2.08 2.85 2.70 3.26 2.62 12.07 5.62
Colon 0.00 0.00 0.00 0.00 0.08 21.60 10.93
Lungs 0.01 0.04 0.02 0.02 8.56 5.63 1.18
Stomach 0.00 0.00 0.00 0.00 3.96 26.15 10.23
Bladder 0.00 0.00 0.00 0.00 0.01 18.20 9.47
Breasts 0.00 0.00 0.00 0.00 10.41 8.06 1.82
Liver 0.00 0.00 0.00 0.00 4.16 24.50 9.65
Oesophagus 0.07 0.17 0.12 0.13 9.03 3.73 0.68
Thvroid 0.38 0.83 0.60 0.70 6.01 0.64 0.03
Skin 1.05 1.49 1.44 1.63 1.36 5.90 2.60
Bone surface 13.38 18.27 17.28 20.89 10.76 45.69 21.14
Remainder
(mSv, ICRP 26)
1.88 2.52 2.31 2.77 1.90 8.34 3.84
He (mSv) 2.54 3.44 3.18 3.81 5.31 17.59 7.67
Remainder
(mSv, ICRP 60)
0.64 0.83 0.78 0.90 0.11 0.99 0.45
E (mSv) 1.06 1.42 1.33 1.56 3.54 15.73 6.81
6.5.2 Spiral CT Examinations
The relevant CT parameters are listed in Table 6.11, for all the routine spiral
CT examinations being made with this model of GE scanner.
Table 6.11: Typical clinical scanning parameters for the spiral examinations with the
Scanner.










Chest 120 150 150 7 1.5 24.4 10 - 19
Liver(I) 120 200 200 10 1.0 18 20-26
Liver (2) 120 220 220 7 1.0 32 18-26
Liver (3) 120 200 200 10 1.0 23 18-26
Liver (4) 120 220 220 5 1.0 21 21 -24
200 200 7 1.0 12 18-20
220 220 7 1.0 33 26 - 18
Abdomen & pelvis 120 150 150 10 1.3 26.4 20-34
Lumbar spine 120 250 250 3 1.0 51 23 -28
* First and last sections of the Rando phantom included in the scan volume
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Organ and Tissue Doses and other Dose Indices:
Table 6.12 shows the calculated organ doses, effective dose equivalent, and
effective dose values for all the routine spiral CT examinations being performed with
this model of GE scanner.
Table 6.12: Calculated organ doses and dose indices for the routine spiral
examinations using the GE HiSpeed Advantage CT scanner.













Gonads 0.01 0.38 0.38 0.41 0.62 5.30 1.57
Red bone marrow 2.69 2.50 3.44 3.12 5.73 4.00 3.71
Colon 0.05 1.82 2.06 1.94 3.31 7.69 3.67
Lungs 8.12 1.82 5.02 4.41 9.15 0.96 0.40
Stomach 3.16 16.91 20.74 18.46 38.03 8.61 5.85
Bladder 0.00 0.28 0.27 0.30 0.47 5.79 1.14
Breasts 9.43 3.18 9.24 8.05 16.75 1.48 0.62
Liver 3.38 15.67 20.00 17.72 36.03 8.16 6.67
Oesophagus 9.10 1.13 3.41 2.96 6.09 0.55 0.22
Thyroid 6.80 0.05 0.11 0.10 0.20 0.03 0.01
Skin 1.32 1.82 2.55 2.29 4.32 1.87 1.89
Bone surface 11.11 9.89 13.66 12.37 22.80 15.12 14.17
Remainder
(mSv, ICRP 26)
1.76 5.21 6.23 5.54 11.05 3.11 3.87
He (mSv) 5.01 6.59 9.14 8.12 16.19 5.71 5.28
Remainder
(mSv, ICRP 60)
0.10 0.66 0.76 0.68 1.31 0.36 0.58
E (mSv) 3.34 4.64 6.40 5.72 11.43 4.95 3.12
6.6 Siemens Somatom Plus CT Scanner
This was also a modern and top of the range RR model of Siemens CT
scanners. The scanner was used for whole body CT examinations including head,
chest, and abdomen and pelvis areas of the body in a radiology department. This
scanner had also had capabilities to perform a variety of conventional and spiral CT
examination. The results of our dose measurement for some of the routine and spiral
CT examination with this model will be mentioned separately.
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6.6.1 Conventional CT Examinations
The relevant CT parameters are listed in Table 6.13, for all routine
conventional CT examinations being made with this model of Siemens scanner.
Table 6.13: Typical clinical scanning parameters for routine conventional
examinations with the Siemens Somatom Plus CT Scanner
Examination kV mA mAs Slice Couch No. Scan
width increment of volume*
(mm) (mm) slices
Head til 120 210 420 10 10 10 4-1
Headt2) 120 210 420 10 10 11 4-0
Posterior fossa 120 210 420 5 5 6 4- 1
10 10 7
Orbit 120 165 165 5 5 8 4-3
Chest tl) 137 100 100 10 10 25 11 - 19
Chest (2) 137 145 145 10 10 26 10 - 19
Abdomen & nelvis tl) 120 210 210 10 10 36 20-34
Abdomen & nelvis t2) 120 210 210 10 15 26 20-34
Abdomen & nelvis t3) 120 210 210 10 10 38 20-34
Pelvis tl) 120 210 210 10 10 17 29-34
Pelvis (2) 120 315 315 10 10 17 29-34
♦First and last sections of the Rando phantom included in the scan volume
Organ and Tissue Doses and other Dose Indices:
Table 6.14 shows the calculated organ doses, effective dose equivalent, and
effective dose values for the routine conventional "head" examinations performed by
this CT scanner. Table 6.15, Table 6.16, and Table 6.17 show similar dose values for
the routine conventional "chest", "abdomen & pelvis", and "pelvis" examinations
performed by this CT scanner.
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Table 6.14: Calculated organ doses and dose indices for different routine conventional
'head" examinations using t le Siemens Somatom Plus CT scanner.
Organ/tissue Calculated dose (mGy)
Head Head Posterior Orbit
fl) (2) fossa
Gonads 0.00 0.00 0.00 0.00
Red bone marrow 2.09 2.12 2.43 0.37
Colon 0.00 0.00 0.00 0.00
Lungs 0.03 0.03 0.05 0.02
Stomach 0.00 0.00 0.00 0.00
Bladder 0.00 0.00 0.00 0.00
Breasts 0.00 0.00 0.01 0.00
Liver 0.00 0.00 0.00 0.00
Oesophagus 0.12 0.13 0.21 0.06
Thvroid 0.59 0.62 0.96 0.24
Skin 1.05 1.07 1.22 0.21
Bone surface 13.80 14.00 16.03 2.42
Remainder (mSv, ICRP 26) 1.91 1.89 2.25 0.39
He (mSv) 2.60 2.59 3.06 0.52
Remainder (mSv, ICRP 60) 0.64 0.63 0.73 0.13
E (mSv) 1.08 1.08 1.26 0.21
Table 6.15: Calculated organ doses and dose indices for two routine conventional
"chest" examinations using; the Siemens Somatom Plus CT scanner.
Organ/tissue Calculated dose (mGv)
Chest (1) Chest (2)
Gonads 0.01 0.01










Bone surface 13.36 20.82
Remainder (mSv, ICRP 26) 2.08 3.26
He (mSv) 5.99 9.60
Remainder (mSv, ICRP 60) 0.12 0.19
E (mSv) 3.97 6.39
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Table 6.16: Calculated organ doses and dose indices for three routine conventional
Organ/tissue Calculated dose (mGv)
Abdomen Abdomen Abdomen
& pelvis (1) & pelvis (2) & pelvis (3)
Gonads 12.34 7.85 13.99
Red bone marrow 7.87 4.81 8.18
Colon 15.66 9.35 16.88
Lungs 1.73 1.16 1.18
Stomach 15.31 9.41 13.13
Bladder 13.75 7.76 14.40
Breasts 2.65 1.75 1.81
Liver 14.45 8.89 12.82
Oesophagus 1.01 0.70 0.70
Thvroid 0.06 0.06 0.05
Skin 3.69 2.29 3.76
Bone surface 30.60 18.70 31.75
Remainder (mSv, ICRP 26) 5.67 3.45 5.93
He (mSv) 11.23 6.96 11.78
Remainder (mSv, ICRP 60) 0.67 0.41 0.68
E (mSv) 9.94 6.12 10.05
Table 6.17: Calculated organ doses and dose indices for two routine conventional
pelvis examinations using the Siemens Somatom Plus CT scanner.
Organ/Tissue Calculated dose (mGv)
Pelvis (1) Pelvis (2)
Gonads 11.71 18.71










Bone surface 15.67 25.02
Remainder (mSv, ICRP 26) 3.48 5.63
He (mSv) 7.37 11.85
Remainder (mSv, ICRP 60) 0.17 0.27
E (mSv) 5.37 8.62
6.6.2 Spiral CT Examinations






CT examinations being performed with this model of Siemens scanner.
Table 6.18: Typical clinical scanning parameters for the routine spiral examinations
with the Siemens Somatom Plus CT Scanner.
Examination kV mA mAs Slice Scan Total Scan
width pitch scan time volume*
(mm) (sec.)
Neck til 120 340 340 3 1.0 24 8 - 10
Neck (2) Larvnx 120 340 340 10 1.0 16 5 - 10
Neck (3) Larvnx 120 230 230 3 1.0 20 8 - 10
Chest 137 145 145 10 1.0 24 11 -20
Abdomen 120 210 210 3 1.0 24 20-22
Abdomen & pelvis 120 210 210 3 1.0 24 20-32
10 1.0 24
* First and last sections of the Rando phantom included in the scan volume
Organ and Tissue Doses and other Dose Indices:
Table 6.19 shows the calculated organ doses, effective dose equivalent, and
effective dose values for all the routine spiral CT examinations performed by this
model of Siemens scanner. It includes three "neck", one "chest", one "abdomen", and
finally one "abdomen & pelvis" spiral CT examination.
Table 6.19: Calculated organ doses and dose indices for different spiral examinations
using the Siemens Somatom Plus CT scanner.









Gonads 0.00 0.00 0.00 0.02 0.10 7.12
Red bone marrow 1.27 2.71 1.00 4.09 1.19 5.91
Colon 0.00 0.00 0.00 0.12 0.57 9.46
Lungs 0.89 1.13 0.69 14.12 1.78 1.78
Stomach 0.02 0.02 0.02 5.67 13.05 14.87
Bladder 0.00 0.00 0.00 0.02 0.08 4.84
Breasts 0.18 0.16 0.18 16.14 2.70 2.70
Liver 0.02 0.02 0.03 5.96 11.41 14.09
Oesophagus 3.56 4.84 2.90 12.89 1.06 1.06
Thvroid 16.13 22.62 17.02 5.51 0.08 0.08
Skin 0.55 1.27 0.53 2.14 0.94 2.88
Bone surface 6.09 14.88 5.16 16.41 4.91 23.16
Remainder (mSv, ICRP 26) 0.49 2.02 0.45 2.87 3.84 5.31
He (mSv) 1.44 3.63 1.34 8.05 4.78 9.11
Remainder (mSv, ICRP 60) 0.02 0.05 0.01 0.16 0.43 0.59
E (mSv) 1.34 2.05 1.28 5.26 3.26 7.25
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6.7 Summary of the Results
In CT dosimetry several variable factors affect the patient doses estimated
from CT practices. These factors must be considered if the patient doses resulting
from CT practices are going to be summarised or compared between different CT
scanner models. The factors affecting, directly or indirectly, patient doses resulting
from CT practices are: scanner rotation angle, clinical protocol, filtration, collimation,
detector efficiency, scan field diameter, slice thickness and spacing or scan pitch, scan
volume, patient size, repeat scans, image matrix size, and reconstruction filters if they
require change of the clinical protocol. Some of these factors are either fixed or pre¬
set with every CT scanner model, others may be selected. The factors like inherent
filtration, collimation, detector efficiency, scan field diameter (source to isocentre
distance) image matrix size, and reconstruction filters are either fixed or pre-set by the
CT manufacturers. For some other factors such as rotation angle and added filtration,
there may be a limited number of options. The other factors that can be selected
include the tube potential (kV) and current time product (mAs), the slice width and
spacing or the pitch setting, and the scan volume.
In CT dosimetry, even if we ignore the pre-set and fixed factors affecting
estimated patient doses, the latter group of factors mentioned above could not entirely
be altered. For example regarding the tube potential, even though some modern CT
scanners allow the users to choose a desirable kV from a very limited number of kV
settings, typically CT scanners operate at 120 to 140 kV. Concerning the mAs setting,
even though there is more flexibility, normally there are several pre-set mAs values for
every particular routine CT examination recommended by the manufacturers based on
the other specific characteristics of CT scanners. Regarding the slice width and table
increment or the pitch and the scan volume normally the user has more control and
options, although the available options are not necessarily similar among different CT
scanner makes and models.
In this study, like any other CT dosimetry study, we did not have any control
on the factors that are either fixed or pre-set within the CT scanners. Regarding the
other category of factors, that could virtually be altered, we tried to control them in a
way that the same protocols were used for similar routine CT examinations for all the
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CT scanners. Nevertheless, this was not completely achievable, due to the constraints
imposed by differences in the scanners' characteristics.
Regarding the tube potential, except for the Siemens CT scanner having its kV
pre-set at 137 kV for the routine chest examinations, the tube potential of all the other
CT scanners were either pre-set or set to operate at 120 kV.
Generally, we used the standard clinical protocols used by the radiographers
and radiologists for every routine CT examination. But, we tried to carry out CT
examinations with the same kV, mAs, slice width, and over the same area and length
of the phantom for similar common examinations with all the CT scanners. In spite of
our efforts, achieving this was not possible for all the similar scanning techniques for
all the CT scanners, because of different practices adopted by their operators. For
example, the "head" and "posterior fossa" examinations were commonly carried out
by most of the scanners over the head area. As can be seen in Table 6.20, there was a
significant variation in the mAs (280-791) and the scan length (100-120 mm) used for
these examinations among the CT scanners. Similar comparison for the "chest"
examinations (Table 6.21) shows that, not only there was a significant variation in the
mAs (120-533) and the scan length (240-270 mm), but also, as mentioned before, two
different kVs (120-137) were used by the CT scanners. Similar comparison for the
"abdomen & pelvis" examinations (Table 6.22) indicates similar variation in the scan
length (312-420 mm) and the mAs (150-533) among the CT scanners.
Regarding the patient size, we used a Rando phantom for all the
measurements and this factor influencing patient dose was not investigated.
For a particular scanner, the patient dose should be related to the total
effective scan volume and the mAs. The effective scan volume is the total scan length
multiplied by the packing factor (that is the slice width divided by the couch increment
for conventional scans or the inverse of the pitch for spiral scans). The relationship
between the patient dose and the scan volume will depend on the region of the body
scanned, e.g. head, chest, abdomen or pelvis. For scanners operating at the same kV,
the effective dose normalised to the effective scan volume and mAs would be
expected to have a relationship to CTDI normalised to mAs. This can also be
investigated for these data.
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To summarise the results and compare different models of the CT scanners for
a similar condition of settings, calculated effective dose values, for the most common
routine scanning techniques, were normalised to 100 mAs. They were then normalised
to 10 mm scan volume and the packing factor of one for every common CT
examination.
The most common routine scanning techniques carried out by the CT scanners
were "head", "posterior fossa", "chest" and "abdomen & pelvis" examinations,
although other special scanning protocols such as "orbit", "neck" or "larynx", "liver",
and "lumbar spine" were also routinely practised by some of the scanners. As was
noted in chapter three and earlier in this chapter, two CT scanners could also perform
spiral scanning techniques.
In the following parts of this section the estimated patient doses assessed from
all the CT scanners have been summarised for the most common scanning techniques.
The dose measurement results for all the scanners have been summarised and grouped
under the patient doses from "head", "chest" and "abdomen & pelvis" scanning
techniques. These groups include the most common CT examination(s) carried out
over the head, chest and abdomen & pelvis areas of the body respectively.
6.7.1 Patient Doses from Head Scanning Techniques
The common routine examinations performed by the CT scanners over the
head area of the body were "head", "posterior fossa", "orbit", and "neck" or "larynx".
The "orbit" and "neck" or "larynx" examinations were only performed by two CT
scanners using quite different protocols for special purposes. Therefore the summary
of patient doses for these examinations will not be mentioned here.
The routine "head" and "posterior fossa" examinations were commonly
performed by most of the CT scanners. The routine "head" examination was not
performed by the GE Sytec scanner. The routine "posterior fossa" examination was
not carried out by the GE 9000HP scanner.
The results of dose measurements for the "head" and "posterior fossa"
examinations on all the CT scanners are summarised in Table 6.20. If the absolute
values of measured effective doses resulting from these examinations are compared, it
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will be noted that the GE Sytec scanner gives the highest and the GE 8800 scanner
the lowest values.
As can be seen in Table 6.20 there has been a variation by a factor of 3.40
between the effective dose absolute values among the CT scanners. On the other hand
the effective dose values normalised to 100 mAs and 10 mm scan volume indicate a
variation of 4.80 among the scanners. But apart from the GE 8800, if the effective
dose values normalised to the measured CTDI values are compared, it will be noted
that there has been a variation factor of 1.58 among all the CT scanners for these
examinations performed on the head region of the body. There have been some
uncertainties with the measured CTDI values for the GE 8800 scanner that will be
explained in the next chapter.
Table 6.20: Summary of the effective dose and normalised effective dose values for
the most common scanning techniques of the head.
CT scanner Examination E
(mSv)








GE 8800 Head 0.77 120 599 100 1.000 0.013 0.191 0.067
GE 8800 Posterior
fossa
0.98 120 726 105 1.000 0.013 0.191 0.067





2.62 120 376 110 1.000 0.063 0.352 0.180
GE HiSpeed
Advantage
Head (1) 1.06 120 280 100 1.000 0.032 0.191 0.198
GE HiSpeed
Advantage
Head (2) 1.42 120 310 120 1.000 0.038 0.191 0.200
GE HiSpeed
Advantage





1.56 120 316 125 1.000 0.039 0.191 0.207
Philips
Tomoscan CX/S





1.70 120 376 120 1.000 0.038 0.190 0.198
Siemens
Somatom Plus
Head (1) 1.08 120 420 100 1.000 0.026 0.135 0.190
Siemens
Somatom Plus





1.26 120 420 100 1.000 0.030 0.135 0.222
E (normal 1): Effective dose normalised to 100 mAs, 10mm scan volume, and packing factor of 1.
E (normal 2): E (normal 1) normalised to the CTDI (mGy/mAs) measured with TLDs for 10 mm slice width.
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As may be noted in Table 6.20, effective dose values for two routine "head"
examinations have been measured for the Siemens CT scanner. The only difference in
scanning technique was in the scan volume of these examinations. However no
significant change in the absolute effective dose value was observed for these
examinations. But about 10% difference was observed between their normalised
effective dose values. This difference is somewhat greater than the total uncertainties
of 7.4% (-6.8% from central dose and 3.0% from calibration factor) estimated for the
developed dosimetry method. Approximately 65% of the effective dose resulting from
a scan of the head arises from the dose to the brain. Increasing scan length beyond the
limits of this organ has, however, a relatively small effect on effective dose. In
addition, except for a small proportion of the bone, red bone marrow, and skin none
of the radiosensitive organs or tissues of the body is affected by the extra scans.
Therefore, we would expect a reduction in effective dose when normalised to the scan
length as happened for the second "head" examination here. Hence, while the
additional scan length of the second head examination has not led to any significant
increase in the absolute effective dose value, the normalisation to the scan volume has
caused a 10% reduction in the normalised effective dose value.
As can be seen in Table 6.20, doses for three "head" examinations were
measured for the GE HiSpeed Advantage CT scanner. The first one, indicating a
lower absolute effective dose value, was performed with a lower mAs and over a
shorter (20 mm) scan length compare with the others. On the other hand, although the
third "head" examination was carried out with a slightly higher mAs value and over
the same scan length as the second one, it indicated a lower absolute effective dose
value. The normalised effective dose value to CTDI indicated no significant difference
between the first two "head" examinations. But, for the third examination this value
was about 13% less, that is higher than the total estimated level of uncertainties
(7.4%). Changes in the scanner characteristics over the time interval (~ 6 months)
between the dose measurements for these head examinations might have contributed
to this significant difference.
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There will be an interesting point if the scanning technique of the routine
"posterior fossa" examination is compared with that of the first routine "head"
examination for the Siemens scanner (Table 6.13). The "posterior fossa" examination
has been composed of six contiguous scans with 5 mm and a further seven scans with
10 mm slice width, instead of ten contiguous scans with 10 mm being normally used
for head examinations. Therefore, although the scan volumes in both of these
scanning techniques have been the same, choosing a thinner slice width at the
beginning for the "posterior fossa" examination has led to a significant increase (17%)
in both the absolute and normalised effective dose values. Changes in the scanner
characteristics over the time interval (~2 months) between the dose measurements for
these examinations may have caused this significant difference.
The relation between the scanning techniques (slice width) of the second
"head" examination and the "posterior fossa" examination with the GE HiSpeed
scanner (Table 6.9) has been similar to that of the Siemens scanner. If a similar
comparison is made between these examinations, it will be noted that the "posterior
fossa" examination has led to a 10% higher absolute effective dose value than that of
the "head" examination. However, there has been no significant difference (< 4%)
between the normalised effective dose values to the CTDI for these examinations.
There has been no significant difference between the absolute values of
effective dose of the "head" and "posterior fossa" examinations for the Philips CT
scanner. However, there has been about 14% difference between the normalised
effective dose values to CTDI for these examinations, which is higher than the total
estimated level of uncertainties (7.6%). But, a proportion (-9%) of this difference is
caused by the longer scan volume of the "posterior fossa" examination than that of the
"head" examination. This can also be explained in the same way made above for the
differences between the two head examinations by the Siemens scanner. While the
additional scan length of the "posterior fossa" has not caused a significant increase in
the absolute effective dose value, the normalisation to the scan volume has led to
about 5% reduction in the normalised effective dose value. Therefore, if this
proportion of the difference is ignored, the differences between the normalised values
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of these examinations with the Philips scanner will not be significant. The dose
measurements for both of these examinations were carried out on the same date.
6.7.2 Patient Doses from Chest Scanning Techniques
Routine "chest" examinations were measured on all the CT scanners except
the GE 8800. Besides conventional "chest" examination, spiral "chest" examination
was also performed by two modern CT scanners included in this study.
The calculated effective dose values for the routine (conventional and spiral)
"chest" examinations on the CT scanners are summarised in Table 6.21. The results
presented in the table indicate that the GE Sytec 3000 Plus gives the highest and the
GE HiSpeed Advantage the lowest patient dose (in terms of absolute effective dose)
for the routine "chest" examination. If the normalised effective dose values (normal 1)
are compared, the old GE 9000HP scanner shows the lowest value, while the GE
Sytec still shows the highest value.
Overall as can be noted from Table 6.21 there has been a variation by a factor
of 4 in the absolute values of effective dose for this examination among the CT
scanners. On the other hand the effective dose values normalised to 100 mAs and 10
mm slice width show a variation factor of 3.00 among the scanners. But if the
effective dose values normalised to CTDI are compared in the table, it will be noted
that there has been a variation factor of 1.88 among the CT scanners for this
examination.
For those scanners operating at 120 kV, normalisation of effective dose to
CTDI shows a variation (maximum/minimum) of 1.46. For the Siemens scanner, the
doses normalised to CTDI are higher because of the greater penetration of the X-ray
beam at its higher tube potential (137 kV).
There is an interesting point if the absolute effective dose values resulting from
conventional and spiral "chest" examinations by the GE HiSpeed Advantage scanner
are compared in the above table. Although the mAs setting of the spiral examination
has been higher than the conventional one (Table 6.11), it has led to a lower effective
dose value because of using a pitch setting greater than one (1.5). However, the
differences between the normalised effective dose values to CTDI for these
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examinations (19%) have been significantly higher than the estimated level of
uncertainty (7.6%) in the dosimetry method. It must be noted that there was a
considerable time interval between these dose measurements.
Table 6.21: Summary of the effective dose and normalised effective dose values for
the most common scanning techniques of the chest.
CT scanner Examination E
(mSv)








GE 9000HP Chest 6.73 120 533 270 0.667 0.070 0.128 0.548
GE Sytec
3000 Plus
Chest 13.50 120 234 250 1.000 0.231 0.352 0.656
GE HiSpeed
Advantage
Chest (1) 3.54 120 120 270 1.000 0.109 0.191 0.572 ,
GE HiSpeed
Advantage




Chest 9.75 120 356 270 0.667 0.152 0.190 0.801 !
Siemens
Somatom Plus
Chest (1) 3.97 137 100 250 1.000 0.159 0.165 0.962
Siemens
Somatom Plus
Chest (2) 6.39 137 145 260 1.000 0.169 0.165 1.027
Siemens
Somatom Plus
Chest (3)* 5.26 137 145 240 1.000 0.151 0.165 0.916
E (normal 1): Effective dose normalised to 100 mAs, 10mm scan volume, and packing factor of 1.
E (normal 2): E ( normal 1) normalised to the CTDI (mGy/mAs) measured with TLDs for 10 mm slice width.
* Spiral mode.
There have also been two conventional and one spiral "chest" examinations
performed by the Siemens CT scanner. For this scanner the second conventional
"chest" examination has been performed with a higher mAs setting. As expected this
has led to a higher effective dose value for this examination, although its scan length
has been 10 mm shorter than the first one (Table 6.13'). There was no significant
difference (< 7.6%) between the normalised effective dose values to CTDI for these
examinations. The spiral "chest" examination, performed almost with the same
scanning technique as the second conventional "chest" examination (Table 6.13), had
a significantly lower (> 20%) absolute effective dose value than that of the
conventional one for this scanner. The only factor that can be taken into account for
this reduction in the dose is the shorter scan volume length (two scans or 20 mm)
used for the spiral mode examination with this scanner. However, the difference
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between the normalised effective dose values to CTD1 for these spiral and
conventional examinations was significant (12%). It must be noted that there was a
considerable time interval between these dose measurements.
Overall significant differences observed between normalised effective dose
values to CTDI for chest examinations using an identical model of CT scanner. A
proportion of this difference can be contributed to the extra scan length of some
"chest" examinations performed over a longer length. But it must be noted that for the
chest examination, unlike the head examinations, increasing the scan length causes a
significant increase in effective dose, because more radiosensitive organs will then be
included and irradiated. However, even if the values were normalised to an equal scan
volume, the difference observed between them will have still been significant.
However, the differences observed between normalised values to CTDI for chest
examinations (19%, and 12% for the GE HiSpeed Advantage and the Siemens
scanners respectively) could have partly been due to the measurement uncertainties
(7.6%). But, it should be noted that there has been a considerable time interval
between the measurements over which the CT scanner characteristics may have been
changed.
6.7.3 Patient Doses from Abdomen and Pelvis Scanning Techniques
The common examinations performed over the abdomen and pelvis areas of
the body were routine "abdomen & pelvis", "abdomen", "liver", and "lumbar spine".
We will only summarise the results for the routine "abdomen & pelvis" examination
performed by all the CT scanners except the GE 8800 scanner. As may have been
noted before, the other scanning techniques were either used by a few of the scanners
or performed with very different scanning techniques.
The absolute effective dose values for all the routine "abdomen & pelvis"
examinations performed by all the CT scanners are summarised in Table 6.22. The
results presented in the table indicate that the GE Sytec 3000 Plus gives the highest
and the GE HiSpeed Advantage CT scanner the lowest patient dose for the routine
"abdomen & pelvis" examination. If the normalised effective dose values (normal 1)
are compared, the old GE 9000HP scanner shows the lowest value, while the GE
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Sytec still shows the highest value.
Table 6.22:Summary of effective dose and normalised effective dose values for the
most common scanning techniques of the abdomen & pelvis.
CT scanner Examination E
(mSv)



























































7.25 120 210 312 1.000 0.111 0.165 0.671
E (normal 1): Effective dose normalised to 100 mAs, 10mm scan volume, and packing factor of 1.
E (normal2): E ( normal 1) normalised to the CTDI (mGy/mAs) measured with TLDs for 10 mm slice width.
* Spiral mode.
As can be seen in Table 6.22 there has been a variation by a factor of 5.3
between the absolute effective dose values for this examination among the CT
scanners. If the variation factor of absolute effective dose value for the "abdomen and
pelvis" examination is compared with that of the "head" and "chest" examinations, it
will be noticed that the variation factor for this examination has been significantly high
among the scanners. This reflects the wide range of scanning techniques used by
different scanners for the routine "abdomen and pelvis" examination. On the other
hand the effective dose value normalised to 100 mAs and 10 mm slice width shows a
variation of 3.8 among the scanners. But if the effective dose values normalised to
CTDI are compared, it will be noted that the there has been a variation factor of 1.68
among the scanners used for this examination.
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As can be seen in Table 6.22, there have been two conventional and one spiral
"abdomen & pelvis" examinations performed by the GE HiSpeed Advantage CT
scanner. In the first conventional "abdomen & pelvis" examination a higher mAs
setting has been used (Table 6.11) that has consequently resulted in a higher effective
dose value than that of the first one. But there is also a significant difference (19%)
between the normalised effective dose values to CTDI for these two conventional
examinations. This difference may be due to changes in the scanner characteristics
over the considerable time interval (six months) between the dose measurements. The
spiral examination has been performed with the same mAs setting as the second
conventional one, except that its pitch has been greater than one (1.3) and its scan
volume length has been 40 mm (four scans) shorter (Table 6.11). Therefore the
resultant absolute value of effective dose from the spiral examination has been
significantly (-38%) lower. But, there has been no significant difference (< 7.6%)
between the normalised effective dose values to CTDI for these examinations.
Three conventional and one spiral "abdomen & pelvis" examinations were
measured on the Siemens CT scanner. Since the second conventional examination was
performed with a couch increment (15 mm) bigger than the slice width (10 mm), it led
to a significantly lower effective dose value, although its scan length was 30 mm
(three slices) longer (Table 6.13). The third conventional "abdomen & pelvis"
examination was only extended over 20 mm more scan length than that of the first one
(Table 6.13). This consequently led to a higher effective dose value for this
examination. The spiral "abdomen & pelvis" examination was performed over a
shorter scan volume (-70 mm) but with a narrower slice width (3 mm) at the
beginning followed by the most common slice width of 10 mm and the pitch value of
one. As a result, as may be noted in Table 6.22, this special scanning technique led to
a significantly lower effective dose value. The range of differences between
normalised effective dose values to CTDI for "abdomen and pelvis" examinations on
this scanner was 1.1-1.25. This may be attributed to the experimental uncertainties
(7.6%) and possible variation in the CT scanner characteristics. For this scanner it
may be noted that the two lowest values of normalised doses to CTDI were for the
second and the fourth examinations, which had the longest and smallest scan lengths
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respectively. This tends to discount any significant influence of this parameter (scan
length) on the overall results for the abdomen and pelvis examinations.
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7. CT Dosimetry using the Monte Carlo Method and the
Mathematical Anthropomorphic Phantom
7.1 Introduction
Generally, Monte Carlo (MC) is a mathematical technique employed to
achieve random sampling of a known probability distribution with the aid of randomly
generated numbers. One of the applications of this method is for studying photon and
electron transport in matter that is used extensively in different fields of medical
radiation physics such as, diagnostic X-ray physics, radiotherapy physics, nuclear
medicine, microdosimetry, electron microscopy, and radiation dosimetry. Because of
the extensive usage of this technique, many review articles have been published on the
principles and applications of this technique. The reader is referred to the review
published by Andreo (1991) on the application of the MC technique in medical
radiation physics. This review is currently an update to the early works and almost a
complete source of information.
For dosimetry purposes this mathematical technique has been applied by
several workers to model exposure conditions during a range of routine, conventional
X-ray examinations (Rosenstein 1976, Drexler et al. 1984, Shrimpton et al. 1991a).
But, so far, there has only been two major efforts to apply this technique for CT
dosimetry, one in Germany and the other one in the UK.
Following a field study (Panzer et al. 1989) conducted in 1989 by the GSF in
the Federal Republic of Germany, Zankl and his colleagues (1991) implemented the
MC technique for CT dosimetry. They compiled a catalogue of mean organ dose
conversion factors (normalised to air kerma free in air on the axis of rotation)
resulting from CT examinations. In this catalogue the doses are calculated for single
axial transverse slices of 1 cm width throughout the body. This is used as a database
from which organ doses resulting from a particular CT examination can be estimated
by summing up the contribution to organ dose from each relevant slice. The
calculations have been performed using a MC code simulating the photon transport in
different materials in two different mathematical phantoms. Mean organ dose
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conversion factors are given per organ and per single CT slice of 1 cm width in the
sex specific mathematical phantoms of Adam (male) and Eva (female). The organ
doses have been calculated for the type of CT scanners most commonly used in
Germany and for three different radiation qualities (Zankl et al. 1992).
Likewise, in 1990 the NRPB carried out a survey of CT practice in the UK
and used this method for estimation of CT doses (Shrimpton et al. 1991a, 1991b;
Jones and Shrimpton 1991). They used a different mathematical phantom, in shape
and size, and provided another data set for different types and models of most of the
operating CT scanners in the UK before 1989. This also enables researchers to
calculate organ doses and effective dose by measuring the CTDI free in air on the
isocentre of these scanners. Many researchers (Shrimpton and Wall 1992, Felmlee et
al. 1990, Geleijns et al. 1994) have used these data sets for estimating the patient
doses for similar CT scanners.
However, it must be born in mind that the problem or limitation of this
dosimetry approach is that data on other CT scanner models, in particular the newer
ones, may not always be available. Although there have been some attempts for
estimating organ doses and effective dose values for some modern CT scanner
models, acquiring data for these models requires expertise in the MC technique as
well as detailed information regarding the scanner design which may not be readily
available.
Unfortunately, the data published by the NRPB is for those models of CT
scanners which were in operation in the UK before 1989 (Shrimpton et al. 1991a,
1991b). This data does not include some of the more advanced and newer models
surveyed in this study. Therefore, we were only able to implement this method for
those rather older types and models of CT scanners. From all six CT scanners in this
study, data were available for three rather older models. Two of these scanners were
replaced with newer models in 1996 for which there was no data set available.
Therefore we were not able to measure organ doses and effective dose values for
three modern CT scanner models using the Monte Carlo dosimetry approach. For
these scanners just the result of our CTDI measurements are presented in this chapter.
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We used an existing computer programme (Le Heron 1993) that incorporates
all data sets provided by the NRPB software report (Jones and Shrimpton 1993)
combined with our own CTDI measurement to assess patient doses resulting from all
routine CT examinations. The principles and results of applying this dosimetry
approach will be presented in this chapter. In the following chapter these results will
be analysed and compared with those from our developed direct CT dosimetry
approach.
7.2 Materials and Methods
In CT dosimetry MC computer techniques are used to simulate the absorption
and scattering of X-ray photons within a mathematical anthropomorphic phantom,
yielding organ doses normalised to the free-in-air dose on the axis of rotation of the
CT scanner, from which effective dose could be derived.
This has been carried out by the NRPB (Jones and Shrimpton 1991) through
extending its existing computer programs for conventional X-ray examinations (Jones
and Wall 1985) to model the complex rotational beam geometric characteristics of CT
scanners.
Different factors affect the predicted dose distribution within the mathematical
phantom. These include (but are not limited to): the radiation quality of the X-ray
beam, the distance between the X-ray focus and the axis of rotation of the CT
scanner, the use of pre-patient beam shaping filters, and CT scanner rotation degree.
These factors vary, extensively, not only from one manufacturer to the other one, but
also among different models of CT scanners from one manufacturer. Therefore, the
NRPB carried out a series of MC calculations for 23 different sets of exposure
conditions relating to 27 models of CT scanners. These scanners accounted for about
85% of all UK CT scanners up until 1989. In each set, 360° CT scans of every 5 mm
transverse slab of the phantom have been simulated for a perfectly collimated beam of
X-rays. These have provided, for all 208 such slabs of the phantom, estimates of
normalised doses to 27 organs or regions of the interest in the phantom. The
normalised doses are expressed in this catalogue as absorbed dose in the organs
relative to the scanner central axis dose free in air.
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The radiation transport in the phantom has been calculated using a MC code
following individual photon histories. The radiation interaction processes considered
by the NRPB have been photoelectric absorption and Compton scattering. They have
taken the cross section data for the photon interactions from several sources (Hubbell
1977, Knight and Roussin 1983, Hubbell 1982) and regarded energy as being
deposited at the point of photon interaction (kerma approximation).
They have claimed that calculation for each slice has involved enough photon
histories in order that the statistical uncertainty (standard error) in the normalised
doses falls below 5% for all important organs receiving significant levels of radiation.
The absorbed doses are obtained by dividing the total amount of energy
deposited in an organ by its mass. All doses presented in this catalogue are mean
doses averaged over the whole organ or tissue, not doses only to that part of the
organ included in the CT slice and irradiated directly.
All dose values in this catalogue are given as organ dose conversion factors,
i.e., organ absorbed doses normalised to a measurable quantity. In the present
catalogue this quantity is CT Dose Index (CTDI), expressed in air kerma free in air at
the axis of rotation. These normalised organ dose data are published by the NRPB as
NRPB-SR250 software report (Jones and Shrimpton 1993) that comprises 23 data
files. These data files allow the calculation of organ doses and effective dose (or
effective dose equivalent) from the CT scan parameters and central axis CTDI value
in air for several different makes and models of CT scanners.
The existing computer program (CTDOSE by Le Heron 1993) used, is written
to run on MSDOS computers. This program enables the calculation of organ doses
and dose indices (effective dose and effective dose equivalent) for CT examinations
performed on the NRPB selection (Shrimpton et al. 1991b) of common CT scanners.
It uses 23 data files containing the results of MC calculations performed by the NRPB
in the UK national survey (Jones and Shrimpton 1993). It requires entering the
measured CTDI value, the CT radiological factors, and the phantom starting position
of the proposed CT examination, to report the resultant organ or tissue doses,
effective dose, and effective dose equivalent.
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7.2.1 CTDI Measurements
As mentioned above in order to calculate the organ or tissue doses the
measurement of the central axis CTDI value in air is required. This CTDI is different
from the FDA (1985) definition of the CTDI, as mentioned in chapter two, that is
normally used for QA measurements of CT scanners.
The definition of the CTDI as used by the NRPB (Shrimpton et al. 1991b) is:
f+oo
CTDI = 1/w D(z)dz (Equation 7.1)J — 00
j*+°°
where w is the nominal slice width (thickness) and D(z)dz is the line integral inJ-oo ^
the Z direction of the dose profile in air (the total area of the dose profile).
This index (CTDI) is measured using either a pencil (CT) ionisation chamber
(IC) or a stack of TLDs positioned along the central axis of rotation of the CT
scanner. TLDs are normally put inside a hollow and cylindrical plastic tube, long
enough to cover the X-ray beam width. The sum of the TLD doses devided by the
nominal slice width is equivalent to the CTDI value. But, for the pencil IC the product
of the average dose by the chamber length is equivalent to the area under the CT dose
profile (CTDI).
We used both of these measurement techniques and our estimates of CTDI
values were obtained using both TLDs and pencil ICs. These measurements were
carried out to determine the CTDI value in air for both the older scanner models for
which MC data files were available from the NRPB national survey (Jones and
Shrimpton 1993) and also for those rather modern models that were not included in
the survey. The TLDs were used in order to be consistent with the NRPB method of
CTDI measurement. The IC was also used firstly, because of its compatibility and
ease of use. On the other hand this approach enabled us to compare these two
dosimetry devices with each other to reach a conclusion about their performance and
future use for the CTDI measurement.
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7.2.1.1 CTDI Measurements with the TLD
The same type of TLD (LiF) that was used in our developed direct dosimetry
approach (chapter 5) was also used for the CTDI measurements.
Calibration measurements were carried out on the TLDs for every CTDI
measurement. The calibration procedure was carried out in the same way that was
done for our developed direct CT dosimetry method. For this purpose a set of twenty
TLDs were used from the same batch of the TLDs used for the CTDI measurement.
These TLDs comprised ten non-dosed controls (exposed only to the background
radiation) and ten dosed controls. The dosed controls were exposed at lOOkV to a
dose of approximately 20 mGy generated from a conventional X-ray machine. The
reader is referred to chapter five for the details of the TLD calibration procedure.
Figure 7.1 and Figure 7.2 show the design of the plastic tube and the device
used in this study for CTDI measurements with the TLDs. Figure 7.3 shows a
photograph of the device and a box of the TLDs used for CTDI measurements.
The TLDs were put in the specially designed plastic tube as shown in Figure
7.2. Then the tube was engaged into a hole in the end of the horizontal arm of the jig
as shown in Figure 7.2. The position of the horizontal arm of the jig was adjusted in a
way that it will always stay on the central axis of the rotation of CT scanners. In order
to achieve the best CT dose profile, for each slice width, sufficient TLDs were used to
encompass completely the whole CT dose profile.
Then for a contiguous stack of TLDs of sufficient length to encompass
completely the CT dose profile, the approximation of Equation 6.1 was used as
follows:
where D, is the dose to /th TLD and t is the (effective) thickness of each TLD. The









Figure 7.1: The design of the plastic tube that held TLDs for CTDI measurement.
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Figure 7.2: The design of the device used for CTDI measurements. For more
explanation refer to the text.
Figure 7.3: A photograph of the device and a box of the TLDs used for CTDI
measurements.
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7.2.1.2 CTDI Measurement with the Pencil lonisation Chamber
If the only purpose of the CTDI measurements would be to derive the integral
dose value, and not the dose profile, it is easier and more versatile to use a pencil IC.
A "Radcal® 20X5-10.3CT" model pencil IC was also used for the CTDI
measurements. Figure 7.4 illustrates this chamber and Figure 7.5 shows its physical
dimensions.
Figure 7.4: The Model 20X5-10.3CT Radcal ® pencil ionisation chamber.
The Radcal pencil IC is mounted at the end of a two meter cable, and an
adapter is also included for use with QA (head or body) phantoms. Three red circle
marks on the chamber body indicate the active volume and centre line of the chamber
for set-up convenience. It has a Polycetal exterior cap, air equivalent walls and
electrode, nominally 10 cm active length, and 3 cm3 active volume. Its energy
dependence is claimed to be within ±5% (for 3-20 mm A1 HVL1).
1 Half Value Layer
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Figure 7.5: Physical Dimensions of the Radcal ® 20X5-10.3CT model pencil
ionisation chamber.
Figure 7.6 shows the chamber energy dependence provided by the
manufacturer. It is also claimed that it could measure integrated exposures from 0.1
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Figure 7.6: Radcal ® 20X5-10.3CT model pencil ionisation chamber energy response.
It has been indicated by the manufacturer that this chamber has been calibrated
with a moderately-filtered X-ray at 150 kV and 10.2 mm A1 HVL after temperature
and pressure correction and its calibration accuracy is claimed to be ±4%. However
some uncertainties were raised when the measured CTDI values with this chamber
were compared with the TLD results. Therefore the chamber was first calibrated
locally against a 3 cm3 Radcal® 2025 model ionisation chamber which had a traceable
calibration. The same radiological parameters used for TLD calibration were also used
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for the calibration of this chamber and the temperature and pressure correction factors
were also taken into account. Later on another pencil IC (Keithley) became available
which had been calibrated at the John Perry Lab. We calibrated the Radcal chamber
against this chamber. The cross calibration carried out in a radiographic output of 120
kV and 20 mAs. This led to a calibration factor of 0.995 for the Radcal pencil IC.
Using the pencil IC, the CTDI value could be approximated by the following
equation:
CTDI = (D x L) / w (Equation 7.3)
where D is the absorbed dose value calculated by multiplying the chamber reading in
roentgen and the roentgen to absorbed dose conversion factor, L is the active length
of the chamber (100 mm) and w is the nominal slice width. The value for the roentgen
to absorbed dose conversion factor was assumed to be 8.73 mGy/R based on the
definition (ICRU 1980) of the roentgen (2.58x10-4 C/Kg), and the reported value
(ICRU 1979) of the average energy (33.85 J/C) required to create an ion pair in air.
7.2.2 Organ and Tissue Doses and Effective Dose Calculations
Having measured the in air CTDI data for a particular scanner under the
condition of exposure used for a CT examination, estimates of organ doses and
patient dose could be determined using the NRPB data set for the scanner. The NRPB
data sets have been published in the format of data files on a floppy disk as the
NRPB-SR250 software report (Jones and Shrimpton 1993). The data files are
provided in look-up tables in the form of organ dose per 5 mm slabs of the
mathematical anthropomorphic phantom, normalised in unit CTDI at the centre of
rotation of the CT scanner in air. However, several steps are required to be carried
out in order to be able to use these normalised organ dose data to estimate patient
dose. These include specifying scan volume and calculating: total normalised organ
doses, packing factor, CTDI, organ doses, and finally total patient dose. The reader is
referred to the NRPB-SR250 report for a full explanation and the required approach
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for carrying out these steps to estimate patient doses from CT examinations using
these CT scanners.
As explained earlier we used an available computer programme called
CTDOSE (Le Heron 1993) enabling the calculation of organ doses and dose indices
for CT examinations performed on NRPB selection of common CT scanners. This
program has incorporated all NRPB data files (Jones and Shrimpton 1993) in the
NRPB look-up tables. In this computer program, the organ doses for a CT
examination, using a particular scanner, are obtained by summing dose contributions
over the extent of the examination. In addition the ICRP dose indices are calculated.
It just requires to determine which 5 mm slabs are included in the scan volume for a
particular examination protocol. To do this the program requires input data including:
the scanner make and model, exposure setting (mAs), slice width, couch increment
(or table feed), number of slices, normalised CTDI value per mAs (free in air), and
finally the start position of the scan series. The output data of the program are: the
dose to the individual organs or tissues, and estimates of the effective dose (ICRP
1991) and effective dose equivalent (ICRP 1977).
Except for the start position of the scan series, all other required input data are
standard for each CT examination and quite straightforward to define for any
particular CT examination. In order to determine the start position, data from the
NRPB Mathematical phantom must be used. This phantom, illustrated in Figure 7.7,
has already been described in chapter two. The NRPB gives a reference plane for each
examination, the upper, and lower extremes. These are given in Table 7.1. For each
examination, the total scan length is determined from the couch increment, slice
width, and number of slices. The scan start position is then placed so that the scans
are equidistant each side of the reference plane (Poletti 1992).
In the CTDOSE program the base of the trunk of the mathematical phantom is
assigned a value of 0 mm and the top of the head 940 mm (Figure 7.7), while in the
original NRPB phantom the base of the trunk is set at 100 mm and the top of the head
as 1040 mm. Therefore for entering the start position in this program for each CT
examination these changes were taken into account. Furthermore some guidance was
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also taken from anatomical landmarks such as the diaphragm, lung apices, and other
organs' location for this purpose (Table 7.2).
Figure 7.7: Lateral and anterior view of the adult mathematical phantom used in the
CTDOSE program. The axis numbers are in cm from the base of the trunk. For more
explanation refer to the text.
Table 7.1: Standard Planes for different types of CT Examinations referred to the
Examination Distance from Base of Trunk (cm)
Reference Plane Lower Plane Upper Plane
Routine head 86.5 76.0 92.5
Posterior fossa 82.5 79.5 86.0
Orbit 83.5 81.5 86.0
Routine chest 55.0 26.5 67.0
Routine abdomen 34.5 0.0 43.5
Routine pelvis 13.5 0.0 43.5
Liver 35.0 21.0 43.5
Lumbar spine 27.0 21.0 35.5
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Table 7.2: Extent (lower and upper limits in mm) of organs and tissues of the
ORGAN / TTSSITF. LOWER LIMIT UPPER LIMIT
LEG BONES - UPPER -100 0
ARM BONES - UPPER 508 680
ARM BONES - MIDDLE 335 508
ARM BONES - LOWER 0 440
PELVIS 0 510
SPINE - UPPER 700 805
SPINE - MIDLLE 341 690
SPINE - LOWER 220 341
SCALL - CRANIUM 810 925







GALL BLADDER 269 366
STOMACH 270 420
SMALL INTESTINE 170 260
ASCENDING COLON 135 230
TRANSVERSE COLON 240 260
DESCENDING COLON 87 230












URINARY BLADDER 25 105
LEG REGION -100 -90
TRUNK REGION 0 690
HEAD REGION 700 930
7.3 CTDI Results
The CTDI measurements were carried out for all the slice width settings for all
the CT scanners models. Both types of common dosimeters, TLDs and pencil IC,
were used for these measurements.
As will be noted in section 7.4, to implement the MC dosimetry approach in
accordance with the technique adopted by the NRPB, the CTDI values estimated by
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the TLD measuring technique were used for the calculation of organs and effective
dose values. In addition the pencil IC was not available to us at the beginning of this
study. However, when the IC became available, it was used in parallel with the TLDs
as much as possible.
As will be noted below, there was a time delay between the TLD and the IC
measurements for some of the GE scanners. This was because the IC was not
available when the CTDI measurements were started. Furthermore, just after carrying
out the CTDI measurements with the IC, these scanners were either taken out of
service or replaced with the newer models and were not accessible anymore.
Consequently, we were not able to use both of the dosimeters, TLDs and pencil IC,
for the CTDI estimation on these scanners at the same time.
An advantage of using TLDs is that in addition to the measurement of CTDI,
it enables us to measure the CT dose profile and beam width. However, because the
thickness of the TLD chip is a significant proportion of the slice width, the method of
integration of dose profile can affect the accuracy with which CTDI is calculated. The
NRPB method is simply to sum the readings of the TLDs as explained earlier in this
chapter. Recently other researchers (Schofield et al. 1996) have integrated CTDI
using a gaussian curve fitted to the data. We also applied this CTDI measuring
technique to our measured TLD data. For simplicity the three CTDI measuring
techniques employed in this study will be referred to as the TLD, the gaussian, and the
IC measuring technique in the rest of this chapter.
In this section our measured CTDI values using both types of the dosimeters
will be presented and compared with each other for every model of the CT scanners in
this study. For those rather older models, included in the NRPB national survey of CT
practice in the UK (Shrimpton et al. 1991b), our measured CTDI values will also be
compared with the NRPB mean values for the same model.
7.3.1 CTDI values
Table 7.3 and Table 7.4 show all individual CTDI values estimated with the IC
and TLDs respectively, for all the CT scanners, for different conditions of exposures
and slice widths. In addition the mean, minimum, maximum, and maximum to
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minimum ratios of the calculated CTDI values are presented in these table for every
CT scanner.
Table 7.5 shows the NRPB reported CTDI mean values from the survey of
CT practice in the UK (Shrimpton et al. 1991b) for three CT scanners included in this
study.
Table 7.3: Estimated CTDI values (mGy/mAs using IC) for all conditions and all

















HEAD BODY HEAD BODY 80 kV lOOkV 120kV 140kV 120kV 137kV
10 0.218 0.230 0.136 0.128 0.377 0.083 0.135 0.203 0.275 0.186 0.117 0.157
7 - - - - - 0.084 0.135 0.204 0.277 - 0.125 0.165
5 0.217 0.229 0.135 0.128 0.376 0.083 0.135 0.204 0.277 0.185 0.123 0.163
3 - - - - 0.399 0.087 0.141 0.213 0.291 - 0.128 0.171
2 - - - 0.125 - - - - - 0.201 - -
1.5 0.241 0.254 0.132 - - - - - - - - -
1 - - - - 0.501 0.087 0.145 0.221 0.309 - 0.168 0.274
MEAN 0.225 0.238 0.134 0.127 0.413 0.085 0.138 0.209 0.286 0.191 0.132 0.186
MIN 0.217 0.229 0.132 0.125 0.376 0.083 0.135 0.203 0.275 0.185 0.117 0.157
MAX 0.241 0.254 0.136 0.128 0.501 0.087 0.145 0.221 0.309 0.201 0.168 0.274
MAX/MIN 1.1 1.1 1.0 1.0 1.3 1.0 1.1 1.1 1.1 1.1 1.4 1.7
Table 7.4: Estimated CTDI values (mGy/mAs using TLDs) for all conditions and all

















HEAD BODY HEAD BODY 80 kV lOOkV 120kV 140kV 120kV 137kV
10 0.191 0.192 0.123 0.128 0.352 0.077 0.139 0.191 0.259 0.190 0.123 0.162
7 - - - - - 0.079 0.131 0.194 0.264 - 0.130 0.165
5 0.187 0.196 0.122 0.129 0.370 0.081 0.140 0.191 0.266 0.184 0.129 0.170
3 - - - - 0.386 0.082 0.143 0.199 0.278 - 0.137 0.175
2 - - 0.119 0.120 - - - - - 0.203 - -
1.5 0.209 0.218 - - - - - - - - - -
1 - - - - 0.520 0.083 0.148 0.213 0.305 - 0.182 0.282
MEAN 0.196 0.202 0.121 0.126 0.407 0.080 0.138 0.194 0.267 0.192 0.140 0.191
MIN 0.187 0.192 0.119 0.120 0.352 0.077 0.131 0.191 0.259 0.184 0.123 0.162
MAX 0.209 0.218 0.123 0.129 0.520 0.082 0.143 0.199 0.278 0.203 0.187 0.282
MAX/MIN 1.1 1.1 1.0 1.1 1.5 1.1 1.1 1.0 1.1 1.1 1.5 1.7
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(120 kV)HEAD BODY HEAD BODY
10 0.117 0.121 0.108 0.113 0.191
5 0.136 0.144 0.107 0.122 0.187
2 - - 0.111 0.096 0.220
1.5 0.135 0.176 - - -
Figure 7.8 demonstrates the differences between our estimated CTDI values
with the TLDs and the IC and the NRPB mean CTDI values for the GE 8800 scanner.
The results show that, our TLD measurements indicate a lower CTDI value (between
13%-17%) compare with that obtained with the pencil IC for this scanner. In addition,
our CTDI values resulting from the TLDs were 24%-63% more than the reported
mean values and even more than the maximum values reported by the NRPB for this
CT scanner (Shrimpton et al. 1991b). It must be noted that there was a time period of
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Figure 7.8: Comparison of measured CTDI values (using the TLDs and the IC) with
the NRPB mean values (Shrimpton et al. 1991b).
Figure 7.9 illustrates the differences between our estimated CTDI values with
the TLDs and the IC and the NRPB mean CTDI values for the GE 9000HP scanner.
These results indicate that the TLD measurements showed a lower CTDI value
(between 4%-9%) compared with the pencil IC. However, the CTDI values resulting
from the TLDs were up to 25% higher than the CTDI mean values and most of them
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were around the maximum CTDI values reported by the NRPB for this model
(Shrimpton et al. 1991b). The maximum discrepancy was for the 2 mm slice width.
This measurement was repeated and confirmed the above gap between our CTDI
values and the NRPB reported value being derived from the measurement on only two
similar CT scanners in the UK national survey of CT practice (Shrimpton et al.
1991b). It must be noted that there was a considerable time gap (four months)
between the TLDs and the IC measurements due to the constraints mentioned earlier.
However, we were able to repeat the CTDI measurements for 10 mm (HEAD filter)
and 5 mm slice widths (BODY filter) using both dosimeters, the TLDs and the IC, at
the same time on this scanner. Nevertheless, the TLDs gave about 10% lower CTDI
values than that of the IC.
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Figure 7.9: Comparison of measured CTDI values (using the TLDs sand the IC) with
the NRPB mean values (Shrimpton et al. 1991b).
Our estimated CTDI values with the TLDs and the IC and the NRPB CTDI
mean values are illustrated in Figure 7.10 for the Philips Tomoscan CX/S scanner.
These results indicate that there was no significant difference between the CTDI
values resulting from the TLDs with those derived from the IC. It must be born in
mind that we were able to carry out both of the CTDI measurement techniques (the
TLDs and the IC) at the same time on this scanner. The differences between our
measured CTDI values using the TLDs and the NRPB mean values are not significant
in view of the reported range of minimum and maximum values for this model. The
168
maximum discrepancy was for the 2 mm slice width for which, the NRPB mean CTD
value was about 10% higher than our CTDI estimates for this scanner.
CTDI values for the Philips Tomoscan CX/S CT scanner
10 5 2
Slice Thickness (mm)
Figure 7.10: Comparison of measured CTDI values (using the TLDs and the IC) with
the NRPB mean values (Shrimpton et al. 1991b).
Figure 7.11 shows our estimated CTDI values with the TLDs and the IC for
the Siemens Somatom Plus scanner. Since this scanner was not included in the NRPB
survey of CT practice, we were not able to compare our measured CTDI values with
the NRPB mean values. Although the results indicated that the TLDs gave a CTDI
value of up to 8% higher than that resulting from the IC, the differences were not
statistically significant. There was no time gap between the TLDs and the IC
measurements for this scanner.
CTDI values for the Siemens Somatom Plus CT scanner
0.300
Slice Thickness (mm)
Figure 7.11: Comparison of CTDI values resulting from the TLDs and the IC
measurements.
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Our estimated CTDI values with the TLDs and the IC are shown in Figure
7.12 for the GE Sytec 3000 Plus Scanner. This scanner, installed in 1993, was not
included in the NRPB survey of CT practice. Therefore there was no reported mean
value by the NRPB for this scanner to enable us to compare our results with. Our
results indicate that there was no significant difference between the CTDI values
resulting from the TLDs and those derived from the IC measurements. It must be
considered that both of the CTDI measurement techniques (the TLDs and the IC)
















Figure 7.12: Comparison of CTDI values resulting from the TLDs and the IC
measurements.
Figure 7.13 demonstrates the differences among our measured CTDI values,
due to choosing different slice width and kV values for the GE HiSpeed Advantage
scanner. Although only the 120 kV setting was used for most of the routine CT
examination protocols with this scanner, CTDI measurements were carried out for all
possible combinations of kV and slice width settings available with this scanner. As
could be noted our results indicate no significant difference between the CTDI values
resulting from the TLDs with that of the IC. This was another modern CT model,
installed in 1995, for which there was no mean CTDI value reported by the NRPB to
enable us to compare our measured CTDI values with.
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Figure 7.13: Comparison of CTDI values resulting from the TLDs and the IC
measurements.
7.3.2 CTDI Analysis
In this section, first the variation of estimated CTDI values by different
measuring techniques, used in this study, will be analysed and discussed. In this regard
different measuring techniques used for estimating the CTDI values will be explained
and the CTDI values resulting from the implementation of these measuring techniques
will be analysed and their differences will be highlighted and explained. Then, the
variation of estimated CTDI values by slice width will be analysed and discussed.
Then, the effect of kV setting on the variation of estimated CTDI values will be
explained. Then, the variation of the estimated CTDI values by scanner model will be
described. Finally, the differences between our estimated CTDI values with the NRPB
reported mean values for the scanners included in the national survey of CT practice
in the UK (Shrimpton et al. 1991a, 1991b; Jones and Shrimpton 1991) will be
discussed and summarised.
171
7.3.2.1 Variation of CTDI by Measuring Technique
As mentioned above, there are one IC and two TLD based measuring
techniques used for the CTDI estimation. As may also be noted above, the length of
the pencil IC used was 10 cm long. Therefore, the estimated CTDI values using the
IC measuring technique was practically the average dose length product of the IC
over 10 cm length, regardless of the slice width settings. On the other hand, as
explained earlier in this chapter, for the TLD measuring technique just sufficient TLD
chips were used in a way that the length of the stack of TLDs would be long enough
to encompass at least three times the slice width settings. The widest slice width
setting available with the CT scanners was 10 mm. Therefore, the estimated CTDI
values using the TLD measuring technique was practically measured over 3 cm
length. Hence, it was required to investigate the effect of different lengths used for the
TLD and IC measuring techniques on the resultant estimated CTDI values. This was
achieved by extending the resulting dose profiles from the TLD measurements over
10 cm length by using a suitable extrapolation process for all slice width settings and
all the CT scanners. Hence, we had four sets of CTDI values for every condition of
exposure and every slice width setting. These data sets were:
I. CTDI values resulting from the TLD measuring technique over 3 cm length (TLD
I measuring technique),
II. CTDI values resulting from the TLD measuring technique extrapolated to 10 cm
length (TLD II measuring technique),
III. CTDI values resulting from the gaussian measuring technique, and
IV. CTDI values resulting from the IC measuring technique.
Overall there were 53 data sets of CTDI measurements for different conditions
of settings on all the CT scanners. As mentioned earlier at the beginning of this study
the pencil IC was not available. When the IC became available we did not have
enough access to two scanners (GE 8800 and GE 9000HP) that were shortly taken
out service. Hence, we were not able to use both of the IC and TLD measuring
techniques at the same time for CTDI estimation on these scanners. Consequently,
there was a considerable time gap between the CTDI measurements with the TLDs
with that of IC for 14 data sets. Therefore, there were 39 sets of measurements in
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which the IC results could be compared directly with the TLDs for measuring CTDI
values (Table 7.6). The average ratio of IC to TLD was 1.015 (range of 0.923 to
1.116) with a standard deviation of 4.9%. There was no significant difference in the
ratios between different slice widths. The uncertainty in this ratio reflects the overall
uncertainty in TLD reading, uncertainties in the measurements in the penumbra due to
the profiles of the TLDs, and error with the integral method. The overall uncertainties
in the estimation of the ratio (two times standard error of the mean; 2 x sem) was ±
0.015 which indicates that the difference is not significant. However the ratio appears
to depend on the scanner (Table 7.7) . This may reflect uncertainties in the calibration
factors on each of the measurement dates. The random uncertainties in the TLD
calibration factor was approximately ± 3% (2 x sem).
able 7.6; Comparison of the IC and the TLD (I) measuring techniques.
Slice width (mm) 10 3-7 <3 All
No. of data sets 9 22 8 39
Average ratio 1.028 1.019 0.991 1.015
Standard deviation 0.056 0.046 0.038 0.049
2 x sem 0.038 0.020 0.027 0.016
Maximum 1.111 1.116 1.048 1.116
Minimum 0.951 0.934 0.923 0.923
Table 7.7: Comparison of the IC and the TLD (I) measuring techniques by CT
scanner model.
CT scanner GE GE GE Philips Siemens All
9000 Sytec HiSpeed Tomoscan Somatom
HP 3000 Advantage cx/s Plus
No. of data sets 2 4 20 3 10 39
Average ratio 1.114 1.021 1.035 0.992 0.960 1.015
Standard deviation 0.002 0.039 0.035 0.011 0.021 0.049
2 x sem 0.004 0.039 0.015 0.013 0.013 0.016
Maximum 1.116 1.071 1.078 1.005 1.005 1.116
Minimum 1.111 0.963 0.964 0.979 0.979 0.923
As mentioned above, other writers have analysed the CTDI results by fitting a
gaussian curve to the TLD data. The results of this analysis for 53 measurements gave
a ratio between the methods of 1.016 ± 0.020, i.e. indicating no significant difference
(Table 7.8). However, further analysis showed that this ratio depends on slice width.
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The values for 10 mm slice widths, slice widths between 3 and 7 mm, and for slice
widths of less than 3 mm were 1.109 ± 0.004, 1.018 ± 0.010 and 0.918 ± 0.023
respectively. The use of a gaussian curve is therefore incorrect.
Table 7.8: Comparison of the gaussian (TLD (III)) and TLD (I) measuring
Slice width (mm) 10 3-7 <3 All
No. of data sets 13 27 13 53
Average ratio 1.109 1.018 0.918 1.016
Standard deviation 0.008 0.027 0.041 0.073
2 x sem 0.004 0.010 0.023 0.020
Maximum 1.122 1.063 0.948 1.122
Minimum 1.088 0.966 0.783 0.783
One reason for the relatively low CTDI value for the TLD measurements may
have been the use of a more limited integration range. The IC integrates over the
length of the chamber (100 mm), where the TLDs were used in a stack which was no
more than three times the nominal slice width, i.e., a maximum length of 30 mm.
The TLD profiles were therefore extrapolated by fitting a curve to the
measured TLD data over a 100 mm length. The average ratio of the results obtained
by extrapolation, to those measured directly from the TLDs over 30 mm length, was
1.020 ± 0.005 (range 0.967-1.074) (Table 7.9).
Table 7.9 : Comparison of the TLD ( II) and TLD (I)
Slice width (mm) 10 3-7 <3 All
No. of data sets 13 27 13 53
Average ratio 1.018 1.023 1.016 1.020
Standard deviation 0.008 0.015 0.030 0.019
2 x sem 0.004 0.006 0.017 0.005
Maximum 1.039 1.063 1.074 1.074
Minimum 1.008 0.985 0.967 0.967
measuring techniques.
Overall from the analysis made above it could be concluded that there was no
significant difference between the estimated CTDI values due to two different
dosimeters (IC and TLDs) used. This conclusion is obviously subject to the
application of, both dosimeters without any considerable time gap during which the
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CT scanner characteristics could be changed. In addition there was no significant
difference between the CTDI integrated from the TLDs over 30 mm with that of 100
mm length. Therefore it is concluded that the longer length of the IC (100 mm) than
that of the stack of TLDs (30 mm) does not have a significant effect on CTDI. On the
other hand there was no significant difference between the CTDI estimated from the
gaussian curve fitted to the TLD values with that resulting from the common TLD
measuring technique. Nevertheless, more analysis confirmed that the ratio between
the gaussian and the TLD measuring technique depended on slice width and the use of
a gaussian curve is therefore incorrect.
7.3.2.2 Variation of CTDI by Slice Width
The integrated dose profile should be proportional to slice width on the
assumption that the output profile across the slice is homogeneous, output is
independent of width because of minimum scatter, and penumbra shape is not a
function of width. Because CTDI is the integrated profile normalised to nominal slice
width, it should therefore be constant for all slice widths for a particular scanner.
Deviation from constancy indicates that the nominal slice widths may be in error.
Normalising the data to the CTDI for a 10 mm slice width shows consistency (within
10%) for all scanners in the survey for slice widths greater than 2 mm (Table 7.10).
However, for narrow slice widths some errors were noted. For the GE 8800 scanner
the CTDI ratios between the 1.5 mm and 10 mm slice widths were 1.10 (for the
HEAD filter) and 1.11 (for the BODY filter), indicating that the true slice width
should be about 10% more than the nominal slice width of 1.5 mm. For the GE
HiSpeed Advantage scanner, the CTDI for a 1 mm slice width relative to that of 10
mm, increased from 1.048 at 80 kV to 1.124 at 140 kV (Table 7.10) indicating that
this error is energy dependent. This is presumably due to collimator leakage or
increased scatter. This effect was also noted for the Siemens scanner in which the
ratio between the 1 mm and 10 mm slice widths was 1.436 and 1.745 for 120 kV and
137 kV respectively (Table 7.10). The high ratio suggests that the true slice width at
this setting was approximately 1.4 mm. A big discrepancy was also found for the GE
Sytec scanner for which the CTDI of a 1 mm slice width was 33% greater than that
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for the 10 mm slice width, indicating that the true slice width was approximately 1.3
mm. As could be noted in the table the ratios have not been influenced by the choice
of the HEAD or the BODY filter for the GE 8800 and GE 9000HP scanners. Similar
variation was observed in the estimated CTDI values using the TLDs by the slice
width (Table 7.11).
Table 7.10: Ratios of estimated CTDI values (with the IC) to that of 10 mm slice
width for all the CT scanners.
Slice widths (mm) 7 5 3 2 1.5 1
GE 8800 (BODY) - 0.996 - - 1.104 -
GE 8800 (HEAD) - 0.995 - - 1.106 -
GE 9000HP (BODY) - 0.993 - 0.971 - -
GE 9000HP (HEAD) - 1.000 - 0.977 - -
GE Sytec 3000 Plus - 0.997 1.058 - - 1.329
GE HiSpeed Advantage (80 kV) 1.012 1.000 1.048 - - 1.048
GE HiSpeed Advantage (100 kV) 1.000 1.000 1.044 - - 1.074
GE HiSpeed Advantage (120 kV) 1.005 1.005 1.049 - - 1.089
GE HiSpeed Advantage (140 kV) 1.007 1.007 1.058 - - 1.124
Philips Tomoscan CX/S - 0.995 - 1.081 - -
Siemens Somatom Plus (120 kV) 1.068 1.051 1.094 - - 1.436
Siemens Somatom Plus (137 kV) 1.051 1.038 1.089 - - 1.745
Table 7.11: Ratios of estimated CTDI values (with the TLDs) to that of 10 mm slice
width for all the CT scanners.
Slice widths (mm) 7 5 3 2 1.5 1
GE 8800 (BODY) - 1.021 - - 1.135 -
GE 8800 (HEAD) - 0.979 - - 1.094 -
GE 9000HP (BODY) - 0.992 - 0.967 - -
GE 9000HP (HEAD) - 1.008 - 0.938 - -
GE Sytec 3000 Plus - 1.051 1.097 - - 1.477
GE HiSpeed Advantage (80 kV) 1.026 1.052 1.065 - - 1.078
GE HiSpeed Advantage (100 kV) 0.942 1.007 1.029 - - 1.065
GE HiSpeed Advantage (120 kV) 1.016 1.000 1.042 - - 1.115
GE HiSpeed Advantage (140 kV) 1.019 1.027 1.073 - - 1.178
Philips Tomoscan CX/S - 0.968 - 1.068 - -
Siemens Somatom Plus (120 kV) 1.057 1.049 1.114 - - 1.480
Siemens Somatom Plus (137 kV) 1.051 1.038 1.089 - - 1.741
The TLDs provided dose profiles enabling us to investigate about the variation
of the CTDI values by the slice widths and to validate the nominal slice widths of the
scanners.
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Figure 7.14 - Figure 7.17 show a few samples of the recorded dose profiles by
the TLDs for the widest and the narrowest slice width settings for the Siemens
Somatom Plus CT scanner.
This allowed the calculation of the full width at half maximum (FWHM) value
for the CT scanners.
As can be noted, the Siemens dose profiles presented in Figure 7.16 and
Figure 7.17 indicate a significantly bigger FWHM value than the nominal slice widths
for the narrowest slice width for the Siemens scanner.
Table 7.12 compares the narrowest nominal slice widths with their estimated
FWHM based on the TLD measurements. These are compared with values referred
from the IC measurements of CTDI. The IC values were calculated by multiplying the
CTDI value normalised to the 10 mm width (from Table 7.10) by the nominal slice
width. The assumption in the calculation is that the true slice width for the nominal 10
mm slice is correct and that the penumbra shapes of the dose profiles are identical for
the largest and smallest slice width. There are significant uncertainties in the FWHM
measured from the profiles for narrow slice widths because of the very poor
resolution given by 0.85 mm thick TLDs in the measurements.
Table 7.12: A comparison between the nominal slice width with the FWHM and the
true values derived from the dose profiles and CTDI ratios for the narrowest slice
widths of all the CT scanners.
CT scanner Option slice width (mm!
nominal value FWHM IC value *
GE 8800 HEAD 1.5 2.01 1.65
BODY 1.5 2.01 1.66
GE 9000HP HEAD 2 2.21 1.94
BODY 2 2.21 1.96
GE Sytec 3000 Plus - 1 1.61 1.05
GE Hi Speed Advantage 80 kV 1 1.20 1.05
100 kV 1 1.80 1.07
120 kV 1 2.01 1.09
140 kV 1 1.81 1.12
Philips Tomoscan CX/S - 2 2.51 2.16
Siemens Somatom Plus 120 kV 1 1.61 1.44
137 kV 1 2.01 1.75
* These values were calculated by multiplying the nominal slice widths by the CTDI ratios of the
slice widths to that of the 10 mm (Table 7.10).
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Axial dose profile for the Siemens Somatom Plus CT Scanne
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Figure 7.14: Free in air recorded dose profile for the Siemens Somatom Plus scanner
(120 kV, 10 mm nominal slice width).
Axial dose profile for the Siemens Somatom Plus CT Scanner
kV = 137, slice width = 10 mm, FWHM = 10.03 mm
—X—TLD reading
-15 -10 -5 0 5 10 15
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Figure 7.15: Free in air recorded dose profile for the Siemens Somatom Plus scanner
(137 kV, 10 mm nominal slice width).
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Axial dose profile for the Siemens Somatom Plus CT Scanner
kV = 120, slice width = 1 mm, FWHM = 2.01 mm
—X—TLD readings
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Figure 7.16: Free in air recorded dose profile for the Siemens Somatom Plus scanner
(120 kV, 1 mm nominal slice width).
Axial dose profile for the Siemens Somatom Plus CT Scanner















Figure 7.17: Free in air recorded dose profile for the Siemens Somatom Plus scanner
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7.3.2.3 Variation of CTDI by Tube Potential
The GE HiSpeed Advantage and the Siemens Somatom Plus scanners had
four and two tube potential settings available respectively. Variation of estimated
CTDI values (with the IC) by the tube potential are summarised in Table 7.13 for
these scanners. The data presented in this table were calculated from the CTDI values
for five slice widths available with either of these scanners.
As could be seen in Table 7.13 the estimated CTDI value has significantly
increased with the increase in the tube potential.
Table 7.7 and Figure 7.19 also demonstrate the variation of estimated CTDI
values with the kV for the GE HiSpeed Advantage and the Siemens Somatom Plus
scanner respectively.
able 7.13: Variation of CTDI values (with the IC) by the kV.
CT scanner GE HiSpeed Advantage Siemens
kV ratio 100/80 120/80 140/80 137/120
No. of data sets 5 5 5 5
Average ratio 1.630 2.464 3.369 1.391
Standard deviation 0.022 0.044 0.104 0.135
2 x sem 0.020 0.039 0.093 0.120
Maximum 1.667 2.540 3.552 1.631
Minimum 1.607 2.429 3.298 1.320
Similar variation was observed in the estimated CTDI values with the TLDs
by the tube potentials for these scanners (Table 7.14).
able 7.14: Variation of CTDI values (with the
CT scanner GE HiSpeed Advantage Siemens
kV ratio 100/80 120/80 140/80 137/120
No. of data sets 5 5 5 5
Average ratio 1.744 2.457 3.411 1.346
Standard deviation 0.057 0.076 0.153 0.116
2 x sem 0.051 0.068 0.136 0.104
Maximum 1.805 2.566 3.675 1.549
Minimum 1.658 2.358 3.284 1.269
















Figure 7.18: variation of estimated CTDI values (using IC) with the tube potential for











Figure 7.19: variation of estimated CTDI values (using IC) with the tube potential for
the GE Siemens Somatom Plus CT Scanner.
7.3.2.4 Variation of CTDI by Scanner Model
Figure 7.20 and Figure 7.21 demonstrate variation of our measured CTDI
values in air normalised to the exposure setting (mGy/mAs), using the TLDs, by
scanner type and tube potential for the nominal slice width of 10 mm and 5 mm
respectively. As can be seen in these figures the CTDI values vary considerably by the
CT scanner make and model and also by the different kV settings used for a particular
scanner.
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Overall, for the nominal slice width of 10 mm (Figure 7.20) the modern model
of GE HiSpeed Advantage (at 80 kV) shows the lowest CTDI value (0.077
mGy/mAs) and the GE Sytec 3000 model (at 120kV) shows the highest CTDI value
(0.352 mGy/mAs). But if the CTDI values for the most common kV setting (120 kV)
for all scanners are noted, although the GE Sytec again shows the highest value, the
GE 9000HP model, with the head filter option, gives the lowest value (0.123
mGy/mAs). Similarly, for 5 mm nominal slice width (Figure 7.21), the GE HiSpeed
Advantage (with 80 kV) shows the lowest (0.081 mGy/mAs) and the GE Sytec 3000
(with 120 kV) shows the highest (0.370 mGy/mAs) CTDI value. If the CTDI values
for the most common kV setting (120kV) are compared with each other for 5 mm
slice width, although again the GE Sytec 3000 demonstrates the highest value, the GE
9000HP scanner, with the head filter, shows the lowest value (0.122 mGy/mAs). It
can be concluded that, the GE Sytec 3000 Plus gives the highest and the GE HiSpeed
Advantage the lowest CTDI values for the same condition of exposures (120 kV and
5 or 10 mm slice width). In addition, it is noted that for both of these nominal slice
width settings there is a significant variation up to a factor of 5 among our measured
CTDI values for different types of CT scanners. This reflects differences in the
scanners' beam geometry and radiation quality. Even for the same radiation quality a
variation of up to a factor of 3 is noted between different types of the CT scanners.
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Figure 7.20: Variation of CTDI values by the type of CT scanner and kV (for 10 mm
slice width).
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figure 7.21: Variation of CTDI values by the type of CT scanner and kV (for 5 mm
slice width).
As noted above there were discrepancies at smaller (< 2mm) slice widths.
Therefore to demonstrate the variation of CTDI values among the CT scanners it is
better to compare the estimated CTDI values for the 10 mm slice width and the most
common tube potential (120 kV). In this regard the maximum, minimum, and
maximum to minimum ratios of the CTDI values, measured with both types of the
dosimeters, for these settings of the slice width and tube potential are summarised in
Table 7.15.
able 7.15: Variation of CTDI among the CT scanners (10 mm slice width, 120 kV)
CTDI measuring technique (IC) TLD (I)
Maximum 0.377 0.352
Minimum 0.117 0.123
Maximum/minimum ratio 3.2 2.9
As can be noted from the table, there was a significant variation in the
estimated CTDI values, with both dosimetry devices (IC and TLD), among different
makes and models of the CT scanners. This variation, being up to a factor of three, is
due to differences in beam geometry, filtration, and radiation quality of the CT
scanners. CTDI in air is principally a function of kV, filtration, and focus to central
axis distance of the CT scanner.
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7.3.2.5 Comparison of CTDI Values with the NRPB Mean Values
In this section our estimated CTDI values with the TLDs (for 10 mm slice
width) have been compared with that of the NRPB from the national survey of CT
practice in the UK (Shrimpton et al. 1991b). This has been done for the scanners
included in the NRPB survey consisting of a GE 8800, a GE 9000HP, and a Philips
Tomoscan CX/S scanner.
The ratios between our estimated CTDI values and the NRPB mean and
maximum values for the same types and model of CT scanner have been calculated
and presented in Table 7.16.
Table 7.16: Ratios between estimated CTDI values with the TLDs for all the CT
scanners and the NRPB values (from the national survey of CT practice in the UK).
CT Scanner Option Mean Max
GE 8800 HEAD 1.641 1.223
BODY 1.579 1.282
GE 9000HP HEAD 1.139 0.984
BODY 1.133 0.992
Philips CX/S - 0.995 0.913
Data presented in the above table show that our estimated CTDI values for the
GE 8800 scanner has not only been more than the NRPB mean value but also
significantly (22% HEAD and 28% BODY) higher than the NRPB maximum values.
For the GE 9000HP scanner too, the above table shows that our estimated CTDI
values have been significantly (14% HEAD, 13% BODY) higher than the NRPB
mean values (Table 7.16). However, as may be noted in the table, the ratios show that
our estimated CTDI values have been less than the NRPB maximum values (2%
HEAD, 1% BODY) for this scanner. For the Philips Tomoscan CX/S scanner the




As mentioned earlier there is neither any data file nor the scanner
specifications data required for calculating organ or tissue doses and effective dose
values for those rather modern models of CT scanners included in this study.
Therefore we were able to calculate organ or tissue doses and effective doses only for
three CT scanners in our study for which data files were available from the NRPB
national survey of CT practice (Jones and Shrimpton 1993). These were a GE 8800, a
GE 9000 HP and a Philips Tomoscan CX/S CT scanner. As mentioned earlier both of
the GE models are not anymore in clinical use and were replaced with a modern GE
HiSpeed Advantage model.
In this section first calculated organ or tissue doses and effective doses based
on our CTDI measurements free in air and the MC dosimetry approach will be
presented. This will be done for all routine examinations performed by these CT
scanners. Then the estimated patient doses by this dosimetry method, in terms of
effective doses, from the three different scanner models in this study will be compared
with each other. Finally our estimated effective dose values will be compared with the
typical effective dose values reported recently by Wall and Hart (1997) from the
NRPB national survey of CT practice in the UK (Shrimpton et al. 1991a, 1991b;
Jones and Shrimpton 1991) for the most routine examinations.
7.4.1 Organs and Effective Doses
Patient doses were estimated in terms of organ or tissue doses, effective dose
equivalent and effective dose values as recommended by the ICRP (1977, 1991). In
order to derive organ or tissue doses and effective doses for CT examinations using
the MC Dosimetry approach and the CTDI data, as described above it was necessary
to determine details of the scan protocols used for all the routine examinations for all
the CT scanners for which data files were available from the NRPB national survey of
CT practice (Shrimpton et al. 1991a, 1991b; Jones and Shrimpton 1991). The
required parameters of scan protocols were: applied potential (kV), exposure setting
(mAs), number of slices (or scan volume), nominal slice width (mm), couch increment
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(or slice spacing or table feed) (mm), physical filter setting (if variable), and starting
position. These parameters were determined by matching clinical scanning conditions
as closely as possible, through consulting with the radiologists and radiographers who
used the CT scanners. These were the same parameters as applied for the dose
assessment using our developed direct dosimetry approach. The typical scanning
parameters listed in Table 7.17, Table 7.18, and Table 7.19 were used for these CT
scanners.
Table 7.17: Typical clinical scanning parameters for the GE 8800 CT Scanner.








Head Head 120 320 737 10 10 4 801
250 576 10 10 4 841
160 369 10 10 2 881
Orbit Head 120 320 737 5 3 9 850
250 576 10 10 1 877
Posterior Head 120 400 922 5 5 7 801
fossa 320 737 10 10 3 836
250 576 10 10 3 866
200 461 10 10 1 896
* Distance from the base of the mathematical phantom in mm (detailed information in section 7.2.2).
Table 7.18: Typica clinical scanning parameters br the GE 9000HP CT Scanner.








Head Head 120 250 888 10 10 5 801
200 710 10 10 6 851
Chest Bodv 120 250 533 10 15 18 400
Abdomen & oelvis Bodv 120 250 533 10 15 28 000
*Distance from the base of the mathematical phantom in mm (detailed information in section 7.2.2).
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Table 7.19: Typical clinical scanning parameters for the Philips Tomoscan CX/S CT
Scanner.
Examination kV mA mAs Slice Couch No. Start
width increment of Position*
(mm) slices
Head 120 220 356 10 10 11 801
Neck 120 220 356 10 10 10 700
Posterior fossa 120 270 437 5 5 6 801
220 356 10 10 9 831
Chest 120 356 356 10 15 18 400
Abdomen & nelvis 120 270 437 10 15 28 000
Lumbar snine 120 270 437 5 5 10 220
* Distance from the base of the mathematical phantom in mm (detailed information in section 7.2.2).
Having determined the CT scanning parameters, the estimated CTDI values
with the TLDs free in air were used in combination with the NRPB data files (Jones
and Shrimpton 1993) and the available software (CTDOSE by Le Heron 1993), as
explained earlier, to determine the radiation doses to organs and tissues of interest,
effective dose equivalent, and effective dose values for all common CT examinations
performed by these scanners.
The CTDI values resulting from our TLD measurements were used for
calculating organ doses, effective dose (E) and effective dose equivalent (HE) values
by this dosimetry approach, although calculating CTDI values using the pencil IC was
more convenient and had better precision and accuracy. The main reason for this was
that when we implemented our developed direct CT dosimetry method we just had
the TLD results available. It is quite obvious that in order to be able to compare our
developed direct method with the MC method it was necessary to use both dosimetry
methods simultaneously. Furthermore, this was decided not only in order to be
consistent with the NRPB dosimetry procedure, but also because of the differences
observed between the CTDI results from the two dosimetry devices for some of the
CT scanners as explained above.
Table 7.20 shows the calculated organ doses, effective dose equivalent, and
effective dose for three common examinations performed by the GE 8800 CT
scanner. The routine scanning parameters for these examinations are mentioned
above. This was one of the earliest and old RR CT scanner and had a very poor and
slow scan and reconstruction time compared with the other models. Although this
scanner had the potential capability for other examinations in the body region, it was
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mainly used for the head region examinations. This was mainly because it was used in
a clinical neuroscience unit dedicated mainly for "head" examinations. However as
mentioned in previous chapters, this scanner was replaced in 1996 with a more
advanced GE model.
Table 7.21 shows the calculated organ doses, effective dose equivalent, and
effective dose values for three common examinations performed by the GE 9000 HP
CT scanner. The routine scanning parameters for these examinations are mentioned
above. Although this CT scanner was a more advanced RR model, compared with the
GE 8800 model, with much better performance and was used for examinations
covering all body regions, it was still quite old and slow compared with the modern
CT scanners. As mentioned earlier, this scanner was also replaced in 1995 with
another more advanced GE model.
Table 7.22 shows the calculated organ doses, effective dose equivalent, and
effective dose values for three common examinations performed by the Philips
Tomoscan CX/S CT scanner. The routine scanning parameters for these examinations
and with this CT model, are mentioned above.
Table 7.20: Calculated organ doses and dose indices for different examinations using
the GE 8800 CT scanner.
Organ/tissue Calculated dose (mGy)
Head Orbit Posterior fossa i
Gonads 0.00 0.00 0.00
Red Bone Marrow 1.73 0.97 2.18
Colon 0.00 0.00 0.00
Lungs 0.07 0.03 0.09
Stomach 0.00 0.00 0.00
Bladder 0.00 0.00 0.00
Breasts 0.02 0.01 0.02
Liver 0.00 0.00 0.01
Oesophagus 0.05 0.01 0.06
Thyroid 1.58 0.42 1.94
Skin 1.35 0.86 1.73
Bone Surface 7.86 4.61 9.93
Remainder (mSv, ICRP 26) 1.80 1.70 2.28
He (mSv) 2.31 1.97 2.19
Remainder (mSv, ICRP 60) 0.77 0.71 0.97
E (mSv) 1.15 0.91 1.46
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Table 7.21: Calculated organ doses and dose indices for different examinations using
the GE 9000 HP CT scanner.
Organ/tissue Calculated dose (mGv)
Head Chest Abdomen & pelvis
Gonads 0.00 0.02 7.95
Red Bone Marrow 1.62 3.74 5.32
Colon 0.00 0.03 11.63
Lungs 0.06 13.92 0.99
Stomach 0.00 2.87 12.44
Bladder 0.00 0.01 16.60
Breasts 0.02 10.38 0.30
Liver 0.00 4.68 10.14
Oesophagus 0.04 18.71 0.22
Thyroid 1.33 1.42 0.02
Skin 1.30 2.46 3.77
Bone Surface 7.42 7.24 6.65
Remainder (mSv, ICRP 26) 1.85 0.92 4.58
He (mSv) 2.31 4.86 7.56
Remainder (mSv, ICRP 60) 0.78 0.53 0.29
E (mSv) 1.14 4.86 7.00
Table 7.22: Calculated organ doses and dose indices for different examinations using







Gonads 0.00 0.00 0.00 0.04 14.90 1.54
Red Bone Marrow 2.00 1.64 2.27 6.01 10.52 2.30
Colon 0.00 0.00 0.00 0.05 22.87 3.85
Lungs 0.07 0.62 0.08 23.03 2.05 0.24
Stomach 0.00 0.02 0.00 4.66 24.65 7.32
Bladder 0.00 0.00 0.00 0.02 28.42 0.68
Breasts 0.02 0.09 0.03 18.32 0.60 0.09
Liver 0.01 0.04 0.01 7.55 20.76 14.66
Oesophagus 0.06 0.58 0.06 26.25 0.46 0.05
Thyroid 1.40 44.75 1.57 2.41 0.05 0.00
Skin 1.95 2.03 2.25 4.05 7.58 2.14
Bone Surface 8.77 5.41 9.92 11.44 12.99 2.97
Remainder
(mSv, ICRP 26)
1.96 0.13 2.11 1.51 8.17 4.76
He (mSv) 2.51 1.92 2.74 8.16 13.90 3.97
Remainder
(mSv, ICRP 60)
0.83 0.09 0.89 0.76 1.00 0.58
E (mSv) 1.26 2.71 1.38 7.70 13.91 2.86
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7.5 Summary and Conclusion
MC CT dosimetry method was implemented for three CT scanners in this
study for which the required data files were available from the NRPB national survey
of CT practice in the UK (Shrimpton et al. 1991a, 1991b; Jones and Shrimpton 1991).
The estimation of patient doses with this dosimetry method, as used in this study, was
quite simple and straightforward compare with the other common CT dosimetry
approaches. Nevertheless, this dosimetry method is only applicable to rather older CT
scanner models included in the NRPB survey. On the other hand developing this
dosimetry method for newer and upcoming scanners requires both the expertise in the
MC technique and the scanner configurations that are not normally readily available.
However the implementation of this dosimetry approach in this study helped us to
compare our developed dosimetry approach with another well established dosimetry
method. This comparison is given in chapter eight. In addition, the measurements of
the CTDI in air for all different CT scanners provided a good base for analysing
different common CTDI measuring techniques and identifying the best technique for
the estimation of CTDI in air. Furthermore, the comprehensive CTDI measurements
carried out provided a good tool to study the variation of this index by slice width, kV
and CT scanner models. Comparison of the estimated patient doses by this dosimetry
approach with the NRPB typical values also provided a good base to evaluate the
performance of the relevant CT scanners regarding the patient doses and the ALARA
principle.
It was noted that the estimated CTDI values for all the scanners for slice
widths greater than 2 mm were consistent, while there were discrepancies for smaller
slice widths. This implied that the true slice widths may be different from the nominal
value for smaller (< 2mm) slice widths for some of the scanners. Further analysing of
these discrepancies, for the scanners with multiple kV options, indicated that this
error was energy dependent. The strong dependence of CTDI on the kV was noted
for the GE HiSpeed Advantage scanner operating at four tube potentials in the range
of 80 to 140 kV. At 120 kV and 10 mm slice width, the lowest and highest value of
CTDI estimated with the IC were 0.117 mGy/mAs (GE 9000HP with the HEAD
filter) and 0.377 mGy/mAs (GE Sytec 3000) respectively. These values were 0.123
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and 0.352 mGy/mAs when estimated with the TLDs. As explained the pencil IC has
the advantages of being more precise than the TLDs and does not need any other
extra work as required for the readout and calibration process of the TLDs.
Therefore, if the only purpose would be estimating CTDI values, not acquiring the CT
dose profile, it is recommended that the pencil IC will be used. Otherwise the TLDs
can be used for CTDI estimation. Based on the discussion made above regarding the
use of TLDs, it is concluded that measuring the dose profile over a length longer than
what was adopted in this study does not influence the resultant CTDI value. In
addition, the gaussian measuring technique leads to incorrect CTDI estimation.
Therefore, if the TLDs are used for the estimation of CTDI, it is recommended that it
will be used based on the simple measuring technique adopted in this study being
based on the NRPB method (Shrimpton et al. 1991b).
It is also concluded that except for the GE 8800 scanner for which the
estimated CTDI values were significantly higher than the maximum values reported by
the NRPB, for the other two scanners the estimated CTDI values fell within the
NRPB reported range. However, as mentioned earlier, the GE 8800 and the GE
9000HP scanners have been replaced with the newer models and are not used
anymore. Furthermore it was noted that there were some uncertainties in the
measurements carried out on the GE 8800 scanner. Unfortunately, because this
scanner was not accessible enough and was later taken out of service, we were not
able to do more investigation on it. Overall, the CTDI values estimated with the TLDs
ranged from 0.077 to 0.520 (Table 7.4), with significant variations up to a factor of
6.8, reflecting differences in the CT scanners' characteristics and the kV settings used
by different types and models of the CT scanners. This variation factor is nearly two
times the factor (3.5) reported by the NRPB resulting from its survey on much more
CT scanners (nearly 200) operating in the UK up until 1989 (Shrimpton et al. 1991a,
1991b; Jones and Shrimpton 1991). This confirms that there is now a greater diversity
in the CT scanner characteristics than what existed about a decade ago.
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8. Comparison of Different Dosimetry Approaches and
Estimated Patient Doses
In this chapter the two dosimetry approaches employed in this study for the
estimation of patient doses from CT examinations will be compared with each other.
In addition the estimated patient doses for similar conventional and spiral
examinations will be compared with each other. Finally, the variation of patient doses
estimated with the developed direct dosimetry method among the CT scanners will be
discussed. Furthermore, the estimated patient doses for the most common CT
examinations will be compared with the NRPB typical doses.
Section one will compare the two dosimetry approaches. In this regard, the
estimated patient doses in terms of the organ doses and the other dose indices
resulting from the developed direct CT dosimetry method will be compared with that
of the MC dosimetry method. In addition, the differences between the two dosimetry
approaches will be highlighted, analysed and discussed. This will be done for those
scanners for which we were able to implement the MC dosimetry approach.
Furthermore, the level of errors involved in both of the dosimetry approaches will be
discussed and compared with each other. Section two will analyse and discuss the
variation of effective dose values resulting from the direct dosimetry approach among
the different CT scanners for every common scanning technique. Patient doses
resulting from the conventional and the spiral examinations, with the direct dosimetry
method, will be compared with each other in section three. Section four discusses the
differences between the estimated effective dose equivalent and effective dose values
for the most common examinations resulting from the direct dosimetry approach.
Finally section five will compare the estimated effective dose values, resulting from
the developed direct dosimetry approach for every CT scanner, with the typical mean
values (Wall and Hart 1977) resulting from the national survey of CT practice in the
UK (Shrimpton et al. 1991a, Shrimpton et al. 1991b, Jones and Shrimpton 1991).
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8.1 Comparison of Patient Doses Resulting from the Direct and the MC
Dosimetry Approaches
As noted in the previous chapter, required data files were not available for all
models of the CT scanners and we were able to implement the MC CT dosimetry
approach only for the three CT scanners. These scanners were a GE 8800, a GE
9000HP, and a Philips Tomoscan CX/S model.
In this section estimated patient doses resulting from the implementation of
both of the dosimetry approaches, i.e. the developed direct method and the MC
method, are compared and their differences are analysed and discussed. The
comparison is made in terms of doses to all organs and tissues of interest, effective
dose equivalent (E) (ICRP 1977) and effective dose (He) (ICRP 1991) values for each
scanner. This is done for all the most common scanning techniques performed by the
three scanners being grouped under "head & neck", "chest", and "abdomen & pelvis".
8.1.1 Head & Neck
In the head and neck region, the tissues which principally contribute to
effective dose are the brain (remainders), red bone marrow (RBM), and bone (and
oesophagus and thyroid for scans of the neck). The relative contribution of these
tissues to effective dose for the measured protocols are shown in Table 8.1 and Table
8.2 for the direct and the MC dosimetry methods respectively.
For all these examinations (except the neck) between 55%-61% (the direct
method) and 66%-78% (the MC method) of the effective dose is due to the dose to
remainder organs, which in turn is mainly due to the dose to the brain. This is because
brain is the only organ included in the ICRP list (ICRJP 1991) which is wholly or
mainly included within the scan volume of these head scanning techniques. A smaller
proportion of the total bone and RBM in the whole body (9-12%) is also included in
the scan volume for these examinations. Hence the contribution of these organs to the
effective dose from the direct method (12-14% bone, 23-26% RBM) (Table 8.1) and
the MC method (5-7% bone, 13-18% RBM) (Table 8.2) was less. For the neck
examinations it is mostly thyroid (direct method: 64% and MC method 83%) which
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contribute to the resulting effective dose. The other main contributions are from
oesophagus and RBM.
Table 8.1: Contribution of organ/tissue doses to effective dose from the direct
Organ/tissue GE 8800 GE 9000HP Philips Tomoscan CX/S
Head Orbit PF* Head Head PF* Neck
RBM 23.1% 25.9% 24.2% 23.4% 23.8% 20.2% 11.7%
Oesophagus 0.4% 0.4% 0.5% 0.4% 0.4% 0.2% 11.6%
Thyroid 1.9% 2.0% 2.7% 2.0% 2.1% 6.3% 64.0%
Bone sarface 12.6% 14.2% 13.2% 12.8% 12.1% 7.3% 4.6%
Remainder (ICRP 60) 60.3% 55.4% 58.2% 60.1% 60.1% 63.1% 1.0%
* Posterior fossa
Table 8.2: Contribution of organ/tissue doses to effective dose from the MC
Organ/tissue GE 8800 GE 9000HP Philips Tomoscan CX/S
Head Orbit PF* Head Head PF* Neck
RBM 18.1% 12.8% 17.9% 17.1% 19.0% 19.7 7.3%
Oesophagus 0.2% 0.1% 0.2% 0.2% 0.2% 0.2 1.1%
Thyroid 6.9% 2.3% 6.6% 5.8% 5.6% 5.7 82.6%
Bone sarface 6.8% 5.1% 6.8% 6.5% 7.0% 7.2 2.0%
Remainder (ICRP 60) 67.0% 78.0% 66.4% 68.4% 65.9% 64.5 3.3%
* Posterior fossa
The ratio of doses derived from the direct and MC dosimetry methods are
shown in Table 8.3. The table includes the ratios of doses to the five most significant
organs/tissues and the ratios of doses to remainder organs and E. It can be seen that
the differences in effective dose values calculated by two methods can be attributed to
the differences in doses to the brain for the examinations of the head because of the
dominant influence of this tissue on the calculation.
The results presented in this table are not consistent. The GE 9000HP and the
Philips CX/S scanners have higher effective doses calculated by the direct method
(8%-47%), whereas for the GE 8800 the measured doses were consistently lower
than those calculated (by between 33% and 38%) for these protocols. It was reported
previously that the CTDI measurements for the GE 8800 scanner were high in
comparison with data published by the NRPB. It is possible that measurement error or
mis-calibration of the scanner may have influenced these results, which unfortunately
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could not be repeated. For the other scanners, CTDI measurements were made in the
scan day as the direct dose measurements providing a greater certainty in the ratios
presented here.
Table 8.3: Ratios of organ/tissue, remainder, brain and effective doses between the
direct and the MC dosimetry methods for the head and nec c examinations.
Organ/tissue GE 8800 GE 9000HP Philips Tomoscan
cx/s
Head Orbit PF* Head Head PF* Neck
RBM 0.87 1.25 0.91 2.02 1.67 1.47 2.37
Oesophagus 1.20 4.00 1.67 3.25 2.33 3.17 15.91
Thvroid 0.19 0.52 0.27 0.50 0.51 0.58 1.14
Bone sarface 1.25 1.73 1.30 2.90 2.31 2.04 3.37
Remainder (mSv, ICRP 60) 0.61 0.44 0.59 1.29 1.22 1.15 0.44
(Brain 0.62 0.44 0.60 1.31 1.24 1.08 1.07)
E (mSv) 0.68 0.62 0.67 1.47 1.33 1.23 1.47
* Posterior fossa
Table 8.4 shows the contribution to effective dose from the different body
organs/tissues for chest examinations from both dosimetry methods. We have
excluded from the table gonads, colon, bladder, skin, thyroid, and bone which have a
negligible contribution. Most of the dose is due to six organs, three of which are
totally included within the chest scan volume (lungs, breasts, and oesophagus), and
three which are partially included (liver, stomach, and RBM). From these
organs/tissues lung, stomach, and RBM have a higher tissue weighting factor (0.12)
than the other three (0.05). The contribution of remainder dose to effective dose is
also high because of the inclusion of the thymus and adrenals in the chest scan
volume.
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Table 8.4: Contribution of organ/tissue doses to effective dose from the direct and
MC dosimetry methods for the chest examination.
Organ/tissue GE 9000HP Philips CX/S
Direct MC Direct MC
RBM 8.1% 9.2% 8.4% 9.4%
Lungs 30.5% 33.6% 31.6% 35.9%
Stomach 13.5% 7.1% 13.4% 7.3%
Breasts 14.9% 10.7% 14.3% 11.9%
Liver 5.7% 4.8% 5.9% 4.9%
Oesophagus 11.0% 19.2% 10.4% 17.0%
Remainder (mSv, ICRP 60) 8.6% 10.9% 7.9% 9.9%
8.1.2 Chest
The ratios of doses between the two dosimetry methods for chest
examinations are shown in Table 8.5 for the GE 9000HP and Philips Tomoscan CX/S
scanners. The ratios between measured and calculated doses are mentioned in the
table for the effective dose and for the above six organs/tissues plus the remainder
having a significant contribution to the effective dose. The direct dosimetry method
indicated an increased effective dose of 38% and 27% for the GE 9000HP and the
Philips scanner respectively. This increase is due to the higher contribution of
stomach, breast and liver to effective dose from which the stomach has a high tissue
weighting factor causing the biggest discrepancy for this organ. The measured doses
to RBM and lung were also higher than the calculated values. But the increase in the
measured effective dose was less affected by these two organs than the other three
organs because the contributions of these organs to effective dose from both
dosimetry methods were very close to each other (Table 8.4). On the other hand the
measured dose to the oesophagus was 11% and 12% less than the MC calculations
for the GE 9000HP and the Philips scanners respectively. This was due to higher
contribution of this organ to effective dose from the MC method than that of the
direct method. However, since the tissue weighting factor for oesophagus is much less
than that of the other five organs and tissues, the much lower dose from the direct
method to this organ is offset by increased doses to other organs/tissues (RBM, lungs,
stomach, breasts, and liver).
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Overall, the differences observed in estimated organ doses between the two
dosimetry methods are due to differences in the shape, size and location or
distribution of these organs in the physical and the mathematical phantoms. In other
words, differences in organ/tissue doses and effective doses reflect differences in the
size, shape and location of the organs/tissues in the physical (Rando) and
computational (mathematical) phantoms. This again reflects the difference between
the defined anatomy of the Rando phantom (Figure 4.1, 4.2, 4.4 and Appendix A) and
the mathematical phantom (Figure 6.7), for which there is a sharp division between
the locations of the thoracic and abdominal organs. The reader is referred to chapter
four and seven for a full description of the physical and mathematical phantoms
respectively.
Table 8.5: Ratios of organ/tissue, remainder, and effective doses between the direct
and the MC dosimetry methods for the c lest examinations.







Remainder (mSv, ICRP 60) 1.09 1.01
E (mSv) 1.38 1.27
8.1.3 Abdomen & Pelvis
For the abdomen and pelvis CT protocols seven organs/tissues contribute
significantly to effective dose. These are gonads, stomach, colon, RBM, bladder, liver,
and remainder organs (including kidneys, lower large intestine (LLI), small intestine
(SI), and pancreas). The contribution of each of these organs to measured and
calculated effective dose is shown in Table 8.6 for the GE 9000HP and the Philips
Tomoscan CX/S scanners.
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Table 8.6: Contribution of organ/tissue doses to effective dose from the direct and
CT scanner GE 9000HP Philips Tomoscan CX/S
CT examination Abdomen & pelvis Abdomen & pelvis Lumbar Spine
Dosimetry method Direct MC Direct MC Direct MC
Gonads 24.3% 22.7% 24.4% 21.4% 22.5% 10.8%
RBM 7.4% 9.1% 8.7% 9.1% 18.3% 9.7%
Colon 16.6% 19.9% 18.2% 19.7% 21.4% 16.2%
Stomach 22.1% 21.3% 20.0% 21.3% 4.7% 30.7%
Bladder 6.9% 11.9% 7.2% 10.2% 4.2% 1.2%
Liver 5.3% 7.2% 7.8% 7.5% 2.5% 8.1%
Remainder (mSv, ICRP 60) 6.8% 4.1% 7.0% 7.2% 19.8% 20.3%
Table 8.7: Ratios of organ/tissue doses and effective dose between the direct and the
CT scanner GE 9000HP Philips CX/S Philips CX/S
CT examination Abdomen & pelvis Abdomen & pelvis Lumbar Spine
Gonads 1.46 1.38 2.40
RBM 1.11 1.15 2.18
Colon 1.13 1.11 1.52
Stomach 1.41 1.13 0.18
Bladder 0.79 0.85 4.01
Liver 1.00 1.26 0.36
RemainderfmSv, ICRP 60) 2.24 1.17 1.12
E (mSv) 1.36 1.21 1.15
It can be seen in Table 8.7 that the direct dosimetry method led to 36% and
21% higher estimates of effective dose for the full scans of "abdomen & pelvis" for
the GE 9000HP and the Philips Tomoscan CX/S scanners respectively. The measured
effective dose for the lumbar spine scan was also 15% more than the calculated value.
Similar to "head & neck" and "chest" scans, a general explanation for the increases in
measured doses for these abdomen and pelvis scans could be the different physical
(Rando) and computational (mathematical) phantoms used by the dosimetry methods
and different assumptions made for the shape, size and location of the radiosensitive
organs in these phantoms.
For those organs which are completely or nearly completely included in the
scan volume, namely gonads, colon, stomach, bladder, and liver, the dose ratio
between dosimetry techniques varies from 0.79 to 1.49 and from 0.85 to 1.38 for
"abdomen & pelvis" scans for the two scanners respectively. These tissues contribute
to approximately 75% of the total dose. The lower values of the mentioned ranges
198
arise from the higher contribution of bladder dose to calculated effective dose.
However, the much lower dose from the direct method to this organ is offset by
increased doses to the other organs (gonads, colon, stomach, and liver) for this
scanning protocol.
For the Philips scanner comparison of dose estimations were made for two
protocols. These were "abdomen & pelvis" covering 14 sections of the Rando
phantom, and "lumbar spine" over three sections. For the direct dosimetry method,
the most significant contributions to effective dose arise from the gonads (ovaries and
testes), RBM, colon, and remainder tissues (upper large intestine (ULI), SI, and
kidneys) for "lumbar spine" examinations. These account for 82% of the dose derived
by this dosimetry method for these examinations. However, for the MC calculations
there is a significant contribution from stomach and liver (30.7% and 8.1%
respectively) for "lumbar spine" scan indicating the differences in the anatomy of the
two phantoms. However, the much lower doses from the direct method to these
tissues are offset by increased doses to gonads, RBM and colon.
8.1.4 Comparison of Measurements Errors in the Dosimetry Approaches
The NRPB (Shrimpton et al. 1991b) has reported an estimate of about 12% as
the overall uncertainty at the 95% confidence level in their measurements of CTDI
normalised to exposure setting when they have combined all random and systematic
components in the manner described by the International Atomic Energy Agency
(IAEA 1985).
In chapter five it was noted that there were 35 TLD calibration data sets in
this study from which the level of uncertainties in the TLD measurements were
determined. An intermittent measurement error caused by the poor contact between
either the TLDs and the trays or the trays and the heater compartment of the TLD
reader was identified. The highest observed level of uncertainties was estimated to be
about 10.8% at the 95% confidence level for an individual TLD calibration
measurement if this error was included. However if the obvious faulty readings were
excluded, the highest uncertainty was about 5.4% in an individual TLD calibration
measurement. The root mean square of the coefficient variation (CV) of all the
199
calibration data sets indicated an overall 4.1% uncertainty (standard deviation) in a
single TLD reading (Table 8.8).
Apart from 20 TLDs (10 irradiated and 10 unirradiated) used for the TLD
calibration measurements, 37 TLDs were used for every CTDI measurement. The
level of uncertainties for the CTDI measurements depends on the nominal slice width.
For narrower slice widths only a few TLDs contribute to the CTDI value, so that the
level of uncertainty will depend on the actual number which contribute to the integral.
For the narrowest (1 mm) and the widest (10 mm) slice widths about 5 and 13 TLDs
contribute to 90% or more of the CTDI values. Therefore, with some simplification
the level of uncertainties in the sum of the TLD readings ranges from 2.2% to 3.6%
at the 95% level of confidence for the widest and the narrowest slice widths
respectively. By taking into account the uncertainties involved in the TLD calibration
measurement (caused by the dosed TLDs), the overall uncertainty in our CTDI
measurements is estimated to range from 4.0% to 5.3% at the 95% confidence level
(Table 8.8) based on the IAEA (1994) recommendations for the calculation of
combined uncertainties. The contribution of the 10 unirradiated TLDs used for the
calibration process was less than 0.3%. Therefore the uncertainty due to these TLDs
was ignored when the overall uncertainties were calculated.
For every patient dose estimate using the developed direct dosimetry method,
apart from 20 TLDs used for the TLD calibration measurements, a pair of TLDs was
used for central axis dose measurements in every section of the Rando phantom inside
the scanned volume and two more sections outside the scan volume. If it is assumed
that each section contributes equally to the effective dose, then the overall uncertainty
depends on the number of phantom central axis dose measurements. This ranges from
6 to 16 for the "head" and "abdomen & pelvis" examinations respectively. The overall
uncertainty for the central phantom TLD measurements ranges from 2.6 to 1.4% at
the 95% level of confidence for the "head" and "abdomen & pelvis" examinations
respectively. By taking into account the uncertainties involved in the TLD calibration
measurement (from the dosed TLDs), the overall experimental uncertainty at the 95%
confidence level in our measurements of measured effective doses is estimated to
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range from 3.6 to 2.9% based on the IAEA (1994) recommendations for the
calculation of combined uncertainties (Table 8.8).
Table 8.8: Percentage of the individual (the calibration and the phantom central doses)
and the overall uncertainties (the CTDI and the "head" and "abdomen & pelvis"
Measurement Uncertainty * (%)
single TLD 4.1
calibration (10 TLDs) 2.6
central doses (2 TLDs) 5.7
CTDI (1 mm slice width) 4.4
CTDI (10 mm slice width) 3.4
Head examination 3.6
Abdomen & pelvis examination 2.9
* This value is derived from the root mean square of the CVs of all the TLDs calibration data sets for the
single TLD measurement. The values are calculated at the 95% level of confidence for the other
measurements.
There are other sources of measurement errors in the MC and developed
direct dosimetry approaches. As the NRPB indicated (Shrimpton et al. 1991b) there is
also about 10% overall uncertainties in calculations of CTDI to tissue dose factors
due to interaction cross section data used and the effect of modelling the body tissues
in terms of only five materials in the MC calculations. Furthermore, the MC technique
takes no account of couch attenuation and ignores any slight over-rotation of the x-
ray beam that may occur in practice.
Another source of measurement errors in the developed direct dosimetry
method was highlighted in chapter six when some of the assumptions were validated.
This uncertainty arises from the assumptions made regarding the similarity of the dose
distribution in parallel sections to the representative sections and the uniformity of the
dose distributions in the phantom sections outside the scan volume for this dosimetry
method. The most significant discrepancy noted was for the "abdomen & pelvis"
examinations for which an overestimation of 10 to 20% in the calculated doses was
noted due to the assumption of the similarity of the dose distribution in parallel
sections to the representative section of the "abdomen & pelvis" area. Therefore, if
this source of uncertainty is also taken into account, the overall uncertainty in the
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developed direct dosimetry method is estimated to range from about 4% in head and
neck to 20% for the abdomen and pelvis.
In addition there are other systematic errors in the two dosimetry techniques.
The phantoms used for the studies are not necessarily representative of a true patient.
In particular the mathematical phantom for the MC calculations is an idealised model
of the human body (Shrimpton et al. 1991b). As was noted in earlier chapters, the
location and shape of the organs in the NRPB mathematical phantom have been
simplified and designed based on simple geometrical shapes, while a more realistic
approach has been followed for the physical phantom used for the developed direct
method. This probably accounts for most of the observed differences between the two
measurements techniques (section 8.1.5). It should also be noted that neither phantom
takes any account of variation in body size and shape.
8.1.5 Summary of Dose Comparison
Overall the developed direct dosimetry method has estimated higher effective
dose values for all routine scanning techniques practised by the GE 9000HP and
Philips Tomoscan CX/S CT scanners. Other researchers (Shrimpton et al. 1991b,
Geleijns et al. 1994, Calzado et al. 1995) have also reported higher patient dose
estimates from the common direct dosimetry method compare with that of the MC
dosimetry method for CT practices. Geleijns et al. (1995) have reported that using the
Rando phantom and the direct dosimetry method has yielded up to 40% higher
effective dose values compared with that of the mathematical phantom and the MC
dosimetry method using the NRPB data files on a Philips CT scanner. Shrimpton et al.
(1991b) have also compared reported organ and effective dose equivalent values
resulting from the common direct CT dosimetry method (Nishizawa et al. 1991) for
four complete examinations for selected types of scanners for similar condition of
exposure with their results from the MC method. They have reported higher effective
dose values from the direct dosimetry method of up to 50%, 60%, and 50% for head,
chest and upper abdomen examinations, respectively.
As noted above the estimates of effective dose values determined by the direct
dosimetry method for two scanners were also higher than that of the MC dosimetry
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method. The estimated effective dose values with the direct dosimetry method for the
Philips Tomoscan CX/S and the GE 9000HP scanners were up to a maximum of 47%
higher than that estimated with the MC dosimetry method. Contrary to the results on
these scanners and what has long been known, the estimated effective dose values
from the developed direct dosimetry method were lower than that of the MC method
for all the scanning techniques used with the GE 8800 scanner. As was noted at the
beginning of this chapter, our estimates of the CTDI values for this scanner were
considerably higher (22-24% more than the maximum values) than the NRPB mean
values reported for this scanner. This made us suspicious about the consistency of the
GE 8800 scanner performance and the accuracy of the measured CTDI values.
However during the course of this study this scanner was replaced with a newer
model and we were not able to carry out more measurements to investigate the large
discrepancies which existed between our measured CTDI values and the NRPB
reported mean values (Shrimpton et al. 1991b). Even when this CT scanner model
was operating, it was difficult to get access. The higher estimates of dose indices for
this scanner with the MC approach could be attributed to overestimated CTDI values.
Hence the patient doses estimated from the MC dosimetry approach for this CT
scanner should be treated with great caution.
While it was not possible to investigate more about the contradictory results
on the GE 8800 scanner, it can be concluded that systematic differences occur when
organ and effective doses are determined with the developed direct dosimetry method
compared with that of the MC dosimetry method. The degree of the differences
yielded in our study are in good agreement with other reports (Shrimpton et al.
1991b, Geleijns et al. 1994). These systematic differences can however be explained.
They are mainly due to differences between the two different phantoms used to
simulate an average human body in the direct and MC dosimetry approaches. The
physical phantom used in the developed direct approach (Rando Alderson) is different
from the mathematical phantom used in the MC approach. The overall shape and size
of the Rando phantom is different from the mathematical phantom. In addition, the
location, shape, and size of the organs of interest in both phantoms are different. The
location and shape of the organs in the mathematical phantom, as used by the NRPB
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(Shrimpton et al. 1991b), have been simplified and designed based on simple
geometrical shapes (Figure 6.7). But, as explained in detail in chapter four and
appendix A, the location and shape of the organs in the Rando phantom were
determined more realistically for the developed direct dosimetry method (Figure 4.5).
For example in the mathematical phantom there is a sharp boundary between thoracic
organs such as lungs and abdominal organs such as liver, stomach and intestines.
However these organs are normally extended over both of these areas of the body. As
another example, the head and neck size of the computational mathematical phantom
is much smaller than that of the physical Rando phantom.
8.2 Variation of Effective Doses among the CT Scanners and the Normalised
Effective Dose
As mentioned in detail in chapter six, several factors affect the patient doses
resulting from CT practices. These factors must be noted if a comparison is going to
be made between different scanner models for a particular CT examination. It was
noted that some of these factors like x-ray inherent filtration, collimation, detector
efficiency, scan field diameter (source to isocentre distance), and so on could not be
controlled. These factors are normally either fixed or pre-set by the manufacturers for
every CT model. It was also noted that there is another category of factors affecting
the patient doses such as the kV, the mAs, the slice width, the couch increment or the
pitch, and the scan length which are controlled by the operator. But, as was noted for
most of these parameters, too, there are either a limited number of options or different
pre-set values recommended by the manufacturers for every particular examination.
These parameters affect image quality and users generally accept protocols
recommended by manufacturers even if the patient dose may be greater than what is
necessary for an adequate image quality.
Therefore due to the constraints imposed by the lack of control over most of
the parameters affecting the patient doses, and in an attempt to compare the CT
scanners in a more similar condition of scanning techniques, the normalised effective
dose value was introduced in chapter six. In this regard the measured effective dose
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values were normalised to 100 mAs, 10 mm scan volume, the packing factor of one,
and the CTDI for all CT examinations and were presented in chapter six.
It is recognised that in practice some of the older scanner models, examined in
this study, do not allow the users to change their exposure setting for a particular CT
examination. In addition, it is recognised that even if a unique mAs setting is virtually
employed by all the CT scanners, the quality of the image produced by different
scanner models will not necessarily be the same. In this respect it is also recognised
that employing a higher mAs setting does not guarantee a better image quality for
different scanner models. For instance we witnessed that even though some of the CT
scanners in this study employ a higher mAs setting than other ones for similar
examinations, they produce a poorer image quality. It is also known that in
normalising effective dose values to 10 mm scan volume, the total scan length for
every particular CT examination should be exactly the same. That was not always
achievable for some of special examinations. On the other hand, while the above
arguments are fully acknowledged, it would be very crude to compare patient doses
resulting from different scanners without regard to this important category of factors
(mAs, slice width and spacing, scan volume, and packing factor) that significantly
affect the resultant patient doses from CT practices.
When the measured data was summarised in chapter six, comparison of the
normalised effective dose values to mAs, scan volume, and CTDI among different CT
scanner revealed that there was not a very significant variation for this value among
different CT scanners for similar scanning protocols. Therefore in this section we will
present the average values of the normalised effective dose values for each of the
three distinct areas of the body, i.e. the head, chest and abdomen & pelvis areas.
These values could provide a reliable tool for rapid estimations of effective dose
values for any specific CT examination performed on the same body region.
Table 8.9 shows the average effective dose values normalised to lOOmAs, 10
mm scan volume, and CTDI for three areas of the "head", "chest" and "abdomen &
pelvis" of the body. These values have been provided by averaging the normalised
effective dose values derived from the measured effective dose values from the
examinations carried out over these areas of body by all the CT scanners excluding
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the GE 8800 scanner. Because there were some uncertainties in the measured CTDI
values for the GE 8800 scanner, as explained earlier in this chapter, this scanner was
excluded from this procedure. For the head area both the routine "head" and
"posterior fossa" examinations have been included. For the chest area both the
conventional and spiral examinations were included. Similar to the "chest" for the
"abdomen & pelvis" area both the spiral and conventional "abdomen & pelvis"
examinations were included.
Table 8.9: Averaged normalise effective dose values to lOOmAs, 10 mm scan volume,
and CTDI over the measured effective dose values from all the CT scanners for three
Body area Head Chest Chest Abdomen & pelvis
(120 kV) (120kV) (137 kV) (120 kV)
No of data sets 11 5 3 10
Mean 0.193 0.652 0.969 0.688
Standard 0.020 0.090 0.046 0.082
deviation
Maximum 0.226 0.801 1.027 0.797
Minimum 0.157 0.548 0.916 0.499
Therefore the above average values could be used to estimate patient doses in
terms of effective doses from CT examinations carried out by any scanner operating at
the above tube potentials. If these values are multiplied by the applied mAs (to 100
mAs), scan volume (to 10 mm), and packing factor for the examination, and the value
of CTDI in air for the scanner a good estimation of the patient dose in terms of the
effective dose could be made for any CT examination carried out.
We believe that these normalised effective dose values could provide a very
good approach to estimate patient dose for most of the scanning techniques used in
CT practices. It is also very likely that if more dose measurements are carried out, the
level of errors involved in the normalised effective dose values will be decreased.
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8.3 Comparison of Patient Doses Resulting from Conventional and Spiral
Examinations
Two CT scanners in this study, Siemens Somatom Plus and GE HiSpeed
Advantage, were capable of performing both the conventional and spiral scanning
techniques. Comparison of patient doses estimated for most of the conventional
examinations with that of the spiral examinations indicated that, there was not a
significant difference between these scanning techniques if similar condition of
exposure and slice width and couch increment (or pitch for spiral examinations) are
selected. In this regard the reader is referred to chapter six for the details of the
results. There is, therefore, a potential for decreasing patient doses with the spiral
examinations by increasing the pitch setting without losing so much imaging
information that will inevitably happen if an equivalent conventional scanning
technique is performed.
8.4 Comparison of Effective Dose and Effective Dose Equivalent Values
As noted in chapter two, effective dose equivalent and effective dose are both
the sum of the doubly weighted absorbed dose in all the tissues and organs of the
body recommended in 1977 and 1990 respectively by the ICRP (ICRP 1977, ICRP
1991). The double weighting factors are the radiation and the tissue weighting factors.
The value of radiation weighting factor has been selected to be representative of the
relative biological effectiveness of the radiation in inducing stochastic effects at low
doses. A value of unity for this factor has been chosen for all radiations of low linear
energy transfer (LET) including X-rays of all energies in both the 1977 and 1990
ICRP recommendations. The tissue weighting factor represents the relative
contribution of the organ/tissue to the total detriment resulting from uniform
irradiation of the whole body. E superseded He in 1990 ICRP recommendations. The
introduction of the name effective dose was associated with the change to equivalent
dose. However, the ICRP emphasised that this change was not connected with
changes in the number or magnitude of the tissue weighting factors. In the 1990
recommendations the ICRP took into account new biological information and trends
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for all organs and tissues and recommended different values of tissue weighting
factors compared with that recommended in 1977 for effective dose equivalent. The
only difference between HE and E is differences in tissue weighting factors. E has
weighting factors for a larger number of specified organs and tissues and is likely to
be a better indicator of the radiation risk than HE (Table 2-2).
We measured and presented HE along with E values throughout this study
because E was not widely used. Furthermore this was done to provide an opportunity
for comparing our results with previous reports on patient doses from CT and other
X-ray practices reporting patient doses in terms of HE. It is useful therefore to
consider the differences that would arise from the differences between the tissue
weighting factors of E and HE for the two dosimetry methods used in this study.
The ratios between HE and E for the most common routine examinations for
both the direct and the MC dosimetry methods are summarised in Table 8.10.
able 8,10: Ratios of HEto E for the most common CT examinations.
CT Dosimetry No. of Mean Standard Maximum Minimum
examination method data sets deviation
Head and direct 13 2.40 0.04 2.44 2.29
posterior fossa MC 5 1.90 0.23 2.03 1.50
Chest direct 8 1.50 0.03 1.53 1.44
MC 2 1.03 0.04 1.06 1.00
Abdomen direct 10 1.15 0.04 1.26 1.12
& pelvis MC 2 1.04 0.06 1.08 1.00
As could be seen in the table, measured HE values (with the direct method)
were greater than the E values by a factor of 2.40, 1.50, and 1.15 for the "head" &
"posterior fossa", "chest" and "abdomen & pelvis" examinations respectively. The
bigger discrepancy in the head is principally through the treatment of remainder
organs. The brain is the main contributor to HE and E in the "head" examinations (see
section 8.3). In ICRP 26, as a remainder organ, the dose equivalent for this organ is
weighted by a factor of 0.06. However, since the dose to the brain is greater than
other main organs, ICRP 60 requires that it is weighted by a factor of 0.025.
On the other hand, there was no significant difference between calculated E
and He values, (from the MC method) except for the head examination for which the E
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and He ratio was 1.90. This indicated a disagreement between the two dosimetry
methods. Therefore, the output data resulting from the computer program, CTDOSE
(Le Heron 1993) used to calculate organ dose, effective dose, and effective dose
equivalent values from the NRPB normalised data files (Jones and Shrimpton 1993)
were thoroughly examined. An inconsistency was found in the CTDOSE program
with the 1977 ICRP recommendations (ICRP 1977) regarding the remainder organs.
Based on the 1977 ICRP recommendations five organs or tissues receiving the
highest dose equivalents should be regarded as the remainder organs. Nevertheless, it
was noted that for some examinations calculated dose values for some other organs
were higher than those taken as remainder organs by the CTDOSE program.
For the chest examination instead of thymus, oesophagus, and adrenals, other
organs (spleen, stomach, and gall bladder) receiving lower doses were taken as the
remainder organs by the CTDOSE. If doses are recalculated on this basis the HE to E
ratio will be 1.46, in good agreement with the direct method. For "abdomen & pelvis"
there is an agreement in the tissues to be used as remainder by the CTDOSE.
Therefore the ratios for the two dosimetry methods are in reasonable agreement. For
examinations of the head area (including "head" and "posterior fossa") part of the
reason for the greater ratios for the direct method is that skin was included as a
remainder tissue. This was not done by the CTDOSE. Including the skin as a
remainder organ would change the HE to E ratio to 2.15 in a better agreement with
the direct method. Overall this meant that thymus, oesophagus, adrenals and skin have
not been regarded as remainder organs for HE calculation by the CTDOSE program.
It must also be noted here that, in the absence of an oesophagus from the NRPB
mathematical phantom, the dose to this organ had been assumed to be the same as
the dose to the thymus (Shrimpton et al. 1991b).
NRPB reported ratios of E to HE (Shrimpton et al. 1991b). Taking the
average of "head" and "posterior fossa" and of "abdomen" and "pelvis" examinations
indicates that the HE to E ratios for "head" & "posterior fossa", "chest", and
"abdomen & pelvis" examinations were 1.82, 1.10, and 1.27 respectively. However, it
must be noted that the remainder doses for E have been calculated in a different way
by the NRPB. They have been done by splitting the relevant remainder tissues
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weighting factors (0.05) equally between mean body dose (as averaged over the entire
mathematical phantom including head and legs) and one other organ receiving the
highest dose among the nine others that comprise the remainder tissues. The NRPB
concluded that the approximations inherent in this approach were likely to have a
minor effect on the estimation of effective dose (Shrimpton et al. 1991b). However
the corrected ratios found between He and E for the MC method contradict the
NRPB conclusion in this regard.
8.5 Comparison of Measured Patient Doses with the NRPB Typical Doses
As mentioned earlier several factors affect the patient doses even if a
comparison of patient doses in terms of organ and effective doses based on the ICRP
recommendations (1991) is going to be made between two identical scanners for a
similar examination protocol. Unfortunately a wide range of examination protocols
are practised at different places for the same examination even when identical CT
scanners are used and there is not an internationally accepted standard for CT
practices.
Furthermore as raised in this study different dosimetry approaches are
followed for the estimation of patient doses. In addition these different dosimetry
approaches have not yet been established and standardised.
For example, two national bodies in the UK (Jones and Shrimpton 1991) and
in Germany (Zankl et al. 1991) have used the MC based CT dosimetry approach and
provided normalised organ doses for a wide range of CT scanners. But these two
widely used MC based CT dosimetry approaches have used different models of
computational phantoms to simulate the human body. Therefore if they are
implemented for estimation of patient doses for the same condition of exposure and
scanning protocol for a particular CT scanner, they will consequently lead to different
results (Geleijns et al. 1994).
There is the same story with the direct CT dosimetry approach using physical
humanoid phantoms. Different physical phantoms have been used for the direct
dosimetry method. In addition, even if the same physical phantom is used, different
techniques are followed for determining the location of organs of interest. On the
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other hand not all the published reports in the literature on the patient doses resulting
from the CT practices have reported details of examination protocols or dosimetry
techniques.
Therefore it is not very sensible to compare our results with others reporting
patient doses for either different scanner models, or different scanning techniques, or
with different dosimetry techniques. The NRPB carried out a national survey of CT
practice in the UK in 1989. The results of this survey were published separately in
three comprehensive parts including: aspects of examination frequency and quality
assurance (Shrimpton et al. 1991a), dosimetric aspects (Shrimpton et al. 1991b) , and
finally normalised organ doses (Jones and Shrimpton 1991). Later on an additional
software report was provided by the NRPB including tables of dose conversion
factors for 23 different models of CT scanners normalised to the CTDI measured free
in the air (Jones and Shrimpton 1993). The latter report has been used extensively by
several other individuals and national bodies (Crawley and Rogers 1994, Calzado et
al. 1995, Geleijns et al. 1995, Naik et al. 1996, Adams et al. 1997, Van Unnik et al.
1997, Wall and Hart 1997) for estimation of patient doses from the same or similar
type of CT scanners.
The typical doses for CT examinations have been extracted and presented in
Table 8.11 from a revision (Wall and Hart 1997) on a recent review of doses to
patients from medical X-ray examinations in the UK by the NRPB (Hart et al. 1996b).
These doses are based on the mean values of the distributions seen in the national
survey of CT practice in the UK (Shrimpton et al. 1991a, Shrimpton et al. 1991b,
Jones and Shrimpton 1991). These typical doses are often taken as guideline CT
doses by researchers in the UK and other countries. Therefore, we compare the
patient doses resulting from the developed direct dosimetry method with these typical
doses for CT examinations. The comparison will be made for the most common CT
examinations performed by all the CT scanners to evaluate the performance of these
scanners against these typical CT doses resulting from the NRPB national survey of
CT practice.
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Table 8.11: Typical effective doses to standard adult patients in the 1990s (From Wall
and Hart 1997),








The results for routine head examinations were lower than the typical value
reported by the NRPB. The exception was the GE Sytec 3000 scanner for which the
effective dose was 2.6 which is still within the reported range of values.
All the estimated effective doses for the routine "posterior fossa" examinations
carried out by four different models of the CT scanners were also less than the typical
CT "head" dose.
For "chest" scans, three out of five scanners gave doses which were below the
NRPB value (8 mSv). Higher doses were noted for the Philips Tomoscan CX/S (9.8
mSv) and the GE Sytec 3000 Plus (13.5 mSv), the latter value is at the upper end of
the range
The NRPB reported doses for "abdomen" and "pelvis" examinations
separately whereas the clinical protocols studied here combined these two regions.
The measured effective doses were all less than the summed typical doses for
abdomen and pelvis apart from the GE Sytec 3000 Plus. For this scanner the dose was
32.8 mSv.
Another point that must be regarded in the above comparisons is that the
doses presented in the above table are based on the MC dosimetry approach employed
by the NRPB in the survey, while our results are based on the direct dosimetry
method. As mentioned earlier in this chapter, our study and other researchers indicate
that the patient doses estimated with the direct CT dosimetry approach could be up to
60% higher than that estimate by the MC approach. Therefore it could be concluded
that the patient doses resulting from almost all typical CT examinations from all the
CT scanners fall either below or around the NRPB reported doses.
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8.6 Summary
In this chapter, it has been shown that the direct dosimetry method
overestimates effective dose by between 15% and 47% when compared with the MC
method. Normalisation of effective dose to mAs, scan volume and CTDI has
produced dose factors for each region of the body which can be used to estimate
effective dose for any scan protocol provided that the in air CTDI is known.
The comparison of dose measurements for conventional and spiral scanning is
given which shows the expected change of the dose with pitch.
A comparison is given of the quantities effective dose equivalent and effective
dose. The biggest differences occur for scans in the head and neck in which HE is
more than double of E due to the weight accorded to remainder tissues.
The doses measured in this study are compared with those from the UK
national survey of CT practice (Wall and Hart 1997). Other than for one of the
scanners tested, the doses were in the same range as for the national survey.
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9. Discussion and Conclusion
9.1 Discussion
This thesis described the underlying principles and assumptions of the direct
CT dosimetry method developed and implemented in this study. The developed direct
dosimetry method is a simple and practical method enabling the assessment of patient
doses resulting from any examination using any CT scanner model independently. All
dosimetry related concepts for the developed dosimetry technique were considered.
Comprehensive dose measurements carried out enabled us to estimate and report the
level of error involved in the approach. In addition, the review of CT dosimetry
methods provided a comprehensive and critical analysis of the methods developed to
date. Furthermore the MC dosimetry approach employed for some of the CT scanners
enabled us to compare the patient doses estimated with the developed dosimetry
method with that of the MC method.
Both the MC and the direct dosimetry approaches used commonly for the
assessment of patient doses from CT examinations have inevitable constraints.
If the common direct CT dosimetry approach is selected, there are 23 organs
and tissues of interest distributed all over the 35 sections of the Rando physical
phantom for which the absorbed dose must be determined. Therefore, to estimate
effective dose value for every particular CT examination more than 200 TLD
measurements are required. Obviously this is a laborious, time consuming, and
impractical way for the routine assessment of patient doses from the fast growing
varieties of scanning techniques.
The constraint with the MC dosimetry approach is that the available
conversion factors do not include all available CT scanners, in particular the newer
models. This becomes important when the older CT scanners are either taken out of
service or replaced with the newer models for which the conversion factors are not
available.
As mentioned in chapter three, the UK Medical Device Agency has set up a
dedicated CT evaluation facility called the ImPACT. This facility has recently (1997)
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decided to carry out a survey to determine the radiation dose characteristics of CT
scanners in current clinical use. This is going to be done by matching newer scanners
to scanners which are represented in the NRPB Monte Carlo data sets, in order that
these data sets might be used for the calculation of patient doses for these scanners.
In another attempt by the National Radiation Laboratory of New Zealand, a
method has been used for measurement of patient dose applicable to all types of CT
scanners in this country, not just those included in the NRPB data sets (Poletti 1996).
They have done this by determining a set of factors to determine the effective dose
from the CTDI measured at 1 cm depth in standard Perspex head and body phantoms,
and the effective length of the scan. These factors have been determined from
comparison of the phantom CTDI measurements with the effective dose determined
for those scanners included in the NRPB data sets.
Apart from the uncertainties involved in these efforts, these surveys will enable
us to find a solution for current newer CT scanners and the problem will exist for
future models that are going to be introduced into clinical practice. Therefore this
dosimetry approach will not easily be applicable for the future models that will come
into clinical practice afterwards.
An attempt has also been made to make the representation of the human body
and its organs in computational phantoms more accurate and realistic by Caon et al.
(1997). They have introduced voxel-based computational models of human anatomy.
They have said that their models represent internal human anatomy more faithfully
than mathematical phantoms such as those of Cristy (1982) that have been used with
some modifications in the MC CT dosimetry approaches. In these computational
models anatomy is represented as voxels being constructed from CT data. They have
claimed that using the MC calculation to determine dose to voxel based phantoms has
given acceptably accurate results when compared to the actual measured values, as
long as the X-ray spectrum is calculated for the scanner and the details of the beam
shaping filter are known. This method may improve the accuracy of currently
available organ doses derived from the unrealistic anatomy of mathematical phantoms
and reduces significant differences observed in this and other studies between the
direct and the MC dosimetry methods.
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To overcome the above constraints in CT dosimetry the direct dosimetry
method was developed by assessing the CT axial and longitudinal dose distributions in
an anthropomorphic physical phantom. Measurement of these dose distributions for
any scanner enables us to quickly measure organ doses and effective dose, and hence
patient doses for any examination protocol with a limited number of TLDs (10-32
apart from the TLDs used for the calibration process).
The reduction of the extensive measurements required by the common direct
dosimetry method was achieved mainly by the assumptions made for these dose
distributions. Further measurements carried out for the validation of the accuracy of
these assumptions revealed the degree of errors caused by them. However the overall
degree of the uncertainties in the developed dosimetry method was not more than the
degree reported for the NRPB MC method. The dosimeters chosen for the dose
measurements (LiF TLDs) showed a good degree of consistency and a low degree of
uncertainty. A systematic error due to the poor contact between the TLD tray and
the heater compartment of the TLD reader was detected and avoided in this study by
using a pair of TLDs for point dose measurements. If this technical problem is sorted
out the number of TLDs required for the patient dose estimates with this dosimetry
method will be halved.
The customised computer spreadsheet developed in this study also provided a
very simple and user friendly tool for further simplification of the developed CT
dosimetry method. The spreadsheet does all the required calculations and reports the
patient doses by executing the macro programs.
The average normalised effective dose values to 100 mAs, 10 mm scan
volume, and CTDI were presented for three areas of the "head", "chest", and
"abdomen & pelvis" of the body in chapter seven. These values could be used to
estimate approximate patient doses for most of the CT examinations carried out in CT
practice with the 120 kV tube potential. This only requires the CT examination
parameter and the scanner CTDI value. If the normalised effective dose values are
multiplied by the CT applied mAs (to 100 mAs), scan volume (to 10 mm), packing
factor, and the CTDI value in air, a good estimation of the effective dose could be
made for the examination.
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The MC dosimetry approach was also implemented in this study for some of
the older scanners for which the conversion factors were available (Jones and
Shrimpton 1993). The results of our proposed direct method were compared with this
commonly used dosimetry method for the most routine examinations performed by
these scanners. The differences observed between the patient doses resulting form the
developed direct dosimetry approach and the MC approach were in a good agreement
with other reports. The free in air CTDI measurements were carried out for all the CT
scanners for all possible combinations of the kVs and slice widths. CTDI values were
estimated using all the common measuring techniques using both of the dosimetry
devices (the TLDs and the pencil IC) used for this purpose. The comprehensive
measurements of the CTDI values provided a good tool to identify the best measuring
technique. This also enabled us to investigate the variation of the CTDI by slice width,
kV, and the scanner model and compare them with values reported by the NRPB from
the national survey of CT practice in the UK (Shrimpton et al 1991a, 1991b; Jones
and Shrimpton 1991).
9.2 Conclusion
The main purpose of the work presented in this thesis was to contribute to the
improvement of the CT dosimetry methods by reviewing the available methods and
proposing a practical and simple method with an acceptable degree of accuracy and
consistency.
The main outcomes of this study were:
1. A detailed review of the importance of CT dosimetry, basic dosimetric
quantities required to be considered, and the CT scanner developments and
characteristics.
2. A detailed and critical review of the common approaches used in CT
dosimetry.
3. Development of a practical direct CT dosimetry method by identifying and
overcoming most of the constraints and limitations imposed by the common
direct and the MC CT dosimetry methods.
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4. Implementation of the developed CT dosimetry method and validating the
assumptions made for it.
5. Implementation of the MC dosimetry method.
6. Assessment and analysis of patient doses using the developed dosimetry
method for all the routine CT practices performed by all the CT scanners in
the NHS hospitals in Lothian and Fife areas of Scotland.
7. Assessment of patient doses using the MC dosimetry method for all the
routine CT practices performed by some of the CT scanners in the NHS
hospitals in Lothian and Fife areas of Scotland.
8. Comparison of patient doses resulting from the developed dosimetry
method with that of the MC method and identifying and explaining their
differences.
9. Introduction of a quick method for the estimation of patient doses for
similar scanning protocols with a good degree of approximation
(normalised effective dose).
The direct dosimetry method developed and proposed in this study provides
an easy, practical, and independent way for estimation of patient doses resulting from
CT practices. This dosimetry method has now been used for several scanner models.
The developed dosimetry method has been successfully implemented to assess the
radiation doses resulting from various examination protocols using the recent modern
CT modalities, that could not easily be investigated by other dosimetry approaches.
For the implementation of this approach for any scanning technique performed by the
CT models included in this study, not more than 30 TLD measurements are required
at 15 central locations of the Rando phantom. To be able to implement this dosimetry
approach for any other CT model a considerable number of TLD measurements are
required to determine the dose distributions in three representative sections of the
Rando physical phantom. But, afterward further patient dose assessment for any
particular scanning technique will not require more than the number of TLD
measurements mentioned above.
We believe that the developed direct CT dosimetry approach overcomes many
limitations imposed by other common approaches. It also provides a reliable and
218
practical method for the assessment of patient doses from CT practices for a wide
range of scan protocols. Estimation of measurement errors in the developed dosimetry
method showed an error in methodology leading to an underestimate of dose by about
8% for chest scan and overestimate by 14% for abdomen & pelvis. This is in addition
to a random error of about 2% due to the TLD. This may be compared with the
overall uncertainties reported (Calzado et al. 1995) for the common MC and direct
dosimetry approaches (18-23% and 10-20% respectively). In addition this level can be
decreased if further work is carried out as outlined in the following section. The major
advantage of the developed direct dosimetry method is that, it could easily and
independently be adapted and implemented for any upcoming new model of CT
scanner to be introduced into clinical practice.
9.3 Future Work
We assumed that the dose distribution in parallel sections of the phantom
inside the CT scanned volume are identical. We also assumed that the dose
distribution in the phantom sections outside the CT scanned volume is uniform. A
limited number of measurements was carried out on one of the CT scanners (Siemens
Somatom Plus). This enabled us to validate the accuracy of these assumptions and to
reveal the level of errors caused by these assumptions in the developed dosimetry
method. It may also be needed to do further investigation for the validation of these
assumptions on other CT scanner models used in this study.
Other assumptions made for our developed direct CT dosimetry method
including the degree of rotation and the use of packing factors to determine doses
from contiguous scanning techniques are exactly the same as those made for the MC
approach by the NRPB.
More improvements in the developed direct CT dosimetry method could be
achieved by choosing extra representative sections in the physical phantom to
decrease the degree of error caused by the significant inhomogeneity existed
especially in the overlap regions between the "chest" and the "abdomen" areas of the
phantom.
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The developed dosimetry method was implemented for six models of the CT
scanners. The implementation of this dosimetry method for other scanners requires a
relatively extensive initial measurements to determine the axial and longitudinal dose
distributions. Consequently the spreadsheet computer program must also be adapted
and the required changes are carried out in the stored data to use it for other scanners.
However when this initial work is carried out, the estimation of patient doses for any
examination protocol can be done with a very limited number of TLD measurements.
The averaged normalised effective dose values presented in chapter seven
were calculated when we reached the end of this study by analysing and comparing
the patient doses resulted from both of the dosimetry methods implemented. These
values could provide a very good approach to estimate patient doses for most of the
common scanning techniques in CT practices. It is very likely that, if further dose
measurements were carried out on other scanners and the values were normalised to
CTDI in a Perspex phantom (instead of free in air), the level of errors observed in the
normalised effective dose values in this study would be decreased.
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Rando Phantom Design
(Location of Organs and Tissues of Interest)
In this appendix the location of organs and tissues of interest are shown for
every slice (section) of the phantom. The design of the Rando phantom for
determining the location of organs and tissues of the interest has been carried out
based on the principles mentioned earlier in chapter four.
There is now a world wide agreement over the orientation of sections and
cross sectional images. Following an extensive effort over the last few years, the axial
cross-sectional images of the body are now viewed in a standard conventional manner
that has been adopted almost in all recent anatomy books and atlases of body sections
and CT images. All cross-sectional images in routine clinical practice are now viewed
from "below" and "looking up" (Figure A. 1).
Figure A. 1: View from below looking up.
This is the logical method in which a doctor approaches for the examination of
a supine patient that is from the right hand, foot end of the coach. The image is thus in
the correct orientation for doctor's palpating right hand. Based on this standard all
axial sections should be displayed with an orientation logo shown in Figure A.2. Here







Figure A.2: The standard orientation used for displaying (viewing) CT cross sectional
images.
Therefore to keep our diagrams consistent with this standard, this approach
has been employed for each diagram in this appendix showing the position of organs
or tissues of interest in a single slice (2.5 cm thick cross-sectional portion) of the
Rando phantom.
Notes on the diagrams
It has been tried to keep a consistent approach for demarcation of organs on
every slice of the phantom. The diagrams are presented in sequence for transverse
slices of the Rando physical phantom showing the corresponding location of organs
and tissues of interest. Every diagram represents one slice of the Rando phantom
starting from the slice number one at the top of the head and finishing at the slice
number thirty four at the base of the trunk of the phantom. Based on the atlas of body
sections and CT images (Ellis et al. 1991) used as a reference for determining the
location of organs and tissues of interest in the phantom, It was assumed that there is
no organ or tissue of interest to be demarcated in slice number of zero, eight, and
thirty five. Therefore no diagram has been presented for these three slices. The shape
and location of organs and tissues of interest were demarcated by taking the relevant
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vertebra of the phantom skeleton as the reference point and then defining the position
of organs and tissues from the relevant sections to the vertebra from the atlas of body
sections and CT images (Ellis et al. 1991). Table A.l shows the corresponding
vertebra (thoracic, lumbar or cervical) taken as the reference point for each slice of
the phantom. Table A.2 shows the list of organs and tissues of interest in each slice of
the phantom excluding bone, red bone marrow and skin found in all slices.
Table A. 1: The position of the corresponding vertebra in the Rando Phantom.
Phantom slice no. Vertebra* no.
5 Q
6 C„ C, 2
7 C2, C3, C3-4
8 C3-4, C5
9 C5, Cfi, C7
10 C7, TI_2
11 T, 2, T3
12 T3, T4.5
13 T4-5, Ts_6















29 L4-5, Ls, Si
30 Ls, Si, S2
31 S2(male)> S3(female)
32 S3(male)? S4(male)j S5(ma]e)
33 S^finale), E-OCCyXfmale ami female)
* C: Cervical Vertebra, T: Thoracic Vertebra, L: Lumbar Vertebra, S: Sacrum Segments.
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Table A.2: The list of organs and tissues of interest in every slice of the Rando
phantom.










10 Thyroid, Oesophagus, Lung
11 Thyroid, Oesophagus, Lung
12 Thymus, Oesophagus, Lung
13 Thymus, Oesophagus, Lung
14 Oesophagus, Lung, Breasts
15 Oesophagus, Lung, Breasts
16 Oesophagus, Lung, Breasts
17 Oesophagus, Lung, Breasts
18 Oesophagus, Lung, Liver, Breasts
19 Lung, Liver, Spleen, Stomach, Breasts
20 Liver, Spleen, Stomach, Adrenal
21 Liver, Spleen, Stomach, Adrenal, Kidney, Pancreas, SI*, ULI*
22 Liver, Spleen, Stomach, Kidney, Pancreas, SI, ULI, LLI*
23 Liver, Kidney, Pancreas, SI, ULI, LLI
24 Liver, Kidney, Pancreas, SI, ULI, LLI
25 Liver, Kidney, SI, ULI, LLI
26 SI, ULI, LLI
27 SI, ULI, LLI
28 SI, ULI, LLI
29 SI, ULI, LLI
30 SI, ULI, LLI, Uterus
31 SI, ULI, LLI, Uterus, Ovaries
32 SI, ULI, LLI, Uterus, Bladder
33 LLI, Bladder, Prostate34 LLI, Bladder, Testis
* SI: small intestine; ULI: upper large intestine; LLI: lower large intestine
In each diagram two perpendicular axes represent the anterior-posterior and
right-left orientations of the slice based on the standard manner of displaying CT
images. In each diagram the outer lines shows the layout of the relevant slice of the
phantom. The position of two pegs (plastic rods) which hold parallel slices of the























































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix C. Macro programs
This appendix includes some of the macro computer programs used for sorting
the organ absorbed doses and calculating the effective dose equivalent and effective
dose values. These macros have been created in the spreadsheets designed with the
Microsoft Excel ™ program and are in visual basic computer language.
I
' EDE Macro Macro
' Effective Dose Equivalent Macro
' Sorting data to calculate the effective dose equivalent based on ICRP













Selection.PasteSpecial Paste:=xlValues, Operation:=xlNone, _
SkipBlanks:=False, Transpose:=False
Application. CutCopyMode = False
Selection. Sort Keyl:=Range("D8"), Orderl:=xlDescending, Header:=_












' Effective Dose Macro











Selection.PasteSpecial Paste:=xlValues, Operation:=xlNone, _
SkipBlanks:=False, Transpose:=False
Application. CutCopyMode = False
Selection.Sort Keyl:=Range("D8"), Orderl:=xlDescending, Header:= _











Selection.PasteSpecial Paste:=xlValues, Operation:=xlNone, _
SkipBlanks:=False, Transpose:=False
Application. CutCopyMode = False
Selection.Sort Keyl:=Range("H8"), Orderl:=xlDescending, Header:=_
xlGuess, OrderCustom:=l, MatchCase:=False, Orientation" _
xlTopToBottom
ActiveWindow. SmallScroll ToRight:=-1
ActiveWindow. SmallScroll Down:=-2
Range("Al"). Select
Application.MaxChange = 0.001
ActiveWorkbook.PrecisionAsDisplayed = False
Calculate
End Sub
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